+

US20020010204A1 - 2- and 2,5-substituted phenylketoenols - Google Patents

2- and 2,5-substituted phenylketoenols Download PDF

Info

Publication number
US20020010204A1
US20020010204A1 US09/809,619 US80961901A US2002010204A1 US 20020010204 A1 US20020010204 A1 US 20020010204A1 US 80961901 A US80961901 A US 80961901A US 2002010204 A1 US2002010204 A1 US 2002010204A1
Authority
US
United States
Prior art keywords
alkyl
substituted
alkoxy
optionally
chlorine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/809,619
Other versions
US6359151B2 (en
Inventor
Folker Lieb
Reiner Fischer
Thomas Bretschneider
Michael Ruther
Alan Graff
Udo Schneider
Christoph Erdelen
Ulrike Wachendorff-Neuman
Wolfram Andersch
Andreas Turberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19716591A external-priority patent/DE19716591A1/en
Application filed by Individual filed Critical Individual
Priority to US09/809,619 priority Critical patent/US6359151B2/en
Priority to US10/006,115 priority patent/US6504036B1/en
Publication of US20020010204A1 publication Critical patent/US20020010204A1/en
Application granted granted Critical
Publication of US6359151B2 publication Critical patent/US6359151B2/en
Priority to US10/264,424 priority patent/US6596873B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/51—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/52—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/29—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups and acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/34—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings containing more than one carboxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/88—Unsaturated compounds containing keto groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/757—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/04—Seven-membered rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Definitions

  • the invention relates to novel phenyl-substituted cyclic ketoenols, to a plurality of processes and intermediates for their preparation and to their use as pesticides.
  • 3-aryl- ⁇ 3 -dihydrofuranone derivatives having herbicidal, acaricidal and insecticidal properties are disclosed in EP-A-528 156, EP-A 0 647 637, WO 95/26345, WO 96/20 196, WO 96/25 395, WO 96/35 664, WO 97/01 535 and WO 97/02 243.
  • Phenyl-pyrone derivatives substituted in the phenyl ring and having herbicidal, acaricidal and insecticidal properties are described in EP-A-588 137, WO 96/25 395, WO 96/35 664, WO 97/01 535 and WO 97/02 243.
  • X represents halogen, alkyl, alkenyl, alkynyl, alkoxy, benzyloxy, halogenoalkyl, halogenoalkoxy, cyano or nitro,
  • Z represents hydrogen, amino, halogen, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally substituted phenoxy, phenylthio, 5- or 6-membered hetaryloxy, 5- or 6-membered hetarylthio, phenylalkyloxy or phenylalkylthio and
  • A represents a respectively optionally substituted radical from the group consisting of alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl and alkylthioalkyl, represents respectively saturated or unsaturated and optionally substituted cycloalkyl or heterocyclyl or represents respectively optionally halogen-, alkyl-, halogenoalkyl-, alkoxy-, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl,
  • B represents alkyl or alkoxyalkyl
  • a and B together with the carbon atom that they are attached to represent a saturated or unsaturated, optionally substituted carbocycle or heterocycle,
  • D represents hydrogen or represents an optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl, saturated or unsaturated heterocyclyl, arylalkyl, aryl, hetarylalkyl or hetaryl or
  • a and D together with the atoms that they are attached to represent a respectively optionally substituted carbocycle or heterocycle
  • G represents hydrogen (a) or represents one of the groups
  • E represents a metal ion equivalent or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur
  • R 1 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl or polyalkoxyalkyl or represents respectively optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl or heterocyclyl or represents respectively optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetarytoxyalkyl,
  • R 2 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl or polyalkoxyalkyl or represents respectively optionally substituted cycloalkyl, phenyl or benzyl,
  • R 3 , R 4 and R 5 independently of one another each represent respectively optionally halogen-substituted alkyl, alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio or cycloalkylthio or represent respectively optionally substituted phenyl, benzyl, phenoxy or phenylthio,
  • R 6 and R 7 independently of one another each represent hydrogen, represent respectively optionally halogen-substituted alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl, represent respectively optionally substituted phenyl or benzyl, or form together with the nitrogen atom that they are attached to an optionally oxygen- or sulphur-containing, optionally substituted cycle.
  • the compounds of the formula (I) can also be present, depending on the nature of the substituents, as geometric and/or optical isomers and isomer mixtures of differing composition which, if appropriate, can be separated in a customary manner. Both the pure isomers and the isomer mixtures, their preparation and use, and compositions comprising them are part of the subject matter of the present invention. In the following, for simplicity, however, compounds of the formula (I) are always referred to, although both pure compounds and, if appropriate, mixtures having different proportions of isomer compounds are intended.
  • A, B, D, G, X and Z are each as defined above.
  • A, B, E, L, M, X, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, E, L, M, X, Z, R, R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, E, L, M, X, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • the compounds of the formulae (I-4) a and (I-4) b can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-4) a and (I-4) b can, if desired, be separated by physical methods in a manner known per se, for example by chromatographic methods.
  • A, D, E, L, M, X, Z, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and R 7 are each as defined above.
  • A, B, X and Z are each as defined above, are obtained by the intramolecular condensation of compounds of the formula (II)
  • A, B, X and Z are each as defined above,
  • R 8 represents alkyl (preferably C 1 -C 6 -alkyl),
  • A, B, X and Z are each as defined above, are obtained by the intramolecular condensation of compounds of the formula (III)
  • A, B, X, Z and R 8 are each as defined above, in the presence of a diluent and in the presence of a base.
  • A, B, X and Z are each as defined above, are obtained by the intramolecular cyclization of compounds of the formula (IV)
  • A, B, X, Z and R 8 are each as defined above and
  • W represents hydrogen, halogen, alkyl (preferably C 1 -C 6 -alkyl) or alkoxy (preferably C 1 -C 8 -alkoxy), if appropriate in the presence of a diluent and in the presence of an acid.
  • A, D, X and Z are each as defined above, are obtained by reacting compounds of the formula (V)
  • a and D are each as defined above, or their silyl enol ethers of the formula (Va)
  • a and D are each as defined above and
  • R 8′ represents alkyl (preferably methyl), with compounds of the formuala (VI)
  • X and Z are each as defined above and
  • Hal represents halogen (preferably chlorine or bromine), if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor.
  • R 1 is as defined above and
  • Hal represents halogen (in particular chlorine or bromine),
  • R 1 is as defined above,
  • R 2 and M are each as defined above,
  • M and R 2 are each as defined above,
  • R 3 is as defined above,
  • L, R 4 and R 5 are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine),
  • Me represents a mono- or divalent metal (preferably an alkali metal or alkaline earth metal, such as lithium, sodium, potassium, magnesium or calcium),
  • t represents the number 1 or 2
  • R 10 , R 11 , R 12 independently of one another each represent hydrogen or alkyl (preferably C 1 -C 8 -alkyl),
  • R 6 and L are each as defined above,
  • L, R 6 and R 7 are each as defined above,
  • novel compounds of the formula (I) have a very good activity as pesticides, preferably as insecticides and acaricides, and that they additionally are very well tolerated by plants, in particular by crops.
  • X preferably represents halogen, C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, benzyloxy, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -halogenoalkoxy, cyano or nitro.
  • Z preferably represents hydrogen, amino, halogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenoxy, phenylthio, thiazolyloxy, pyridinyloxy, pyrimidinyloxy, pyrazolyloxy, phenyl-C 1 -C 4 -alkyloxy or phenyl-C 1 -C 7 -alkylthio.
  • Het preferably represents one of the groups
  • A preferably represents respectively optionally halogen-substituted C 1 -C 12 -alkyl, C 2 -C 8 -alkenyl, C 1 -C 10 -alkoxy-C 1 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl or C 1 -C 10 -alkylthio-C 1 -C 6 -alkyl, preferably represents optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or preferably represents respectively optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -halogenoalkyl-, C 1 -C 6 -alkoxy-, C
  • B preferably represents C 1 -C 12 -alkyl or C 1 -C 8 -alkoxy-C 1 -C 6 -alkyl or
  • A, B and the carbon atom that they are attached to preferably represent C 3 -C 10 -cycloalkyl or C 5 -C 10 -cycloalkenyl where in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by C 1 -C 8 -alkyl, C 3 -C 10 -cycloalkyl, C 1 -C 8 -halogenoalkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkylthio, halogen or phenyl or
  • A, B and the carbon atom that they are attached to preferably represent C 5 -C 6 -cycloalkyl which is substituted by an alkylenediyl group optionally containing one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxy group or an alkylenedithioyl group forming a further five- to eight-membered ring with the carbon atom that it is attached to, or
  • A, B and the carbon atom that they are attached to preferably represent C 3 -C 8 -cycloalkyl or C 5 -C 8 -cycloalkenyl in which two carbon atoms are linked to each other by respectively optionally C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy- or halogen-substituted C 3 -C 6 -alkanediyl, C 3 -C 6 -alkenediyl or C 4 -C 6 -alkanedienediyl, one methylene group in each case being optionally replaced by oxygen or sulphur.
  • D preferably represents hydrogen, preferably represents respectively optionally halogen-substituted C 1 -C 12 -alkyl, C 3 -C 8 -alkenyl, C 3 -C 8 -alkynyl, C 1 -C 10 -alkoxy-C 2 -C 8 -alkyl, poly-C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl or C 1 -C 10 -alkylthio-C 2 -C 8 -alkyl, preferably represents optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy- or C 1 -C 4 -halogenoalkyl-substituted C 3 -C 8 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or preferably represents respectively optionally halogen-, C 1 -C 6 alkyl in which
  • a and D together preferably represent a C 3 -C 6 -alkanediyl, C 3 -C 6 -alkenediyl or C 4 -C 6 -alkadienediyl group in which respectively optionally one methylene group is replaced by oxygen or sulphur and which are respectively optionally substituted by halogen or respectively optionally halogen-substituted C 1 -C 10 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylthio, C 3 -C 7 -cycloalkyl, phenyl or benzyloxy or by a further C 3 -C 6 -alkanediyl, C 3 -C 6 -alkenediyl or C 4 -C 6 -alkadienediyl group forming a fused ring, in which optionally respectively one methylene group is replaced by oxygen or sulphur and which are optionally substituted
  • a and D together represent a C 3 -C 6 -alkanediyl or C 3 -C 6 -alkenediyl group containing in each case optionally one of the following groups
  • G preferably represents hydrogen (a) or represents one of the groups
  • E represents a metal ion equivalent or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 preferably represents respectively optionally halogen-substituted C 1 -C 20 -alkyl, C 2 -C 20 -alkenyl, C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl, C 1 -C 8 -alkylthio-C 1 -C 8 -alkyl or poly-C 1 -C 8 -alkoxy-C 1 -C 8 -alkyl or preferably represents optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
  • [0146] preferably represents optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl-, C 1 -C 6 -halogenoalkoxy-, C 1 -C 6 -alkylthio- or C 1 -C 6 -alkylsulphonyl-substituted phenyl,
  • [0147] preferably represents optionally halogen-, nitro-, cyano-, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl- or C 1 -C 6 -halogenoalkoxy-substituted phenyl-C 1 -C 6 -alkyl,
  • [0148] preferably represents optionally halogen- or C 1 -C 6 -alkyl-substituted 5- or 6-membered hetaryl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl and thienyl),
  • [0149] preferably represents optionally halogen- or C 1 -C 6 -alkyl-substituted phenoxy-C 1 -C 6 -alkyl or
  • [0150] preferably represents optionally halogen-, amino- or C 1 -C 6 -alkyl-substituted 5- or 6-membered hetaryloxy-C 1 -C 6 -alkyl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of pyridyloxy-C 1 -C 6 -alkyl, pyrimidyloxy-C 1 -C 6 -alkyl and thiazolyloxy-C 1 -C 6 -alkyl).
  • R 2 preferably represents respectively optionally halogen-substituted C 1 -C 20 -alkyl, C 2 -C 20 -alkenyl, C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl or poly-C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl,
  • [0152] preferably represents optionally halogen-, C 1 -C 6 -alkyl- or C 1 -C 6 -alkoxy-substituted C 3 -C 8 -cycloalkyl or
  • [0153] preferably represents respectively optionally halogen-, cyano-, nitro-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 6 -halogenoalkyl- or C 1 -C 6 -halogenoalkoxy-substituted phenyl or benzyl.
  • R 3 preferably represents optionally halogen-substituted C 1 -C 8 -alkyl or respectively optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R 4 and R 5 independently of one another each preferably represent respectively optionally halogen-substituted C 1 -C 8 -alkyl, C 1 -C 8 -alkoxy, C 1 -C 8 -alkylamino, di-(C 1 -C 8 -alkyl)-amino, C 1 -C 8 -alkylthio or C 3 -C 8 -alkenylthio or preferably represent respectively optionally halogen-, nitro-, cyano-, C 1 -C 4 -alkoxy-, C 1 -C 4 -halogenoalkoxy-, C 1 -C 4 -alkylthio-, C 1 -C 4 -halogeno-alkylthio-, C 1 -C 4 -alkyl- or C 1 -C 4 -halogenoalkyl-substituted phenyl, phenoxy or phenylthio.
  • R 6 and R 7 independently of one another each preferably represent hydrogen, preferably represent respectively optionally halogen-substituted C 1 -C 8 -alkyl, C 3 -C 8 -cycloalkyl, C 1 -C 8 -alkoxy, C 3 -C 8 -alkenyl or C 1 -C 8 -alkoxy-C 2 -C 8 -alkyl, preferably represent respectively optionally halogen-, C 1 -C 8 -alkyl-, C 1 -C 8 -halogenoalkyl- or C 1 -C 8 -alkoxy-substituted phenyl or benzyl or together preferably represent an optionally C 1 -C 6 -alkyl-substituted C 3 -C 6 -alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • R 13 preferably represents hydrogen or respectively optionally halogen-substituted C 1 -C 8 -alkyl or C 1 -C 8 -alkoxy, preferably represents optionally halogen-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 3 -C 8 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or preferably represents respectively optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C 1 -C 4 -alkyl or phenyl-C 1 -C 4 -alkoxy.
  • R 14 preferably represents hydrogen or C 1 -C 8 -alkyl or
  • R 13 and R 14 together preferably represent C 4 -C 6 -alkanediyl.
  • R 15 and R 16 are identical or different and each preferably represent C 1 -C 6 -alkyl or
  • R 15 and R 16 together preferably represent a C 2 -C 4 -alkanediyl radical which is optionally substituted by C 1 -C 6 -alkyl or by optionally halogen-, C 1 -C 4 -alkyl-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -alkoxy-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • R 17 and R 18 independently of one another each preferably represent hydrogen, preferably represent optionally halogen-substituted C 1 -C 8 -alkyl or preferably represent optionally halogen-, C 1 -C 6 -alkyl-, C 1 -C 6 -alkoxy-, C 1 -C 4 -halogenoalkyl-, C 1 -C 4 -halogenoalkoxy-, nitro- or cyano-substituted phenyl or
  • R 19 and R 20 independently of one another each preferably represent C 1 -C 10 -alkyl, C 2 -C 10 -alkenyl, C 1 -C 10 -alkoxy, C 1 -C 10 -alkylamino, C 3 -C 10 -alkenylamino, di-(C 1 -C 10 -alkyl)-amino or di-(C 3 -C 10 -alkenyl)-amino.
  • X particularly preferably represents fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, benzyloxy, C 1 -C 2 -halogenoalkyl, C 1 -C 2 -halogenoalkoxy, cyano or nitro.
  • Z particularly preferably represents hydrogen, amino, fluorine, chlorine, bromine, C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 2 -halogenoalkyl, C 1 -C 2 -halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 2 -halogenoalkyl-, C 1 -C 2 -halogenoalkoxy-, nitro- or cyano-substituted phenoxy or benzyloxy.
  • Het particularly preferably represents one of the groups
  • B particularly preferably represents C 1 -C 10 -alkyl or C 1 -C 6 -alkoxy-C 1 -C 4 -alkyl or
  • D particularly preferably represents hydrogen, particularly preferably represents respectively optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl or C 1 -C 6 -alkoxy, particularly preferably represents optionally fluorine-, chlorine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy- or C 1 -C 2 -halogenoalkyl-substituted C 3 -C 7 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -halogenoalkyl, C 1 -C 4 -alkoxy-, C 1 -C 4 -halogenoalkoxy-, cyano- or nitro-substituted phenyl, furanyl, imidazo
  • a and D together particularly preferably represent a C 3 -C 5 -alkanediyl or C 3 -C 5 -alkenediyl group in which in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by fluorine, chlorine or by respectively optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 1 -C 4 -alkoxy, C 3 -C 4 -alkylthio.
  • G particularly preferably represents hydrogen (a) or represents one of the groups
  • E represents a metal ion equivalent or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 particularly preferably represents respectively optionally fluorine- or chlorine-substituted C 1 -C 16 -alkyl, C 2 -C 16 -alkenyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 6 -alkylthio-C 1 -C 6 -alkyl or poly-C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl or particularly preferably represents optionally fluorine-, chlorine-, C 1 -C 5 -alkyl- or C 1 -C 5 -alkoxy-substituted C 3 -C 7 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
  • [0183] particularly preferably represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 3 -halogenoalkyl-, C 1 -C 3 -halogenoalkoxy-, C 1 -C 4 -alkylthio- or C 1 -C 4 -alkylsulphonyl-substituted phenyl,
  • [0184] particularly preferably represents optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 3 -halogenoalkyl- or C 1 -C 3 -halogenoalkoxy-substituted phenyl-C 1 -C 4 -alkyl,
  • [0185] particularly preferably represents respectively optionally fluorine-, chlorine-, bromine- or C 1 -C 4 -alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
  • [0186] particularly preferably represents optionally fluorine-, chlorine-, bromine- or C 1 -C 4 -alkyl-substituted phenoxy-C 1 -C 3 -alkyl or
  • [0187] particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, amino- or C 1 -C 4 -alkyl-substituted pyridyloxy-C 1 -C 5 -alkyl, pyrimidyloxy-C 1 -C 5 -alkyl or thiazolyloxy-C 1 -C 5 -alkyl.
  • R 2 particularly preferably represents respectively optionally fluorine- or chlorine-substituted C 1 -C 16 -alkyl, C 2 -C 16 -alkenyl, C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl or poly-C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl,
  • [0189] particularly preferably represents optionally fluorine-, chlorine-, C 1 -C 4 -alkyl- or C 1 -C 4 -alkoxy-substituted C 3 -C 7 -cycloalkyl or
  • [0190] particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C 1 -C 4 -alkyl-, C 1 -C 3 -alkoxy-, C 1 -C 3 -halogenoalkyl- or C 1 -C 3 -halogenoalkoxy-substituted phenyl or benzyl.
  • R 3 particularly preferably represents optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl or respectively optionally fluorine-, chlorine-, bromine-, C 1 -C 4 -alkyl-, C 1 -C 4 -alkoxy-, C 1 -C 2 -halogenoalkoxy-, C 1 -C 2 -halogenoalkyl-, cyano-, or nitro-substituted phenyl or benzyl.
  • R 4 and R 5 independently of one another each particularly preferably represent respectively optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkylamino, di-(C 1 -C 6 -alkyl)-amino, C 3 -C 6 -alkylthio or C 3 -C 4 -alkenylthio or particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C 1 -C 3 -alkoxy-, C 1 -C 3 -halogenoalkoxy-, C 1 -C 3 -alkylthio-, C 1 -C 3 -halogenoalkylthio-, C 1 -C 3 -alkyl- or C 1 -C 3 -halogenoalkyl-substituted phenyl, phenoxy or pheny
  • R 6 and R 7 independently of one another each particularly preferably represent hydrogen, particularly preferably represent respectively optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 6 -alkoxy, C 3 -C 6 -alkenyl or C 1 -C 6 -alkoxy-C 2 -C 6 -alkyl, particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, C 1 -C 5 -halogenoalkyl-, C 1 -C 5 -alkyl- or C 1 -C 5 -alkoxy-substituted phenyl or benzyl, or together particularly preferably represent an optionally C 1 -C 4 -alkyl-substituted C 3 -C 6 -alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • R 13 particularly preferably represents hydrogen or respectively optionally fluorine- or chlorine-substituted C 1 -C 6 -alkyl or C 1 -C 6 -alkoxy, particularly preferably represents optionally fluorine-, C 1 -C 2 -alkyl- or C 1 -C 2 -alkoxy-substituted C 3 -C 7 -cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, C 1 -C 5 -alkyl-, C 1 -C 5 -alkoxy-, C 1 -C 2 -halogenoalkyl-, C 1 -C 2 -halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C 1 -C 3 -alkyl or phenyl-C 1 -C 2 -alkyloxy.
  • R 14 particularly preferably represents hydrogen or C 1 -C 6 -alkyl or
  • R 13 and R 14 together particularly preferably represent C 4 -C 6 -alkanediyl.
  • R 15 and R 16 are identical or different and each particularly preferably represent C 1 -C 4 -alkyl or
  • R 15 and R 16 together particularly preferably represent a C 2 -C 3 -alkanediyl radical which is optionally substituted by C 1 -C 4 -alkyl or by optionally fluorine-, chlorine-, bromine-, C 1 -C 2 -alkyl-, C 1 -C 2 -halogenoalkyl-, C 1 -C 2 -alkoxy-, C 1 -C 2 -halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • X very particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro,
  • Z very particularly preferably represents hydrogen, amino, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro.
  • B very particularly preferably represents C 1 -C 8 -alkyl or C 1 -C 4 -alkoxy-C 1 -C 2 -alkyl or
  • D very particularly preferably represents hydrogen, very particularly preferably represents respectively optionally fluorine-substituted C 1 -C 4 -alkyl or C 1 -C 4 -alkoxy or C 3 -C 6 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or very particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro- substituted phenyl, furanyl, pyridyl, thienyl or benzyl,
  • G very particularly preferably represents hydrogen (a) or represents one of the groups
  • E represents a metal ion equivalent or an ammonium ion
  • L represents oxygen or sulphur
  • M represents oxygen or sulphur.
  • R 1 very particularly preferably represents respectively optionally fluorine- or chlorine-substituted C 1 -C 14 -alkyl, C 2 -C 14 -alkenyl, C 1 -C 4 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 4 -alkylthio-C 1 -C 6 -alkyl, poly-C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl or very particularly preferably represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, i-propyl-, n-butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C 3 -C 6 -cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and
  • [0216] very particularly preferably represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl,
  • [0217] very particularly preferably represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted benzyl,
  • [0218] very particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted furanyl, thienyl or pyridyl,
  • [0219] very particularly preferably represents optionally fluorine-, chlorine-, methyl- or ethyl-substituted phenoxy-C 1 -C 4 -alkyl or
  • [0220] very particularly preferably represents respectively optionally fluorine-, chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C 1 -C 4 -alkyl, pyrimidyloxy-C 1 -C 4 -alkyl or thiazolyloxy-C 1 -C 4 -alkyl.
  • R 2 very particularly preferably represents respectively optionally fluorine- or chlorine-substituted C 1 -C 14 -alkyl, C 2 -C 14 -alkenyl, C 1 -C 4 -alkoxy-C 2 -C 6 -alkyl or poly-C 1 -C 4 -alkoxy-C 2 -C 6 -alkyl,
  • [0222] very particularly preferably represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C 3 -C 6 -cycloalkyl,
  • [0223] or very particularly preferably represents respectively optionally fluorine-, chlorine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl or benzyl.
  • R 3 very particularly preferably represents optionally fluorine- or chlorine-substituted methyl, ethyl, propyl, iso-propyl, n-butyl, tert-butyl or respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, iso-propyl-, tert-butyl-, methoxy-, ethoxy-, iso-propoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R 4 and R 5 independently of one another each very particularly preferably represent respectively optionally fluorine- or chlorine-substituted C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkylamino, di-(C 1 -C 4 -alkyl)-amino or C 1 -C 4 -alkylthio or very particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, methyl-, methoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl, phenoxy or phenylthio.
  • R 6 and R 7 independently of one another each very particularly preferably represent hydrogen, very particularly preferably represent respectively optionally fluorine- or chlorine-substituted C 1 -C 4 -alkyl, C 3 -C 6 -cycloalkyl, C 1 -C 4 -alkoxy, C 3 -C 4 -alkenyl or C 1 -C 4 -alkoxy-C 2 -C 4 -alkyl, very particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, methyl-, methoxy- or trifluoromethyl-substituted phenyl or benzyl, or together very particularly preferably represent an optionally methyl- or ethyl-substituted C 5 -C 6 -alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl can, as far as possible, in each case be straight-chain or branched, also in combination with hetero atoms, for example in alkoxy.
  • Optionally substituted radicals can be mono- or polysubstituted, it being possible in the case of polysubstitution for the substituents to be identical or different.
  • a and B are each as defined in Table 1 with
  • a and B are each as defined in Table 1 with
  • a and B are each as defined in Table 4 with
  • a and B are each as defined in Table 4 with
  • a and B are each as defined in Table 7 with
  • a and B are each as defined in Table 7 with
  • a and D are each as defined in Table 10 with
  • a and D are each as defined in Table 10 with
  • A, B, X, Z and R 8 are each as defined above,
  • acylamino acid esters of the formula (II) are obtained, for example, when amino acid derivatives of the formula (XVIII)
  • A, B and R 8 are as defined above,
  • X and Z are each as defined above and
  • Hal represents chlorine or bromine
  • A, B, X and Z are each as defined above,
  • A, B, X and Z are each as defined above, are novel.
  • a and B are each as defined above,
  • X and Z are each as defined above and
  • Hal represents chlorine or bromine
  • X and Z are each as defined above,
  • halogenating agents for example thionyl chloride, thionyl bromide, oxalyl chloride, phosgene, phosphorus trichloride, phosphorus tribromide or phosphorus pentachloride
  • a diluent for example optionally chlorinated aliphatic or aromatic hydrocarbons such as toluene or methylene chloride
  • the compounds of the formula (XXII) are novel with the exception of 2,5-dichlorophenylacetic acid (CAS 5398798), 5-chloro-2-methoxyphenylacetic acid (CAS 7569-6-22), 2-chloro-5-methylphenylacetic acid (CAS 81682-39-5), 2,5-difluorophenylacetic acid (CAS 85068-27-5), 2-bromo-5-methylphenylacetic acid (BRN 3 249 577) and 2-chloro-5-trifluoromethylphenylacetic acid (CAS 22893-39-6), they can be prepared by methods known from the literature (Organikum, 15th edition, p. 533, VEB Deutscher Verlag dermaschineen, Berlin 1977).
  • the compounds of the formula (XXII) are obtained, for example, by hydrolysing substituted phenylacetic acid esters of the formula (XXIII)
  • X, Z and R 8 are each as defined above,
  • the compounds of the formula (XXIII) are novel with the exception of methyl 2,5-dichlorophenylacetate (CAS 96129-66-7) and methyl 5-chloro-2-methoxy-phenylacetate (CAS 26939-01-5), they can be prepared by methods known in principle.
  • X and Z are each as defined above,
  • alkoxides for example alkali metal alkoxides such as sodium methoxide or sodium ethoxide
  • a diluent for example the alcohol derived from the alkoxide
  • an acid preferably an inorganic acid, such as sulphuric acid
  • R 21 represents alkyl, preferably C 1 -C 6 -alkyl
  • the substituted cyclic aminocarboxylic acids of the formula (XXIa), in which A and B form a ring, are in general obtainable by the Bucherer-Bergs synthesis or by the Strecker synthesis and are in each case obtained here in different isomeric forms.
  • the isomers in the following designated as ⁇ for the sake of simplicity
  • the radicals R and the carboxyl group are equatorial
  • the isomers in the following designated as ⁇ for the sake of simplicity
  • A, B, X, Z and R 8 are each as defined above,
  • a and B are each as defined above,
  • A, B, X and Z are each as defined above,
  • A, B, X, Z and R 8 are each as defined above,
  • A, B and R 8 are each as defined above,
  • A, B, W, X, Z and R 8 are each as defined above,
  • X, R 8 and Z are each as defined above,
  • A, B and W are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine),
  • benzylthio-carbonyl halides of the formula (XXX) are known in some cases andlor can be prepared by known methods (J. Antibiotics (1983), 26, 1589).
  • halogenocarbonylketenes of the formula (VI) in which Z does not represent hydrogen, which are required as starting materials in process (D), are novel. They can be prepared in a simple manner by methods known in principle (cf., for example, Org. Prep. Proced. Int., 7, (4), 155-158, 1975 and DE 1 945 703).
  • X and Z are each as defined above and
  • Hal represents chlorine or bromine
  • X and Z are each as defined above,
  • [0369] are reacted with acid halides, for example thionyl chloride, phosphorus(V) chloride, phosphorus(III) chloride, oxalyl chloride, phosgene or thionyl bromide, if appropriate in the presence of catalysts, for example diethylformamide, methylstearylformamide or triphenylphosphine and, if appropriate, in the presence of bases, for example pyridine or triethylamine, at a temperature between ⁇ 20° C. and 200° C., preferably between 0° C. and 150° C.
  • acid halides for example thionyl chloride, phosphorus(V) chloride, phosphorus(III) chloride, oxalyl chloride, phosgene or thionyl bromide
  • catalysts for example diethylformamide, methylstearylformamide or triphenylphosphine
  • bases for example pyridine or trieth
  • substituted phenylmalonic acids of the formula (XXXI) in which Z does not represent hydrogen are novel. However, they may be prepared in a simple manner by known processes (cf., for example, Organikum, VEB Deutscher Verlag dermaschineen, Berlin 1977, p. 517 ff), for example by hydrolysis of substituted phenylmalonic esters of the formula (XXXII)
  • X, Z and R 8 are each as defined above.
  • A, D and R 8′ are each as defined above,
  • R 8 , X and Z are each as defined above, and Z is not hydrogen, are novel.
  • the acid halides of the formula (VII), carboxylic anhydrides of the formula (VIII), chloroformic acid esters or chloroformic acid thioesters of the formula (IX), chloromonothioformic acid esters or chlorodithioformic acid esters of the formula (X), sulphonyl chlorides of the formula (XII), phosphorus compounds of the formula (XIII) and metal hydroxides, metal alkoxides or amines of the formula (XIV) and (XV) and isocyanates of the formula (XVI) and carbamoyl chlorides of the formula (XVII) additionally required as starting materials for carrying out processes (F), (G), (H), (I), (J) and (K) according to the invention are generally known compounds of organic or inorganic chemistry.
  • Process (A) is characterized in that compounds of the formula (II) in which A, B, X, Z and R 8 are each as defined above are subjected to an intramolecular condensation in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (A) according to the invention are all organic solvents which are inert to the reaction participants.
  • Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and n-methyl-pyrrolidone, and also alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol.
  • Suitable bases (deprotonating agents) for carrying out process (A) according to the invention are all customary proton acceptors.
  • Alkali metals such as sodium or potassium can also be used.
  • alkali metal and alkaline earth metal amides and hydrides such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • reaction temperature can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • Process (A) according to the invention is generally carried out under atmospheric pressure.
  • reaction component of the formula (II) and the deprotonating base are generally employed in equimolar to approximately double equimolar amounts. However, it is also possible to use one component or the other in a relatively large excess (up to 3 mol).
  • Process (B) is characterized in that compounds of the formula (III) in which A, B, X, Z and R 8 are each as defined above are condensed intramolecularly in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (B) according to the invention are all organic solvents which are inert to the reaction participants.
  • Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, and additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone.
  • Alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol can also be used.
  • Suitable bases (deprotonating agents) for carrying out the process (B) according to the invention are all customary proton acceptors.
  • Alkali metals such as sodium or potassium can also be used. Suitable are also alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide.
  • reaction temperature can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • Process (B) according to the invention is generally carried out under atmospheric pressure.
  • reaction components of the formula (III) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use one component or the other in a relatively large excess (up to 3 mol).
  • Process (C) is characterized in that compounds of the formula (IV) in which A, B, W, X, Z and R 8 are each as defined above are cyclized intramolecularly in the presence of an acid and, if appropriate, in the presence of a diluent.
  • Suitable diluents for the process (C) according to the invention are all organic solvents which are inert to the reaction participants.
  • Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore halogenated hydrocarbons, such as dichloromethane, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene, and additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone.
  • Alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol can also be used.
  • the acid employed can, if appropriate, also be used as a diluent.
  • Acids which can be employed in process (C) according to the invention are all customary inorganic and organic acids, for example hydrohalic acids, sulphuric acid, alkyl-, aryl- and haloalkyl sulphonic acids; halogenated alkylcarboxylic acids, for example trifluoroacetic acid, are used in particular.
  • reaction temperature can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C.
  • Process (C) according to the invention is generally carried out under atmospheric pressure.
  • reaction components of the formulae (IV) and the acid are employed, for example, in equimolar amounts. However, it is, if appropriate, also possible to employ the acid in catalytic amounts.
  • Process (D) is characterized in that carbonyl compounds of the formula (V) or their silyl enol ethers of the formula (Va) are reacted with ketene acid halides of the formula (VI), if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor.
  • Acid acceptors which can be used when carrying out process (D) according to the invention are all customary acid acceptors.
  • tertiary amines such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecene (DBU), diazabicyclononene (DBN), Hünig base or N,N-dimethyl-aniline.
  • DABCO diazabicyclooctane
  • DBU diazabicycloundecene
  • DBN diazabicyclononene
  • Hünig base or N,N-dimethyl-aniline.
  • reaction temperature can be varied within a relatively wide range.
  • the reaction is expediently carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 220° C.
  • Process (D) according to the invention is preferably carried out under atmospheric pressure.
  • reaction components of the formulae (V) and (VI) and, if appropriate, the acid acceptor are in general employed in approximately equimolar amounts. However, it is also possbile to use one component or the other in a relatively large excess (up to 5 mol).
  • Process (E ⁇ ) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with carboxylic acid halides of the formula (VII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
  • Suitable diluents for the process (EcL) according to the invention are all solvents inert to the acid halides.
  • Those preferably utilizable are hydrocarbons, such as benzine, benzene, toluene, xylene and tetraline, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, and also ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxan, moreover carboxylic acid esters, such as ethyl acetate, and also strongly polar solvents, such as dimethylformamide, dimethylsulphoxide and sulpholane. If the stability to hydrolysis of the acid halide permits, the reaction can also be carried out in the presence of water.
  • Suitable acid-binding agents in the reaction of process (E ⁇ ) according to the invention are all customary acid acceptors.
  • Those preferably utilizable are tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecene (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, and also alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • tertiary amines such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecene (DBU), diazabicyclononene (DBN), Hünig
  • reaction temperature in the process (E ⁇ ) according to the invention can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 20° C. and +150° C., preferably between 0° C. and 100° C.
  • Process (ED) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are each reacted with carboxylic anhydrides of the formula (VIII), if appropriate in the presence of a diluent and if appopriate in the presence of an acid-binding agent.
  • Preferred diluents for the process (E ⁇ ) according to the invention are those diluents which are also preferred when using acid halides. Otherwise, a carboxylic anhydride employed in excess may also simultaneously function as diluent.
  • Possible acid-binding agents added in process (E ⁇ ) are preferably those acid-binding agents that are also preferred when using acid-halides.
  • reaction temperature in the process (E ⁇ ) according to the invention can be varied within a relatively wide range.
  • the reaction is carried out at temperatures between ⁇ 20° C. and +150° C., preferably between 0° C. and 100° C.
  • Process (F) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with chloroformic acid esters or chloroformic acid thioesters of the formula (IX), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
  • Suitable acid-binding agents for process (F) according to the invention are all customary acid acceptors.
  • Those preferably utilizable are tertiary amines, such as triethylamine, pyridine, DABCO, DBU, DBA, Huinig base and N,N-dimethylaniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, additionally alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide.
  • tertiary amines such as triethylamine, pyridine, DABCO, DBU, DBA, Huinig base and N,N-dimethylaniline
  • alkaline earth metal oxides such as magnesium oxide and calcium oxide
  • alkali metal and alkaline earth metal carbonates such as sodium carbonate, potassium carbonate and calcium carbonate and also alkali metal hydroxides such as sodium hydroxide and
  • Suitable diluents for the process (F) according to the invention are all solvents which are inert to the chloroformic acid esters or chloroformic acid thioesters.
  • Those preferably utilizable are hydrocarbons, such as benzine, benzene, toluene, xylene and tetraline, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, additionally ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxan, moreover carboxylic acid esters, such as ethyl acetate, furthermore nitriles, such as acetonitrile, and also strongly polar solvents, such as dimethylformamide, dimethyl sulphoxide and sulpholane
  • reaction temperature can be varied within a relatively wide range.
  • the reaction temperature is generally between ⁇ 20° C. and +100° C., preferably betwveen 0° C. and 50° C.
  • Process (F) according to the invention is in general carried out under atmospheric pressure.
  • the starting materials of the formulae (I-1-a) to (I-4-a) and the appropriate chloroformic acid ester or chloroformic acid thioester of the formula (IX) are in general each used in approximately equivalent amounts. However, it is also possible to employ one component or the other in a relatively large excess (up to 2 mol). Work-up is carried out according to customary methods. In general, a procedure is used in which precipitated salts are removed and the reaction mixture which remains is concentrated by stripping off the diluent.
  • Process (G) according to the invention is characterized in that compounds of the formula (I-1-a) to (I-4-a) are in each case reacted with compounds of the formula (X) in the presence of a diluent and, if appropriate, in the presence of an acid-binding agent.
  • Diluents which may be added, if appropriate, are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides, and also halogenoalkanes.
  • the enolate salt of the compounds (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents, for example sodium hydride or potassium tert-butoxide, the further addition of acid-binding agents can be dispensed with.
  • strong deprotonating agents for example sodium hydride or potassium tert-butoxide
  • acid-binding agents customary inorganic or organic bases are suitable; sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned by way of example.
  • Process (H) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with sulphonyl chlorides of the formula (XII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
  • Process (H) is preferably carried out in the presence of a diluent.
  • Suitable diluents are all inert polar organic solvents, such as ethers, amides, ketones, carboxylic acid esters, nitrites, sulphones, sulphoxides or halogenated hydrocarbons such as methylene chloride.
  • the enolate salt of the compounds (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents (for example sodium hydride or potassium tert-butoxide), the further addition of acid-binding agents can be dispensed with.
  • strong deprotonating agents for example sodium hydride or potassium tert-butoxide
  • acid-binding agents customary inorganic or organic bases are suitable; sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned by way of example.
  • reaction can be carried out at atmospheric pressure or at elevated pressure; it is preferably carried out at atmospheric pressure. Work-up takes place according to customary methods.
  • the process (I) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with phosphorus compounds of the formula (XIII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
  • the process (I) is preferably carried out in the presence of a dituent.
  • Suitable diluents are all inert polar organic solvents, such as ethers, carboxylic acid esters, halogenated hydrocarbons, ketones, amides, nitriles, sulphones, sulphoxides, etc.
  • Acetonitrile, dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride are preferably employed.
  • Acid-binding agents which may be added, if appropriate, are customary inorganic or organic bases, such as hydroxides, carbonates or amines.
  • bases such as hydroxides, carbonates or amines.
  • sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned.
  • the reaction may be carried out at atmospheric pressure or at elevated pressure; it is preferably carried out at atmospheric pressure. Work-up takes place according to conventional methods of organic chemistry.
  • the end products are preferably purified by crystallization, chromatographic purification or by so-called “incipient distillation”, i.e. removal of the volatile constituents in vacuo.
  • Process (J) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with metal hydroxides or metal alkoxides of the formula (XIV) or amines of the formula (XV), if appropriate in the presence of a diluent.
  • Preferred diluents for process (J) according to the invention are ethers such as tetrahydrofuran, dioxan and diethyl ether or else alcohols such as methanol, ethanol and isopropanol, but also water.
  • Process (J) according to the invention is generally carried out under atmospheric pressure.
  • the reaction temperature is in general between ⁇ 20° C. and 100° C., preferably between 0° C. and 50° C.
  • Process (K) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with (K ⁇ ) compounds of the formula (XVI), if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or (K ⁇ ) with compounds of the formula (XVII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
  • Process (K ⁇ ) is preferably carried out in the presence of a diluent.
  • Suitable diluents are all inert organic solvents, such as aromatic hydrocarbons, halogenated hydrocarbons, ethers, amides, nitrites, sulphones or sulphoxides.
  • Catalysts may, if desired, be added to accelerate the reaction.
  • the catalysts employed can very advantageously be organotin compounds, for example dibutyltin dilaurate.
  • the reaction is preferably carried out at atmospheric pressure.
  • Possible diluents optionally added are all inert polar organic solvents, such as ethers, carboxylic acid esters, nitrites, ketones, amides, sulphones, sulphoxides or halogenated hydrocarbons.
  • the enolate salt of the compound (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents (e.g. sodium hydride or potassium tertiary butoxide), the further addition of acid-binding agents can be dispensed with.
  • strong deprotonating agents e.g. sodium hydride or potassium tertiary butoxide
  • customary inorganic or organic bases are suitable; those which may be mentioned by way of example are sodium hydroxide, sodium carbonate, potassium carbonate, triethylamine or pyridine.
  • reaction can be carried out at atmospheric pressure or at elevated pressure, preferably at atmospheric pressure. Work-up takes place according to customary methods.
  • the active compounds are suitable for controlling animal pests, preferably arthropods and nematodes, in particular insects and arachnida, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene field. They are active against normally sensitive and resistant species and against all or some stages of development.
  • animal pests preferably arthropods and nematodes, in particular insects and arachnida, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene field. They are active against normally sensitive and resistant species and against all or some stages of development.
  • the abovementioned pests include:
  • Thysanura for example, Lepisma saccharina.
  • Thysanoptera for example, Hercinothrips femoralis and Thrips tabaci.
  • Acarina for example, Acarus siro , Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora , Boophilus spp., Rhipicephalus spp., Amblyomma spp., Hyalomma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa , Panonychus spp. and Tetranychus spp.
  • the active compounds according to the invention are distinguished by a high insecticidal and acaricidal activity.
  • insects which are injurious to plants, such as, for example, against the larvae of the mustard beetle ( Phaedon cochleariae ), against the larvae of the green rice leaf hopper ( Nephotettix cincticeps ) or against the caterpillars of the cabbage moth ( Plutella maculipennis ) (cf. the Use Examples).
  • the active compounds can be converted into the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, dusting agents, pastes, soluble powders, granules, suspension-emulsion concentrates, natural and synthetic materials impregnated with active compound, and very fine capsules in polymeric substances.
  • formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is liquid solvents and/or solid carriers, optionally with the use of surface-active agents, that is emulsifying agents and/or dispersing agents and/or foam-forming agents.
  • organic solvents can, for example, also be used as auxiliary solvents.
  • liquid solvents there are suitable in the main: aromatics, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics and chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes of methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example petroleum fractions, mineral and vegetable oils, alcohols, such as butanol or glycol as well as their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethyl sulphoxide, as well as water.
  • aromatics such as xylene, toluene or alkylnaphthalenes
  • ammonium salts and ground natural minerals such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as highly disperse silica, alumina and silicates, as solid carriers for granules there are suitable: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite as well as synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks; as emulsifying and/or foam-forming agents there are suitable: for example non-ionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkylsulphates, arylsulphonates as
  • Adhesives such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, as well as natural phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in the formulations. Further additives can be mineral and vegetable oils.
  • colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • inorganic pigments for example iron oxide, titanium oxide and Prussian Blue
  • organic dyestuffs such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs
  • trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc.
  • the formulations in general contain between 0.1 and 95 per cent by weight of active compound, preferably between 0.5 and 90%.
  • the active compound according to the inv,ention can be present in its commercially available formulations and in the use forms prepared from these formulations, as a mixture with other active compounds, such as insecticides, attractants, sterilizing agents, acaricides, nematicides, fungicides, growth-regulating substances or herbicides.
  • active compounds such as insecticides, attractants, sterilizing agents, acaricides, nematicides, fungicides, growth-regulating substances or herbicides.
  • the insecticides include, for example, phosphates, carbamates, carboxylates, chlorinated hydrocarbons, phenylureas and substances produced by microorganisms.
  • bronopol dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations.
  • anilides such as, for example, diflufenican and propanil; arylcarboxylic acids such as, for example, dichloropicolinic acid, dicamba and picloram; aryloxyalkanoic acids such as, for example, 2,4-D, 2,4-DB, 2,4-DP, fluroxypyr, MCPA, MCPP and triclopyr; aryloxy-phenoxy-alkanoic esters such as, for example, diclofop-methyl, fenoxaprop-ethyl, fluazifop-butyl, haloxyfop-methyl and quizalofop-ethyl; azinones such as, for example, chloridazon and norflurazon; carbamates such as, for example, chlorpropham, desmedipham, phenmedipham and propham; chloroacetanilides such as, for example, alachlor, acetochlor, butachlor, metazachlor, me
  • the active compound according to the invention can furthermore be present in its commercially available formulations and in the use forms prepared from these formulations, as a mixture with synergistic agents.
  • Synergistic agents are compounds which increase the action of the active compounds without it being necessary for the synergistic agent added to be active itself.
  • the active compound content of the use forms prepared from the commercially available formulations can vary within wide limits.
  • the active compound concentration of the use forms can be from 0.0000001 to 95% by weight of active compound, preferably between 0.0001 and 1% by weight.
  • the active compounds When used against hygiene pests and pests of stored products, the active compounds are distinguished by an excellent residual action on wood and clay as well as a good stability to alkali on limed substrates.
  • the active compounds according to the invention are not only active against plant, hygiene and stored-product pests, but also, in the veterinary medicine sector, against animal parasites (ectoparasites), such as ixodid ticks, argasid ticks, scab mites, trombiculid mites, flies (stinging and sucking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
  • animal parasites ectoparasites
  • ixodid ticks such as argasid ticks, scab mites, trombiculid mites, flies (stinging and sucking), parasitic fly larvae, lice, hair lice, bird lice and fleas.
  • parasites include:
  • Nematocerina and Brachycerina for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyi
  • Acarapis spp. for example Acarapis spp., Cheyletiella spp., Ornitrocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Octodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp..
  • the active compounds of the formula (I) according to the invention are also suitable for controlling arthropods which attack agricultural livestock, such as, for example, cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, honey bees, other domestic animals, such as, for example, dogs, cats, cage birds, aquarium fish, and so-called experimental animals such as, for example, hamsters, guinea-pigs, rats and mice.
  • arthropods By controlling these arthropods, it is intended to reduce mortality and decreased performance (in meat, milk, wool, hides, eggs, honey and the like), so that more economical and simpler animal keeping is made possible by using the active compounds according to the invention.
  • the active compounds according to the invention are used in a known manner by enteral administration, for example in the form of tablets, capsules, drinks, drenches, granules, pastes, boluscs, the feed-through method, suppositories, by parenteral administration, such as, for example, by means of injections (intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants, by nasal application, by dermal administration, for example in the form of dipping or bathing, spraying, pouring-on and spotting-on, washing, dusting, and with the aid of shaped articles which comprise active compound, such as collars, ear tags, tail marks, limb bands, halters, marking devices and the like.
  • enteral administration for example in the form of tablets, capsules, drinks, drenches, granules, pastes, boluscs, the feed-through method, suppositories
  • parenteral administration such as, for example, by means of injections (intra
  • the active compounds of the formula (I) can be used as formulations (for example powders, emulsions, flowables) which comprise the active compounds in an amount of 1 to 80% by weight, either directly or after dilution by a factor of 100 to 10,000, or they may be used in the form of a chemical bath.
  • formulations for example powders, emulsions, flowables
  • insects may be mentioned by way of example and as being preferred, but without any limitation:
  • Kalotermes flavicollis Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, Coptotermes formosanus.
  • Industrial materials are to be understood as meaning, in the present context, non-live materials such as, preferably, synthetic materials, glues, sizes, paper and board, leather, wood and timber products, and paint.
  • the materials to be very particularly protected against attack by insects are wood and timber products.
  • Wood and timber products which can be protected by the composition according to the invention or mixtures comprising such a composition are to be understood as meaning, for example, construction timber, wooden beams, railway sleepers, bridge components, jetties, wooden vehicles, boxes, pallets, containers, telephone poles, wood lagging, windows and doors made of wood, plywood, particle board, joiner's articles, or wood products which, quite generally, are used in the construction of houses or in joinery.
  • the active compounds can be used as such, in the form of concentrates or generally customary formulations, such as powders, granules, solutions, suspensions, emulsions or pastes.
  • the formulations mentioned can be prepared in a manner known per se, for example by mixing the active compounds with at least one solvent or diluent, emulsifier, dispersant and/or binder or fixative, water repellent, if appropriate desiccants and UV stabilizers and, if appropriate, colorants and pigments and other processing auxiliaries.
  • the insecticidal compositions or concentrates used for the protection of wood and wooden materials comprise the active compound according to the invention at a concentration of 0.0001 to 95% by weight, in particular 0.001 to 60% by weight.
  • compositions or concentrates employed depends on the species and the occurrence of the insects and on the medium. The optimum rate of application can be determined upon use in each case by test series. However, in general, it suffices to employ 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of the active compound, based on the material to be protected.
  • the solvent and/or diluent used is an organochemical solvent or solvent mixture and/or an oily or oil-type organochemical solvent or solvent mixture of low volatility and/or a polar organochemical solvent or solvent mixture and/or water and, if appropriate, an emulsifier and/or wetting agent.
  • Organochemical solvents which are preferably employed are oily or oil-type solvents having an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C.
  • Substances which are used as such oily and oil-type solvents which have low volatility and are insoluble in water are suitable mineral oils or their aromatic fractions, or mineral-oil-containing solvent mixtures, preferably white spirit, petroleum and/or alkylbenzene.
  • Substances which are advantageously used are mineral oils with a boiling range of 170 to 220° C., white spirit with a boiling range of 170 to 220° C., spindle oil with a boiling range of 250 to 350° C., petroleum or aromatics of boiling range 160 to 280° C., essence of turpentine and the like.
  • liquid aliphatic hydrocarbons with a boiling range of 180 to 210° C. or high-boiling mixtures of aromatic and aliphatic hydrocarbons with a boiling range of 180 to 220° C. and/or spindle oil and/or monochloro- naphthalene, preferably ⁇ -monochloronaphthalene, are used.
  • organic oily or oil-type solvents of low volatility having an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C. can be partially replaced by organochemical solvents of high or medium volatility, with the proviso that the solvent mixture also has an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C., and that the insecticide/fungicide mixture is soluble or emulsifiable in this solvent mixture.
  • part of the organochemical solvent or solvent mixture is replaced by an aliphatic polar organochemical solvent or solvent mixture.
  • Substances which are preferably used are aliphatic organochemical solvents having hydroxyl and/or ester and/or ether groups, such as, for example, glycol ether, esters and the like.
  • the organochemical binders used within the scope of the present invention are the synthetic resins and/or binding drying oils which are known per se and can be diluted with water and/or are soluble or dispersible or emulsifiable in the organochemical solvents employed, in particular binders composed of, or comprising, an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenol resin, hydrocarbon resin, such as indene/coumarone resin, silicone resin, drying vegetable and/or drying oils and/or physically drying binders based on a natural and/or synthetic resin.
  • binders composed of, or comprising, an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenol resin, hydrocarbon resin, such as
  • the synthetic resin used as the binder can be employed in the form of an emulsion, dispersion or solution. Up to 10% by weight of bitumen or bituminous substances can also be used as binders. In addition, colorants, pigments, water repellents, odour-masking substances and inhibitors or anticorrosives known per se and the like can also be employed.
  • the composition or the concentrate preferably comprises, in accordance with the invention, at least one alkyd resin or modified alkyd resin and/or a drying vegetable oil as the organochemical binder.
  • alkyd resins with an oil content of over 45% by weight, preferably 50 to 68% by weight.
  • binder can be replaced by a fixative (mixture) or a plasticizer (mixture).
  • fixative mixture
  • plasticizer mixture
  • additives are intended to prevent volatilization of the active compounds and crystallization or precipitation. They preferably replace 0.01 to 30% of the binder (based on 100% of binder employed).
  • the plasticizers are from the chemical classes of the phthalic esters, such as dibutyl phthalate, dioctyl phthalate or benzylbutyl phthalate, the phosphoric esters, such as tributyl phosphate, the adipic esters, such as di-(2-ethylhexyl) adipate, the stearates, such as butyl stearate or amyl stearate, the oleates, such as butyl oleate, the glycerol ethers or relatively high-molecular-weight glycol ethers, glycerol esters and p-toluene-sulphonic esters.
  • the phthalic esters such as dibutyl phthalate, dioctyl phthalate or benzylbutyl phthalate
  • the phosphoric esters such as tributyl phosphate
  • the adipic esters such as di-(2-e
  • Fixatives are chemically based on polyvinyl alkyl ethers, such as, for example, polyvinyl methyl ether, or ketones, such as benzophenone or ethylene benzophenone.
  • Particularly suitable as a solvent or diluent is also water, if appropriate as a mixture with one or more of the abovementioned organochemical solvents or diluents, emulsifiers and dispersants.
  • the ready-to-use compositions can additionally comprise one or more other insecticides and, if appropriate, additionally one or more fungicides.
  • Suitable additional components which may be admixed are, preferably, the insecticides and fungicides mentioned in WO 94/29 268.
  • the compounds mentioned in that document are expressly part of the present application.
  • Very particularly preferred components which may be admixed are insecticides, such as chlorpyriphos, phoxim, silafluofin, alphamethrin, cyfluthrin, cypermethrin, deltamethrin, permethrin, imidacloprid, NI-25, flufenoxuron, hexaflumuron and triflumuron, and fungicides, such as epoxyconazole, hexaconazole, azaconazole, propiconazole, tebuconazole, cyproconazole, metconazole, imazalil, dichlorofluanide, tolylfluanide, 3-iodo-2-propinylbutyl carbamate, N-octyl-isothiazolin-3-one and 4,5-dichloro-N-octylisothiazolin-3-one.
  • insecticides such as chlorpyriphos, phoxim,
  • reaction mixture is added dropwise to 500 ml of ice-cold 1N HCl, and the precipitated product is filtered off with suction, washed with water and dried in a vacuum drying cabinet.
  • [0611] B At 0° C., 10.7 g of the compound (2) in 20 ml of THF are added dropwise to 32 ml of a solution of lithium diisopropylamide (LDA) (65.8 mmol) in 50 ml of THF, and the mixture is stirred at 0° C. for 30 minutes. The solution A is then added dropwise at this temperature, and the mixture is stirred for a further 1 hour without cooling.
  • LDA lithium diisopropylamide
  • the mixture is admixed with 175 ml of MTBE and a few drops of water.
  • the mixture is concentrated, admixed with water and extracted with methylene chloride. The extract is dried and concentrated.
  • Example A Phaedon larvae test Solvent 7 parts by weight of dimethylformamide Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • Cabbage leaves Brassica oleracea
  • Cabbage leaves Brassica oleracea
  • the destruction in % is determined. 100% means that all the beetle larvae have been killed; 0% means that none of the beetle larvae have been killed.
  • Cabbage leaves Brassica oleracea
  • Cabbage leaves Brassica oleracea
  • caterpillars of the diamond-back moth caterpillars of the diamond-back moth (Plutella maculipennis) while the leaves are still moist.
  • the destruction in % is determined. 100% means that all the caterpillars have been killed; 0% means that none of the caterpillars have been killed.
  • Cabbage leaves Brassica oleracea
  • Cabbage leaves Brassica oleracea
  • caterpillars of the owlet moth Spodoptera frugiperda
  • the destruction in % is determined. 100% means that all the caterpillars have been killed; 0% means that none of the caterpillars have been killed.
  • Cabbage leaves Brassica oleracea
  • the peach aphid Myzus persicae
  • the destruction in % is determined. 100% means that all the aphids have been killed; 0% means that none of the aphids have been killed.
  • Rice seedlings ( Oryzae sativa ) are treated by being dipped into the preparation of the active compound of the desired concentration and are infested with larvae of the green rice leaf hopper ( Nephotettix cincticeps ) while the seedling,s are still moist.
  • the destruction in % is determined. 100% means that all the larvae have been killed; 0% means that none of the larvae have been killed.
  • Bean plants Phaseolus vulgaris ) heavily infested by all stages of the common spider mite ( Tetranychus urticae ) are dipped into a preparation of the active compound of the desired concentration.
  • the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed.
  • Bean plants Phaseolus vulgaris ) heavily infested by all stages of the common spider mite ( Tetranychus urticae ) are dipped into a preparation of the active compound of the desired concentration.
  • the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed.
  • Plum trees Prunus domestica ) approximately 30 cm in height which are severely infested by all stages of the fruit tree spider mite ( Panonychus ulmi ) are sprayed with an active compound preparation of the desired concentration.
  • the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed.
  • test tube which contains 1 cm 3 of horse meat. 500 ⁇ l of the dilution to be tested are pipetted onto this horse meat.
  • the test tubes are placed in plastic beakers whose bottom is covered with sea sand, and kept in a climatized room (26° C. ⁇ 1.5° C., 70% ⁇ 10% relative humidity). The activity is examined (larvicidal action) after 24 hours and again after 48 hours. After emergence of the larvae (about 72 h), the test tubes are removed and perforated plastic lids are fitted to the beakers. After 1.5 times the development time (hatching of the control flies), the hatched flies and the pupae/coccoons are counted.
  • the activity criterion is the incidence of death in the treated larvae after 48 h (larvicidal effect), or the inhibition of the hatching of adults from pupae or the inhibition of pupa formation.
  • the criterion for the in vitro activity of a substance is the inhibition of the development of the flies, or a development standstill before the adult stage. 100% larvicidal action means that all the larvae have been killed after 48 hours. 100% development-inhibitory action means that no adult flies have hatched.
  • Example K Test with Boophilus microplus resistant/SP resistant Parkhurst strain Test animals: adult females which have sucked themselves full Solvent: dimethyl sulphoxide
  • the test is carried out in 5 replications. 1 ⁇ l of the solutions is injected into the abdomen, and the animals are transferred into dishes and kept in a controlled-environment cabinet. The activity is determined via the inhibition of oviposition. 100% means that no tick has deposited eggs.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The invention relates to novel phenyl-substituted cyclic ketoenols of the formula (I)
Figure US20020010204A1-20020124-C00001
in which
Het represents one of the groups
Figure US20020010204A1-20020124-C00002
in which A, B, D, G, X and Z are each as defined in the description, to a plurality of processes and intermediates for their preparation, and to their use as pesticides.

Description

  • The invention relates to novel phenyl-substituted cyclic ketoenols, to a plurality of processes and intermediates for their preparation and to their use as pesticides. [0001]
  • It has already been disclosed that certain phenyl-substituted cyclic ketoenols are active as insecticides, acaricides and/or herbicides. [0002]
  • Also known are 1H-arylpyrrolidine-dione derivatives (EP-A-456 063, EP-A-521 334, EP-A-596 298, EP-A-613 884, EP-A-613 885, DE 44 40 594, WO 94/01 997, WO 95/01 358, WO 95/26 954, WO 95/20 572, EP-A-0 668 267, WO 96/25 395, WO 96/35 664, WO 97/01 535 and WO 97/02 243). [0003]
  • It is known that certain substituted Δ[0004] 3-dihydrofuran-2-one derivatives have herbicidal properties (cf. DE-A-4 014 420). The synthesis of the tetronic acid derivatives used as starting materials (such as, for example, 3-(2-methyl-phenyl)-4-hydroxy-5-(4-fluorophenyl)-Δ3-dihydrofuran-2-one) is likewise described in DE-A-4 014 420. Compounds of similar structure without details of an insecticidal and/or acaricidal activity are known from the publication Campbell et al., J. Chem. Soc., Perkin Trans. 1, 1985, (8) 1567-76. Furthermore, 3-aryl-Δ3-dihydrofuranone derivatives having herbicidal, acaricidal and insecticidal properties are disclosed in EP-A-528 156, EP-A 0 647 637, WO 95/26345, WO 96/20 196, WO 96/25 395, WO 96/35 664, WO 97/01 535 and WO 97/02 243.
  • Certain phenyl-pyrone derivatives unsubstituted in the phenyl ring have already been disclosed (cf. A.M. Chirazi, T. Kappe and E. Ziegler, Arch. Pharm. 309, 558 (1976) and K.-H. Boltze and K. Heidenbluth, Chem. Ber. 91, 2849), a possible utility for these compounds as pesticides not being indicated. Phenyl-pyrone derivatives substituted in the phenyl ring and having herbicidal, acaricidal and insecticidal properties are described in EP-A-588 137, WO 96/25 395, WO 96/35 664, WO 97/01 535 and WO 97/02 243. [0005]
  • However, the acaricidal and insecticidal activity and/or spectrum of action, and/or the toleration of the known compounds by plants, in particular by crops, is not always satisfactory. [0006]
  • The invention, accordingly, provides compounds of the formula (I) [0007]
    Figure US20020010204A1-20020124-C00003
  • in which [0008]
  • X represents halogen, alkyl, alkenyl, alkynyl, alkoxy, benzyloxy, halogenoalkyl, halogenoalkoxy, cyano or nitro, [0009]
  • Z represents hydrogen, amino, halogen, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally substituted phenoxy, phenylthio, 5- or 6-membered hetaryloxy, 5- or 6-membered hetarylthio, phenylalkyloxy or phenylalkylthio and [0010]
  • Het represents one of the groups [0011]
    Figure US20020010204A1-20020124-C00004
  • in which [0012]
  • A represents a respectively optionally substituted radical from the group consisting of alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl and alkylthioalkyl, represents respectively saturated or unsaturated and optionally substituted cycloalkyl or heterocyclyl or represents respectively optionally halogen-, alkyl-, halogenoalkyl-, alkoxy-, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl, [0013]
  • B represents alkyl or alkoxyalkyl or [0014]
  • A and B together with the carbon atom that they are attached to represent a saturated or unsaturated, optionally substituted carbocycle or heterocycle, [0015]
  • D represents hydrogen or represents an optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl, saturated or unsaturated heterocyclyl, arylalkyl, aryl, hetarylalkyl or hetaryl or [0016]
  • A and D together with the atoms that they are attached to represent a respectively optionally substituted carbocycle or heterocycle, [0017]
  • G represents hydrogen (a) or represents one of the groups [0018]
    Figure US20020010204A1-20020124-C00005
  • in which [0019]
  • E represents a metal ion equivalent or an ammonium ion, [0020]
  • L represents oxygen or sulphur, [0021]
  • M represents oxygen or sulphur, [0022]
  • R[0023] 1 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl or polyalkoxyalkyl or represents respectively optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl or heterocyclyl or represents respectively optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetarytoxyalkyl,
  • R[0024] 2 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl or polyalkoxyalkyl or represents respectively optionally substituted cycloalkyl, phenyl or benzyl,
  • R[0025] 3, R4 and R5 independently of one another each represent respectively optionally halogen-substituted alkyl, alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio or cycloalkylthio or represent respectively optionally substituted phenyl, benzyl, phenoxy or phenylthio,
  • R[0026] 6 and R7 independently of one another each represent hydrogen, represent respectively optionally halogen-substituted alkyl, cycloalkyl, alkenyl, alkoxy, alkoxyalkyl, represent respectively optionally substituted phenyl or benzyl, or form together with the nitrogen atom that they are attached to an optionally oxygen- or sulphur-containing, optionally substituted cycle.
  • The compounds of the formula (I) can also be present, depending on the nature of the substituents, as geometric and/or optical isomers and isomer mixtures of differing composition which, if appropriate, can be separated in a customary manner. Both the pure isomers and the isomer mixtures, their preparation and use, and compositions comprising them are part of the subject matter of the present invention. In the following, for simplicity, however, compounds of the formula (I) are always referred to, although both pure compounds and, if appropriate, mixtures having different proportions of isomer compounds are intended. [0027]
  • Including the meanings (1) to (4) of the group Het, the following principal structures (I-1) to (I-4) result: [0028]
    Figure US20020010204A1-20020124-C00006
  • in which [0029]
  • A, B, D, G, X and Z are each as defined above. [0030]
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-1-a) to (I-1-g) result if Het represents the group (1) [0031]
    Figure US20020010204A1-20020124-C00007
  • in which [0032]
  • A, B, E, L, M, X, Z, R[0033] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-2-a) to (I-2-g) result if Het represents the group (2) [0034]
    Figure US20020010204A1-20020124-C00008
  • in which [0035]
  • A, B, E, L, M, X, Z, R, R[0036] 2, R3, R4, R5, R6 and R7 are each as defined above.
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-3-a) to (I-3-g) result if Het represents the group (3) [0037]
    Figure US20020010204A1-20020124-C00009
  • in which [0038]
  • A, B, E, L, M, X, Z, R[0039] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Depending on the position of the substituent G, the compounds of the formula (I-4) can be present in the two isomeric forms of formulae (I-4)[0040] a and (I-4)b
    Figure US20020010204A1-20020124-C00010
  • which is intended to be expressed by the dashed line in the formula (I-4). [0041]
  • The compounds of the formulae (I-4)[0042] a and (I-4)b can be present both as mixtures and in the form of their pure isomers. Mixtures of the compounds of the formulae (I-4)a and (I-4)b can, if desired, be separated by physical methods in a manner known per se, for example by chromatographic methods.
  • For better clarity, in the following in each case only one of the possible isomers is shown. This does not exclude the possibility that the compounds can optionally be present in the form of the isomer mixtures or in the other respective isomer form. [0043]
  • Including the various meanings (a), (b), (c), (d), (e), (f) and (g) of the group G, the following principal structures (I-4-a) to (I-4-g) result if Het represents the group (4) [0044]
    Figure US20020010204A1-20020124-C00011
  • in which [0045]
  • A, D, E, L, M, X, Z, R[0046] 1, R2, R3, R4, R5, R6 and R7 are each as defined above.
  • Furthermore, it has been found that the novel compounds of the formula (I) are obtained by one of the processes described below: [0047]
  • (A) Compounds of the formula (I-1-a) [0048]
    Figure US20020010204A1-20020124-C00012
  • in which [0049]
  • A, B, X and Z are each as defined above, are obtained by the intramolecular condensation of compounds of the formula (II) [0050]
    Figure US20020010204A1-20020124-C00013
  • in which [0051]
  • A, B, X and Z are each as defined above, [0052]
  • and [0053]
  • R[0054] 8 represents alkyl (preferably C1-C6-alkyl),
  • in the presence of a diluent and in the presence of a base, [0055]
  • (B) Furthermore, it was found that compounds of the formula (I-2-a) [0056]
    Figure US20020010204A1-20020124-C00014
  • in which [0057]
  • A, B, X and Z are each as defined above, are obtained by the intramolecular condensation of compounds of the formula (III) [0058]
    Figure US20020010204A1-20020124-C00015
  • in which [0059]
  • A, B, X, Z and R[0060] 8 are each as defined above, in the presence of a diluent and in the presence of a base.
  • (C) Furthermore, it was found that compounds of the formula (I-3-a) [0061]
    Figure US20020010204A1-20020124-C00016
  • in which [0062]
  • A, B, X and Z are each as defined above, are obtained by the intramolecular cyclization of compounds of the formula (IV) [0063]
    Figure US20020010204A1-20020124-C00017
  • in which [0064]
  • A, B, X, Z and R[0065] 8 are each as defined above and
  • W represents hydrogen, halogen, alkyl (preferably C[0066] 1-C6-alkyl) or alkoxy (preferably C1-C8-alkoxy), if appropriate in the presence of a diluent and in the presence of an acid.
  • (D) Furthermore, it was found that compounds of the formula (I-4-a) [0067]
    Figure US20020010204A1-20020124-C00018
  • in which [0068]
  • A, D, X and Z are each as defined above, are obtained by reacting compounds of the formula (V) [0069]
    Figure US20020010204A1-20020124-C00019
  • in which [0070]
  • A and D are each as defined above, or their silyl enol ethers of the formula (Va) [0071]
    Figure US20020010204A1-20020124-C00020
  • in which [0072]
  • A and D are each as defined above and [0073]
  • R[0074] 8′ represents alkyl (preferably methyl), with compounds of the formuala (VI)
    Figure US20020010204A1-20020124-C00021
  • in which [0075]
  • X and Z are each as defined above and [0076]
  • Hal represents halogen (preferably chlorine or bromine), if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor. [0077]
  • Furthermore, it was found [0078]
  • (E) that the compounds of the formulae (I-1-b) to (I-4-b) shown above in which A, B, D, R[0079] 1, X and Z are each as defined above are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above
  • α) with acid halides of the formula (VII) [0080]
    Figure US20020010204A1-20020124-C00022
  • in which [0081]
  • R[0082] 1 is as defined above and
  • Hal represents halogen (in particular chlorine or bromine), [0083]
  • or [0084]
  • β) with carboxylic anhydrides of the formula (VIII) [0085]
  • R1—CO—O—CO—R1  (VIII)
  • in which [0086]
  • R[0087] 1 is as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent; [0088]
  • (F) that the compounds of the formulae (I-1-c) to (I-4-c) shown above in which A, B, D, R[0089] 2, M, X and Z are each as defined above and L represents oxygen are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above, in each case
  • with chloroformic esters or chloroformic thioesters of the formula (IX) [0090]
  • R2—M—CO—Cl  (IX)
  • in which [0091]
  • R[0092] 2 and M are each as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent; [0093]
  • (G) that compounds of the formulae (I-1-c) to (I-4-c) shown above in which A, B, D, R[0094] 2, M, X and Z are each as defined above and L represents sulphur are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above, in each case
  • with chloromonothioformic esters or chlorodithioformic esters of the formula (X) [0095]
    Figure US20020010204A1-20020124-C00023
  • in which [0096]
  • M and R[0097] 2 are each as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, [0098]
  • (H) that compounds of the formulae (I-1-d) to (I-4-d) shown above in which A, B, D, R[0099] 3, X and Z are each as defined above are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above, in each case
  • with sulphonyl chlorides of the formula (XII) [0100]
  • R3—SO2—Cl  (XII)
  • in which [0101]
  • R[0102] 3 is as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, [0103]
  • (I) that compounds of the formulae (I-1-e) to (I-4-e) shown above in which A, B, D, L, R[0104] 4, R5, X and Z are each as defined above are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above, in each case
  • with phosphorus compounds of the formula (XIII) [0105]
    Figure US20020010204A1-20020124-C00024
  • in which [0106]
  • L, R[0107] 4 and R5 are each as defined above and
  • Hal represents halogen (in particular chlorine or bromine), [0108]
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, [0109]
  • (J) that compounds of the formulae (I-I-f) to (1-4-f) shown above in which A, B, D, E, X and Z are each as defined above are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) in which A, B, D, X and Z are each as defined above, in each case [0110]
  • with metal compounds or amines of the formulae (XIV) or (XV) [0111]
    Figure US20020010204A1-20020124-C00025
  • in which [0112]
  • Me represents a mono- or divalent metal (preferably an alkali metal or alkaline earth metal, such as lithium, sodium, potassium, magnesium or calcium), [0113]
  • t represents the number 1 or 2 and [0114]
  • R[0115] 10, R11, R12 independently of one another each represent hydrogen or alkyl (preferably C1-C8-alkyl),
  • if appropriate in the presence of a diluent; [0116]
  • (K) that compounds of the formulae (I-1-g) to (I-4-g) shown above in which A, B, D, L, R[0117] 6, R7, X and Z are each as defined above are obtained by reacting compounds of the formulae (I-1-a) to (I-4-a) shown above in which A, B, D, X and Z are each as defined above, in each case
  • α) with isocyanates or isothiocyanates of the formula (XVI) [0118]
  • R6—N═C═L  (XVI)
  • in which [0119]
  • R[0120] 6 and L are each as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or [0121]
  • β) with carbamoyl chlorides or thiocarbamoyl chlorides of the formula (XVII) [0122]
    Figure US20020010204A1-20020124-C00026
  • in which [0123]
  • L, R[0124] 6 and R7 are each as defined above,
  • if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0125]
  • Furthermore, it has been found that the novel compounds of the formula (I) have a very good activity as pesticides, preferably as insecticides and acaricides, and that they additionally are very well tolerated by plants, in particular by crops. [0126]
  • Formula (I) provides a general definition of the compounds according to the invention. Preferred substituents or ranges of the radicals shown in the formulae mentioned hereinabove and hereinbelow are illustrated below: [0127]
  • X preferably represents halogen, C[0128] 1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy, benzyloxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, cyano or nitro.
  • Z preferably represents hydrogen, amino, halogen, C[0129] 1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenoxy, phenylthio, thiazolyloxy, pyridinyloxy, pyrimidinyloxy, pyrazolyloxy, phenyl-C1-C4-alkyloxy or phenyl-C1-C7-alkylthio.
  • Het preferably represents one of the groups [0130]
    Figure US20020010204A1-20020124-C00027
  • A preferably represents respectively optionally halogen-substituted C[0131] 1-C12-alkyl, C2-C8-alkenyl, C1-C10-alkoxy-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl or C1-C10-alkylthio-C1-C6-alkyl, preferably represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or preferably represents respectively optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyl, naphthyl, phenyl-C1-C6-alkyl, naphthyl-C1-C6-alkyl or hetaryl having 5 or 6 ring atoms and one to three hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, indolyl, thiazolyl and thienyl).
  • B preferably represents C[0132] 1-C12-alkyl or C1-C8-alkoxy-C1-C6-alkyl or
  • A, B and the carbon atom that they are attached to preferably represent C[0133] 3-C10-cycloalkyl or C5-C10-cycloalkenyl where in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by C1-C8-alkyl, C3-C10-cycloalkyl, C1-C8-halogenoalkyl, C1-C8-alkoxy, C1-C8-alkylthio, halogen or phenyl or
  • A, B and the carbon atom that they are attached to preferably represent C[0134] 5-C6-cycloalkyl which is substituted by an alkylenediyl group optionally containing one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxy group or an alkylenedithioyl group forming a further five- to eight-membered ring with the carbon atom that it is attached to, or
  • A, B and the carbon atom that they are attached to preferably represent C[0135] 3-C8-cycloalkyl or C5-C8-cycloalkenyl in which two carbon atoms are linked to each other by respectively optionally C1-C6-alkyl-, C1-C6-alkoxy- or halogen-substituted C3-C6-alkanediyl, C3-C6-alkenediyl or C4 -C6-alkanedienediyl, one methylene group in each case being optionally replaced by oxygen or sulphur.
  • D preferably represents hydrogen, preferably represents respectively optionally halogen-substituted C[0136] 1-C12-alkyl, C3-C8-alkenyl, C3-C8-alkynyl, C1-C10-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl or C1-C10-alkylthio-C2-C8-alkyl, preferably represents optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkyl-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or preferably represents respectively optionally halogen-, C1-C6 alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyl, hetaryl having 5 or 6 ring atoms and one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl and triazolyl), phenyl-C1-C6-alkyl or hetaryl-C1-C6-alkyl having 5 or 6 ring atoms and one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of furanyl-, imidazolyl-, pyridyl-, thiazolyl-, pyrazolyl-, pyrimidyl-, pyrrolyl-, thienyl- and triazolyl-C1-C6-alkyl) or
  • A and D together preferably represent a C[0137] 3-C6-alkanediyl, C3-C6-alkenediyl or C4-C6-alkadienediyl group in which respectively optionally one methylene group is replaced by oxygen or sulphur and which are respectively optionally substituted by halogen or respectively optionally halogen-substituted C1-C10-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C7-cycloalkyl, phenyl or benzyloxy or by a further C3-C6-alkanediyl, C3-C6-alkenediyl or C4-C6-alkadienediyl group forming a fused ring, in which optionally respectively one methylene group is replaced by oxygen or sulphur and which are optionally substituted by C1-C6-alkyl, or
  • A and D together represent a C[0138] 3-C6-alkanediyl or C3-C6-alkenediyl group containing in each case optionally one of the following groups
    Figure US20020010204A1-20020124-C00028
  • G preferably represents hydrogen (a) or represents one of the groups [0139]
    Figure US20020010204A1-20020124-C00029
  • E (f) or [0140]
    Figure US20020010204A1-20020124-C00030
  • in which [0141]
  • E represents a metal ion equivalent or an ammonium ion, [0142]
  • L represents oxygen or sulphur and [0143]
  • M represents oxygen or sulphur. [0144]
  • R[0145] 1 preferably represents respectively optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio-C1-C8-alkyl or poly-C1-C8-alkoxy-C1-C8-alkyl or preferably represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
  • preferably represents optionally halogen-, cyano-, nitro-, C[0146] 1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl-, C1-C6-halogenoalkoxy-, C1-C6-alkylthio- or C1-C6-alkylsulphonyl-substituted phenyl,
  • preferably represents optionally halogen-, nitro-, cyano-, C[0147] 1-C6-alkyl, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl-C1-C6-alkyl,
  • preferably represents optionally halogen- or C[0148] 1-C6-alkyl-substituted 5- or 6-membered hetaryl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl and thienyl),
  • preferably represents optionally halogen- or C[0149] 1-C6-alkyl-substituted phenoxy-C1-C6-alkyl or
  • preferably represents optionally halogen-, amino- or C[0150] 1-C6-alkyl-substituted 5- or 6-membered hetaryloxy-C1-C6-alkyl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen (in particular from the group consisting of pyridyloxy-C1-C6-alkyl, pyrimidyloxy-C1-C6-alkyl and thiazolyloxy-C1-C6-alkyl).
  • R[0151] 2 preferably represents respectively optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C2-C8-alkyl or poly-C1-C8-alkoxy-C2-C8-alkyl,
  • preferably represents optionally halogen-, C[0152] 1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl or
  • preferably represents respectively optionally halogen-, cyano-, nitro-, C[0153] 1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl or benzyl.
  • R[0154] 3 preferably represents optionally halogen-substituted C1-C8-alkyl or respectively optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R[0155] 4 and R5 independently of one another each preferably represent respectively optionally halogen-substituted C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylamino, di-(C1-C8-alkyl)-amino, C1-C8-alkylthio or C3-C8-alkenylthio or preferably represent respectively optionally halogen-, nitro-, cyano-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, C1-C4-alkylthio-, C1-C4-halogeno-alkylthio-, C1-C4-alkyl- or C1-C4-halogenoalkyl-substituted phenyl, phenoxy or phenylthio.
  • R[0156] 6 and R7 independently of one another each preferably represent hydrogen, preferably represent respectively optionally halogen-substituted C1-C8-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, C3-C8-alkenyl or C1-C8-alkoxy-C2-C8-alkyl, preferably represent respectively optionally halogen-, C1-C8-alkyl-, C1-C8-halogenoalkyl- or C1-C8-alkoxy-substituted phenyl or benzyl or together preferably represent an optionally C1-C6-alkyl-substituted C3-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • R[0157] 13 preferably represents hydrogen or respectively optionally halogen-substituted C1-C8-alkyl or C1-C8-alkoxy, preferably represents optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or preferably represents respectively optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C4-alkyl or phenyl-C1-C4-alkoxy.
  • R[0158] 14 preferably represents hydrogen or C1-C8-alkyl or
  • R[0159] 13 and R14 together preferably represent C4-C6-alkanediyl.
  • R[0160] 15 and R16 are identical or different and each preferably represent C1-C6-alkyl or
  • R[0161] 15 and R16 together preferably represent a C2-C4-alkanediyl radical which is optionally substituted by C1-C6-alkyl or by optionally halogen-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • R[0162] 17 and R18 independently of one another each preferably represent hydrogen, preferably represent optionally halogen-substituted C1-C8-alkyl or preferably represent optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl or
  • R[0163] 17 and R18 together with the carbon atom that they are attached to preferably represent optionally C1-C4-alkyl-substituted C5-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur.
  • R[0164] 19 and R20 independently of one another each preferably represent C1-C10-alkyl, C2-C10-alkenyl, C1-C10-alkoxy, C1-C10-alkylamino, C3-C10-alkenylamino, di-(C1-C10-alkyl)-amino or di-(C3-C10-alkenyl)-amino.
  • X particularly preferably represents fluorine, chlorine, bromine, C[0165] 1-C4-alkyl, C1-C4-alkoxy, benzyloxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, cyano or nitro.
  • Z particularly preferably represents hydrogen, amino, fluorine, chlorine, bromine, C[0166] 1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkyl-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenoxy or benzyloxy.
  • Het particularly preferably represents one of the groups [0167]
    Figure US20020010204A1-20020124-C00031
  • A particularly preferably represents respectively optionally fluorine- or chlorine-substituted C[0168] 1-C10-alkyl, C2-C6-alkenyl, C1-C8-alkoxy-C1-C6-alkyl, poly-C1-C6-alkoxy-C1-C6-alkyl or C1-C8-alkylthio-C1-C6-alkyl or particularly preferably represents optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, cyano, or nitro-substituted phenyl, furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, indolyl, thiazolyl, thienyl or phenyl-C1-C4-alkyl.
  • B particularly preferably represents C[0169] 1-C10-alkyl or C1-C6-alkoxy-C1-C4-alkyl or
  • A, B and the carbon atom that they are attached to particularly preferably represent C[0170] 3-C8-cycloalkyl or C5-C8-cycloalkenyl where one methylene group in each case is optionally replaced by oxygen or sulphur and which are optionally substituted by C1-C6-alkyl, C3-C8-cycloalkyl, C1-C3-halogenoalkyl, C1-C6-alkoxy, C1-C6-alkylthio, fluorine, chlorine or phenyl or
  • A, B and the carbon atom that they are attached to particularly preferably represent C[0171] 5-C6-cycloalkyl which is substituted by an alkylenediyl group optionally containing one or two not directly adjacent oxygen or sulphur atoms or by an alkylenedioxy group or by an alkylenedithiol group which forms together with the carbon atom that it is attached to a further five- to seven-membered ring or
  • A, B and the carbon atom that they are attached to particularly preferably represent C[0172] 3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two carbon atoms are linked to each other by respectively optionally C1-C4-alkyl-, C1-C4-alkoxy-, fluorine-, chlorine- or bromine-substituted C3-C5-alkanediyl or C3-C5-alkenediyl, one methylene group in each case being optionally replaced by oxygen or sulphur, or are linked to each other by butadienediyl.
  • D particularly preferably represents hydrogen, particularly preferably represents respectively optionally fluorine- or chlorine-substituted C[0173] 1-C6-alkyl or C1-C6-alkoxy, particularly preferably represents optionally fluorine-, chlorine-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C2-halogenoalkyl-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl, furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl, triazolyl or phenyl-C1-C4-alkyl or
  • A and D together particularly preferably represent a C[0174] 3-C5-alkanediyl or C3-C5-alkenediyl group in which in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by fluorine, chlorine or by respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C1-C4-alkoxy, C3-C4-alkylthio. C3-C6-cycloalkyl, phenyl or benzyloxy or
  • in which in each case optionally one of the following groups is contained: [0175]
    Figure US20020010204A1-20020124-C00032
  • G particularly preferably represents hydrogen (a) or represents one of the groups [0176]
    Figure US20020010204A1-20020124-C00033
  • E (f) or [0177]
    Figure US20020010204A1-20020124-C00034
  • in which [0178]
  • E represents a metal ion equivalent or an ammonium ion, [0179]
  • L represents oxygen or sulphur and [0180]
  • M represents oxygen or sulphur. [0181]
  • R[0182] 1 particularly preferably represents respectively optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkylthio-C1-C6-alkyl or poly-C1-C6-alkoxy-C1-C6-alkyl or particularly preferably represents optionally fluorine-, chlorine-, C1-C5-alkyl- or C1-C5-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
  • particularly preferably represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C[0183] 1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, C1-C4-alkylthio- or C1-C4-alkylsulphonyl-substituted phenyl,
  • particularly preferably represents optionally fluorine-, chlorine-, bromine-, C[0184] 1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl-C1-C4-alkyl,
  • particularly preferably represents respectively optionally fluorine-, chlorine-, bromine- or C[0185] 1-C4-alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
  • particularly preferably represents optionally fluorine-, chlorine-, bromine- or C[0186] 1-C4-alkyl-substituted phenoxy-C1-C3-alkyl or
  • particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, amino- or C[0187] 1-C4-alkyl-substituted pyridyloxy-C1-C5-alkyl, pyrimidyloxy-C1-C5-alkyl or thiazolyloxy-C1-C5-alkyl.
  • R[0188] 2 particularly preferably represents respectively optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C2-C6-alkyl or poly-C1-C6-alkoxy-C2-C6-alkyl,
  • particularly preferably represents optionally fluorine-, chlorine-, C[0189] 1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl or
  • particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C[0190] 1-C4-alkyl-, C1-C3-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl or benzyl.
  • R[0191] 3 particularly preferably represents optionally fluorine- or chlorine-substituted C1-C6-alkyl or respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkoxy-, C1-C2-halogenoalkyl-, cyano-, or nitro-substituted phenyl or benzyl.
  • R[0192] 4 and R5 independently of one another each particularly preferably represent respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylamino, di-(C1-C6-alkyl)-amino, C3-C6-alkylthio or C3-C4-alkenylthio or particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C3-alkoxy-, C1-C3-halogenoalkoxy-, C1-C3-alkylthio-, C1-C3-halogenoalkylthio-, C1-C3-alkyl- or C1-C3-halogenoalkyl-substituted phenyl, phenoxy or phenylthio.
  • R[0193] 6 and R7 independently of one another each particularly preferably represent hydrogen, particularly preferably represent respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-alkenyl or C1-C6-alkoxy-C2-C6-alkyl, particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, C1-C5-halogenoalkyl-, C1-C5-alkyl- or C1-C5-alkoxy-substituted phenyl or benzyl, or together particularly preferably represent an optionally C1-C4-alkyl-substituted C3-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • R[0194] 13 particularly preferably represents hydrogen or respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl or C1-C6-alkoxy, particularly preferably represents optionally fluorine-, C1-C2-alkyl- or C1-C2-alkoxy-substituted C3-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, C1-C5-alkyl-, C1-C5-alkoxy-, C1-C2-halogenoalkyl-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C3-alkyl or phenyl-C1-C2-alkyloxy.
  • R[0195] 14 particularly preferably represents hydrogen or C1-C6-alkyl or
  • R[0196] 13 and R14 together particularly preferably represent C4-C6-alkanediyl.
  • R[0197] 15 and R16 are identical or different and each particularly preferably represent C1-C4-alkyl or
  • R[0198] 15 and R16 together particularly preferably represent a C2-C3-alkanediyl radical which is optionally substituted by C1-C4-alkyl or by optionally fluorine-, chlorine-, bromine-, C1-C2-alkyl-, C1-C2-halogenoalkyl-, C1-C2-alkoxy-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenyl.
  • X very particularly preferably represents fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro, [0199]
  • Z very particularly preferably represents hydrogen, amino, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro. [0200]
  • Het very particularly preferably represents one of the groups [0201]
    Figure US20020010204A1-20020124-C00035
  • A very particularly preferably represents respectively optionally fluorine- or chlorine-substituted C[0202] 1-C8-alkyl, C2-C4-alkenyl, C1-C6-alkoxy-C1-C4-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or C1-C6-alkylthio-C1-C4-alkyl, or very particularly preferably represents optionally fluorine-, chlorine-, methyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or very particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl, pyridyl or benzyl.
  • B very particularly preferably represents C[0203] 1-C8-alkyl or C1-C4-alkoxy-C1-C2-alkyl or
  • A, B and the carbon atom that they are attached to very particularly preferably represent C[0204] 3-C8-cycloalkyl or C5-C8-cycloalkenyl in which in each case optionally one methylene group is replaced by oxygen or sulphur and which are optionally substituted by methyl, ethyl, n-propyl, iso-propyl, butyl, iso-butyl, sec-butyl, tert-butyl, cyclohexyl, trifluoromethyl, methoxy, ethoxy, n-propoxy, iso-propoxy, butoxy, iso-butoxy, sec-butoxy, tert-butoxy, methylthio, ethylthio, fluorine, chlorine or phenyl or
  • A, B and the carbon atom that they are attached to very particularly preferably represent C[0205] 3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two carbon atoms are linked together by C3-C4-alkanediyl or C3-C4-alkenediyl in which in each case optionally one methylene group is replaced by oxygen or sulphur, or are linked together by butadienediyl.
  • D very particularly preferably represents hydrogen, very particularly preferably represents respectively optionally fluorine-substituted C[0206] 1-C4-alkyl or C1-C4-alkoxy or C3-C6-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or very particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro- substituted phenyl, furanyl, pyridyl, thienyl or benzyl,
  • or [0207]
  • A and D together very particularly preferably represent a C[0208] 3-C5-alkanediyl or C3-C5-alkenediyl group in which in each case optionally one methylene group is replaced by oxygen or sulphur and which are optionally substituted by fluorine, chlorine or by respectively optionally fluorine- or chlorine-substituted C1-C6-allryl, C1-C4-alkoxy, C1-C4-alkylthio, C3-C6-cycloalkyl, phenyl or benzyloxy.
  • G very particularly preferably represents hydrogen (a) or represents one of the groups [0209]
    Figure US20020010204A1-20020124-C00036
  • E (f or [0210]
    Figure US20020010204A1-20020124-C00037
  • in which [0211]
  • E represents a metal ion equivalent or an ammonium ion, [0212]
  • L represents oxygen or sulphur and [0213]
  • M represents oxygen or sulphur. [0214]
  • R[0215] 1 very particularly preferably represents respectively optionally fluorine- or chlorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C1-C6-alkyl, C1-C4-alkylthio-C1-C6-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or very particularly preferably represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, i-propyl-, n-butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
  • very particularly preferably represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl, [0216]
  • very particularly preferably represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted benzyl, [0217]
  • very particularly preferably represents respectively optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted furanyl, thienyl or pyridyl, [0218]
  • very particularly preferably represents optionally fluorine-, chlorine-, methyl- or ethyl-substituted phenoxy-C[0219] 1-C4-alkyl or
  • very particularly preferably represents respectively optionally fluorine-, chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C[0220] 1-C4-alkyl, pyrimidyloxy-C1-C4-alkyl or thiazolyloxy-C1-C4-alkyl.
  • R[0221] 2 very particularly preferably represents respectively optionally fluorine- or chlorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C2-C6-alkyl or poly-C1-C4-alkoxy-C2-C6-alkyl,
  • very particularly preferably represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C[0222] 3-C6-cycloalkyl,
  • or very particularly preferably represents respectively optionally fluorine-, chlorine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl or benzyl. [0223]
  • R[0224] 3 very particularly preferably represents optionally fluorine- or chlorine-substituted methyl, ethyl, propyl, iso-propyl, n-butyl, tert-butyl or respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, iso-propyl-, tert-butyl-, methoxy-, ethoxy-, iso-propoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl.
  • R[0225] 4 and R5 independently of one another each very particularly preferably represent respectively optionally fluorine- or chlorine-substituted C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylamino, di-(C1-C4-alkyl)-amino or C1-C4-alkylthio or very particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, methyl-, methoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl, phenoxy or phenylthio.
  • R[0226] 6 and R7 independently of one another each very particularly preferably represent hydrogen, very particularly preferably represent respectively optionally fluorine- or chlorine-substituted C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C3-C4-alkenyl or C1-C4-alkoxy-C2-C4-alkyl, very particularly preferably represent respectively optionally fluorine-, chlorine-, bromine-, methyl-, methoxy- or trifluoromethyl-substituted phenyl or benzyl, or together very particularly preferably represent an optionally methyl- or ethyl-substituted C5-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
  • Particular preference is given to compounds of the formula (I) in which Z does not represent hydrogen. [0227]
  • Preference is also given to those compounds where D does not represent methyl. [0228]
  • The abovementioned definitions or illustrations of radicals mentioned generally or in preferred ranges can be combined with each other as desired, i.e. also between the respective ranges and preferred ranges. They apply correspondingly to the final products and to the precursors and intermediates. [0229]
  • For the purpose of the invention, preference is given to compounds of the formula (I) in which there exists a combination of the meanings mentioned above as preferred (preferably). [0230]
  • For the purpose of the invention, particular preference is given to compounds of the formula (I) in which there exists a combination of the meanings mentioned above as particularly preferred. [0231]
  • For the purpose of the invention, very particular preference is given to compounds of the formula (I) in which there exists a combination of the meanings mentioned above as very particularly preferred. [0232]
  • Saturated or unsaturated hydrocarbon radicals such as alkyl or alkenyl can, as far as possible, in each case be straight-chain or branched, also in combination with hetero atoms, for example in alkoxy. [0233]
  • Optionally substituted radicals can be mono- or polysubstituted, it being possible in the case of polysubstitution for the substituents to be identical or different. [0234]
  • In addition to the compounds mentioned in the Preparation Examples, the following compounds of the formula (I-1-a) may be specifically mentioned: [0235]
    TABLE 1
    X = CH3; Z = CH3
    Figure US20020010204A1-20020124-C00038
    A B
    CH3 CH3
    C2H5 CH3
    C3H7 CH3
    i-C3H7 CH3
    C4H9 CH3
    i-C4H9 CH3
    s-C4H9 CH3
    t-C4H9 CH3
    C2H5 C2H5
    C3H7 C3H7
    Figure US20020010204A1-20020124-C00039
         		CH3
    Figure US20020010204A1-20020124-C00040
         		CH3
    Figure US20020010204A1-20020124-C00041
         		CH3
    —(CH2)2—
    —(CH2)4—
    —(CH2)5—
    —(CH2)6—
    —(CH2)7—
    —(CH2)2—O—(CH2)2—
    —(CH2)2—S—(CH2)2—
    —CH2—CHCH3—(CH2)3—
    —(CH2)2—CHCH2—(CH2)2—
    —(CH2)2—CHC2H5—(CH2)2—
    —(CH2)2—CHC3H7—(CH2)2—
    —(CH2)2—CHi-C3H7—(CH2)2—
    —(CH2)2—CHOCH3—(CH2)2—
    —(CH2)2—CHOC2H5—(CH2)2—
    —(CH2)2—CHOC3H7—(CH2)2—
    —(CH2)2—CHiO—C3H7—(CH2)2—
    —(CH2)2C(CH3)2—(CH2)2—
    —CH2—(CHCH3)2—(CH2)2—
    Figure US20020010204A1-20020124-C00042
    Figure US20020010204A1-20020124-C00043
    Figure US20020010204A1-20020124-C00044
    Figure US20020010204A1-20020124-C00045
    Figure US20020010204A1-20020124-C00046
  • Table 2 [0236]
  • A and B are each as defined in Table 1 with [0237]
  • X═CH3; Z═Cl
  • Table [0238] 3
  • A and B are each as defined in Table [0239] 1 with
  • X═Cl; Z═CH3
  • In addition to the compounds mentioned in the preparation examples, the following compounds of the formula (I-2-a) may be specifically mentioned: [0240]
    TABLE 4
    X = CH3; Z = CH3
    A B
    CH3 CH3
    C2H5 CH3
    C3H7 CH3
    i-C3H7 CH3
    C4H9 CH3
    i-C4H9 CH3
    s-C4H9 CH3
    t-C4H9 CH3
    C2H5 CH3
    C3H7 CH3
    Figure US20020010204A1-20020124-C00047
         		CH3
    Figure US20020010204A1-20020124-C00048
         		CH3
    Figure US20020010204A1-20020124-C00049
         		CH3
    —(CH2)2—
    —(CH2)4—
    —(CH2)5—
    —(CH2)6—
    —(CH2)7—
    —(CH2)2—O—(CH2)2—
    —(CH2)2—S—(CH2)2—
    —CH2—CHCH3—(CH2)3—
    —(CH2)2—CHCH3—(CH2)2—
    —(CH2)2—CHC2H5—(CH2)2—
    —(CH2)2—CHC3H7—(CH2)2—
    —(CH2)2—CHi-C3H7—(CH2)2—
    —(CH2)2—CHOCH3—(CH2)2—
    —(CH2)2—CHOC2H5—(CH2)2—
    —(CH2)2—CHOC3H7—(CH2)2—
    —(CH2)2—CHiO—C3H7—(CH2)2—
    —(CH2)2—C(CH3)2—(CH2)2—
    —CH2—(CHCH3)2—(CH2)2—
    Figure US20020010204A1-20020124-C00050
    Figure US20020010204A1-20020124-C00051
    Figure US20020010204A1-20020124-C00052
    Figure US20020010204A1-20020124-C00053
    Figure US20020010204A1-20020124-C00054
  • Table 5 [0241]
  • A and B are each as defined in Table 4 with [0242]
  • X═CH3; Z═Cl
  • Table 6: [0243]
  • A and B are each as defined in Table 4 with [0244]
  • X═Cl; Z═CH3
  • In addition to the compounds mentioned in the preparation examples, the following compounds of the formula (I-3-a) may be specifically mentioned: [0245]
    TABLE 7
    X = CH3; Z = CH3
    Figure US20020010204A1-20020124-C00055
    A B
    CH3 CH3
    C2H5 CH3
    C3H7 CH3
    i-C3H7 CH3
    C4H9 CH3
    i-C4H9 CH3
    s-C4H9 CH3
    t-C4H9 CH3
    C2H5 C2H5
    C3H7 C3H7
    Figure US20020010204A1-20020124-C00056
         		CH3
    Figure US20020010204A1-20020124-C00057
         		CH3
    Figure US20020010204A1-20020124-C00058
         		CH3
    —(CH2)2—
    —(CH2)4—
    —(CH2)5—
    —(CH2)6—
    —(CH2)7—
    —(CH2)2—O—(CH2)2—
    —(CH2)2—S—(CH2)2—
    —CH2—CHCH3—(CH2)3—
    —(CH2)2—CHCH3—(CH2)2—
    —(CH2)2—CHC2H5—(CH2)2—
    —(CH2)2—CHC3H7—(CH2)2—
    —(CH2)2—CHi-C3H7—(CH2)2—
    —(CH2)2—CHOCH3—(CH2)2—
    —(CH2)2—CHOC2H5—(CH2)2—
    —(CH2)2—CHOC3H7—(CH2)2—
    —(CH2)2CHiO—C3H7—(CH2)2—
    —(CH2)2—C(CH3)3—(CH2)2—
    —CH2—(CHCH3)2—(CH2)2—
    Figure US20020010204A1-20020124-C00059
    Figure US20020010204A1-20020124-C00060
    Figure US20020010204A1-20020124-C00061
    Figure US20020010204A1-20020124-C00062
    Figure US20020010204A1-20020124-C00063
  • Table 8 [0246]
  • A and B are each as defined in Table 7 with [0247]
  • X═CH3; Z═Cl
  • Table 9 [0248]
  • A and B are each as defined in Table 7 with [0249]
  • X═Cl; Z═CH3
  • In addition to the compounds mentioned in the Preparation Examples, the following compounds of the formula (I-4-a) may be specifically mentioned: [0250]
    TABLE 10
    X = CH3; Z = CH3
    Figure US20020010204A1-20020124-C00064
    A D
    CH3
    Figure US20020010204A1-20020124-C00065
    CH3
    Figure US20020010204A1-20020124-C00066
    CH3
    Figure US20020010204A1-20020124-C00067
    CH3
    Figure US20020010204A1-20020124-C00068
    CH3
    Figure US20020010204A1-20020124-C00069
    CH3
    Figure US20020010204A1-20020124-C00070
    CH3
    Figure US20020010204A1-20020124-C00071
    CH3
    Figure US20020010204A1-20020124-C00072
    CH3
    Figure US20020010204A1-20020124-C00073
    CH3 C5H9
    CH3 C3H5
    (CH2)3
    (CH2)4
    C(CH3)2OC(CH3)2
  • Table 11 [0251]
  • A and D are each as defined in Table 10 with [0252]
  • X═CH3; Z═Cl
  • Table 12 [0253]
  • A and D are each as defined in Table 10 with [0254]
  • X═Cl; Z═CH3
  • If according to process (A) ethyl N-[(3-chloro-6-methyl)-phenylacetyl]-1-amino-4-ethyl-cyclohexane-carboxylate is used as starting material, the course of the process according to the invention can be represented by the following reaction scheme: [0255]
    Figure US20020010204A1-20020124-C00074
  • If according to process (B) ethyl O-[(2,5-dichloro)-phenylacetyl]-2-hydroxyisobutyrate is used, the course of the process according to the invention can be represented by the following reaction scheme: [0256]
    Figure US20020010204A1-20020124-C00075
  • If according to process (C) ethyl 2-[(2-chloro-5-methyl)-phenyl]-4-(4-methoxy)-benzylmercapto-4-methyl-3-oxo-valerate is used, the course of the process according to the invention can be represented by the following reaction scheme: [0257]
    Figure US20020010204A1-20020124-C00076
  • If, for example, according to process (D) (chlorocarbonyl)-2-[(3-chloro-6-methyl)-phenyl]-ketene and 4-fluoro-propiophenone are used as starting materials, the course of the process according to the invention can be represented by the following reaction scheme: [0258]
    Figure US20020010204A1-20020124-C00077
  • If according to process (Eα) 3-[(2,5-dichloro)-phenyl]-5,5-dimethyl-pyrrolidine-2,4-dione and pivaloyl chloride are used as starting materials, the course of the process according to the invention can be represented by the following reaction scheme: [0259]
    Figure US20020010204A1-20020124-C00078
  • If according to process (E) (variant β) 3-[(2,5-dichloro)-phenyl]-4- hydroxy-5-methyl-5-phenyl-Δ[0260] 3-dihydrofuran-2-one and acetic anhydride are used as starting materials, the course of the process according to the invention can be represented by the following reaction scheme:
    Figure US20020010204A1-20020124-C00079
  • If according to process (F) 8-[(2-chloro-5-methyl)-phenyl]-5,5-pentamethylene-pyrrolidine-2,4-dione and ethoxyethyl chloroformate are used as starting materials, the course of the process according to the invention can be represented by the following reaction scheme: [0261]
    Figure US20020010204A1-20020124-C00080
  • If according to process (G) 3-[(2-bromo-5-methyl)-phenyl]-4-hydroxy-5-methyl-6-(3-pyridyl)-pyrone and methyl chloromonothioformate are used as starting materials, the course of the reaction can be represented in the following manner: [0262]
    Figure US20020010204A1-20020124-C00081
  • If according to process (H) 2-[(2,5-dimethyl)-phenyl]-5,5-[(3-methyl)-pentamethylene]pyrrolidine-2,4-dione and methanesulphonyl chloride are used as starting materials, the course of the reaction can be represented by the following reaction scheme: [0263]
    Figure US20020010204A1-20020124-C00082
  • If according to process (I) 2-[(2-chloro-5-methyl)-phenyl]-4-hydroxy-5-methyl-6-(2-pyridyl)-pyrone and 2,2,2-trifluoroethyl chloromethanethio-phosphonate are used as starting materials, the course of the reaction can be represented by the following reaction scheme: [0264]
    Figure US20020010204A1-20020124-C00083
  • If according to process (J) 3-[(2,5-dichloro)-phenyl]-5-cyclopropyl-5-methyl-pyrrolidine-2,4-dione and NaOH are used as components, the course of the process according to the invention can be represented by the following reaction scheme: [0265]
    Figure US20020010204A1-20020124-C00084
  • If according to process (K) (variant α) 3-[(2-chloro-5-methyl)-phenyl]-4-hydroxy-5,5-tetramethylene-Δ[0266] 3-dihydro-furan-2-one and ethyl isocyanate are used as starting materials, the course of the reaction can be represented by the following reaction scheme:
    Figure US20020010204A1-20020124-C00085
  • If according to process (K) (variant β) 3-[(2-chloro-5-methyl)-phenyl]-5,5-dimethyl-pyrrolidine-2,4-dione and dimethylcarbamoyl chloride are used as starting materials, the course of the reaction can be represented by the following scheme: [0267]
    Figure US20020010204A1-20020124-C00086
  • The compounds of the formula (II) [0268]
    Figure US20020010204A1-20020124-C00087
  • in which [0269]
  • A, B, X, Z and R[0270] 8 are each as defined above,
  • required as starting materials in process (A) according to the invention are novel. [0271]
  • The acylamino acid esters of the formula (II) are obtained, for example, when amino acid derivatives of the formula (XVIII) [0272]
    Figure US20020010204A1-20020124-C00088
  • in which [0273]
  • A, B and R[0274] 8 are as defined above,
  • are acylated using substituted phenylacetyl halides of the formula (XIX) [0275]
    Figure US20020010204A1-20020124-C00089
  • in which [0276]
  • X and Z are each as defined above and [0277]
  • Hal represents chlorine or bromine, [0278]
  • (Chem. Reviews 52, 237-416 (1953); Bhattacharya, Indian J. Chem. 6, 341-5, 1968) [0279]
  • or when acylamino acids of the formula (XX) [0280]
    Figure US20020010204A1-20020124-C00090
  • in which [0281]
  • A, B, X and Z are each as defined above, [0282]
  • are esterified (Chem. Ind. (London) 1568 (1968)). [0283]
  • The compounds of the formula (XX) [0284]
    Figure US20020010204A1-20020124-C00091
  • in which [0285]
  • A, B, X and Z are each as defined above, are novel. [0286]
  • The compounds of the formula (XX) are obtained when amino acids of the formula (XXI) [0287]
    Figure US20020010204A1-20020124-C00092
  • in which [0288]
  • A and B are each as defined above, [0289]
  • are acylated using substituted phenylacetyl halides of the formula (XIX) [0290]
    Figure US20020010204A1-20020124-C00093
  • in which [0291]
  • X and Z are each as defined above and [0292]
  • Hal represents chlorine or bromine, [0293]
  • according to Schotten-Baumann (Organikum, VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p.505). [0294]
  • Some of the compounds of the formula (XIX) are novel. They can be prepared by known methods. [0295]
  • The compounds of the formula (XIX) are obtained, for example, by reacting substituted phenylacetic acids of the formula (XXII) [0296]
    Figure US20020010204A1-20020124-C00094
  • in which [0297]
  • X and Z are each as defined above, [0298]
  • with halogenating agents (for example thionyl chloride, thionyl bromide, oxalyl chloride, phosgene, phosphorus trichloride, phosphorus tribromide or phosphorus pentachloride), if appropriate in the presence of a diluent (for example optionally chlorinated aliphatic or aromatic hydrocarbons such as toluene or methylene chloride) at temperatures from −20° C. to 150° C., preferably from −10° C. to 100° C. [0299]
  • The compounds of the formula (XXII) are novel with the exception of 2,5-dichlorophenylacetic acid (CAS 5398798), 5-chloro-2-methoxyphenylacetic acid (CAS 7569-6-22), 2-chloro-5-methylphenylacetic acid (CAS 81682-39-5), 2,5-difluorophenylacetic acid (CAS 85068-27-5), 2-bromo-5-methylphenylacetic acid (BRN 3 249 577) and 2-chloro-5-trifluoromethylphenylacetic acid (CAS 22893-39-6), they can be prepared by methods known from the literature (Organikum, 15th edition, p. 533, VEB Deutscher Verlag der Wissenschaften, Berlin 1977). The compounds of the formula (XXII) are obtained, for example, by hydrolysing substituted phenylacetic acid esters of the formula (XXIII) [0300]
    Figure US20020010204A1-20020124-C00095
  • in which [0301]
  • X, Z and R[0302] 8 are each as defined above,
  • at temperatures between 0° C. and 150° C., preferably between 20° C. and 100° C., in the presence of an acid (for example an inorganic acid such as hydrochloric acid) or of a base (for example of an alkali metal hydroxide such as sodium hydroxide or potassium hydroxide) and, if appropriate, of a diluent (for example of an aqueous alcohol such as methanol or ethanol). [0303]
  • The compounds of the formula (XXIII) are novel with the exception of methyl 2,5-dichlorophenylacetate (CAS 96129-66-7) and methyl 5-chloro-2-methoxy-phenylacetate (CAS 26939-01-5), they can be prepared by methods known in principle. [0304]
  • The compounds of the formula (X)GII) are obtained, for example, by reacting substituted 1,1,1-trichloro-2-phenylethanes of the formula (XXII) [0305]
    Figure US20020010204A1-20020124-C00096
  • in which [0306]
  • X and Z are each as defined above, [0307]
  • first with alkoxides (for example alkali metal alkoxides such as sodium methoxide or sodium ethoxide) in the presence of a diluent (for example the alcohol derived from the alkoxide) at temperatures between 0° C. and 150° C.) preferably between 20° C. and 120° C., and then reacting with an acid (preferably an inorganic acid, such as sulphuric acid) at temperatures between −20° C. and 150° C., preferably 0° C. and 100° C. (cf. DE 3 314 249). [0308]
  • The compounds of the formula (XXIV) are novel, they can be prepared by methods known in principle. [0309]
  • The compounds of the formula (XXIV) are obtained, for example, when anilines of the formula (XXV) [0310]
    Figure US20020010204A1-20020124-C00097
  • in which [0311]
  • X and Z are as defined above, [0312]
  • are reacted with vinylidene chloride (CH[0313] 2═CCl2) in the presence of an alkyl nitrite of the formula (XXVI)
  • R21—ONO  (XXVI)
  • in which [0314]
  • R[0315] 21 represents alkyl, preferably C1-C6-alkyl,
  • in the presence of copper(II) chloride and, if appropriate, in the presence of a diluent (for example of an aliphatic nitrite such as acetonitrile) at a temperature of −20° C. to 80° C., preferably 0° C. to 60° C. [0316]
  • The compounds of the formulae (XXV) and (XXVI) are known compounds of organic chemistry. Copper(II) chloride and vinylidene chloride have long been known and are commercially available. [0317]
  • Some of the compounds of the formulae (XVIII) and (XXI) are known and/or they can be prepared by known processes (see, for example, Compagnon, Miocque Ann. Chim. (Paris) [14] 5, p. 11-22, 23-27 (1970)). [0318]
  • The substituted cyclic aminocarboxylic acids of the formula (XXIa), in which A and B form a ring, are in general obtainable by the Bucherer-Bergs synthesis or by the Strecker synthesis and are in each case obtained here in different isomeric forms. Thus, according to the conditions of the Bucherer-Bergs synthesis mainly the isomers (in the following designated as β for the sake of simplicity) in which the radicals R and the carboxyl group are equatorial are obtained, while according to the conditions of the Strecker synthesis mainly the isomers (in the following designated as α for the sake of simplicity) are obtained in which the amino group and the radicals R are equatorial. [0319]
    Figure US20020010204A1-20020124-C00098
  • (L. Munday, J. Chem. Soc. 4372 (1961); J. T. Eward, C. Jitrangeri, Can. J. Chem. 53 3339 (1975). [0320]
  • Furthermore the starting materials of the formula (II) [0321]
    Figure US20020010204A1-20020124-C00099
  • in which [0322]
  • A, B, X, Z and R[0323] 8 are each as defined above,
  • used in the above process (A) can be prepared by reacting aminonitriles of the formula (XXVII) [0324]
    Figure US20020010204A1-20020124-C00100
  • in which [0325]
  • A and B are each as defined above, [0326]
  • with substituted phenylacetyl halides of the formula (XIX) [0327]
    Figure US20020010204A1-20020124-C00101
  • in which [0328]
  • X, Z and Hal are each as defined above, [0329]
  • to give compounds of the formula (XXVIII) [0330]
    Figure US20020010204A1-20020124-C00102
  • in which [0331]
  • A, B, X and Z are each as defined above, [0332]
  • and then subjecting these to an acidic alcoholysis. [0333]
  • The compounds of the formula (XXVIII) are also novel. [0334]
  • The compounds of the formula (III) [0335]
    Figure US20020010204A1-20020124-C00103
  • in which [0336]
  • A, B, X, Z and R[0337] 8 are each as defined above,
  • required as starting materials in process (B) according to the invention are novel. [0338]
  • They can be prepared in a simple manner by methods known in principle. [0339]
  • The compounds of the formula (III) are obtained, for example, when 2-hydroxycarboxylic acid esters of the formula (XXIX) [0340]
    Figure US20020010204A1-20020124-C00104
  • in which [0341]
  • A, B and R[0342] 8 are each as defined above,
  • are acylated using substituted phenylacetyl halides of the formula (XIX) [0343]
    Figure US20020010204A1-20020124-C00105
  • in which [0344]
  • X, Z and Hal are each as defined above [0345]
  • (Chem. Reviews 52, 237-416 (1953)). [0346]
  • The compounds of the formula (IV) [0347]
    Figure US20020010204A1-20020124-C00106
  • in which [0348]
  • A, B, W, X, Z and R[0349] 8 are each as defined above,
  • required as starting materials in the above process (C) are novel. [0350]
  • They can be prepared by methods known in principle. [0351]
  • The compounds of the formula (IV) are obtained, for example, when substituted phenylacetic acid esters of the formula (XXIII) [0352]
    Figure US20020010204A1-20020124-C00107
  • in which [0353]
  • X, R[0354] 8 and Z are each as defined above,
  • are acylated using 2-benzylthio-carbonyl halides of the formula (XXX) [0355]
    Figure US20020010204A1-20020124-C00108
  • in which [0356]
  • A, B and W are each as defined above and [0357]
  • Hal represents halogen (in particular chlorine or bromine), [0358]
  • in the presence of strong bases (see, for example, M. S. Chambers, E. J. Thomas, D. J. Williams, J. Chem. Soc. Chem. Commun., (1987), 1228). [0359]
  • The benzylthio-carbonyl halides of the formula (XXX) are known in some cases andlor can be prepared by known methods (J. Antibiotics (1983), 26, 1589). [0360]
  • The halogenocarbonylketenes of the formula (VI) in which Z does not represent hydrogen, which are required as starting materials in process (D), are novel. They can be prepared in a simple manner by methods known in principle (cf., for example, Org. Prep. Proced. Int., 7, (4), 155-158, 1975 and DE 1 945 703). [0361]
  • The compounds of the formula (VI) [0362]
    Figure US20020010204A1-20020124-C00109
  • in which [0363]
  • X and Z are each as defined above and [0364]
  • Hal represents chlorine or bromine, [0365]
  • are obtained when substituted phenylmalonic acids of the formula (XXXI) [0366]
    Figure US20020010204A1-20020124-C00110
  • in which [0367]
  • X and Z are each as defined above, [0368]
  • are reacted with acid halides, for example thionyl chloride, phosphorus(V) chloride, phosphorus(III) chloride, oxalyl chloride, phosgene or thionyl bromide, if appropriate in the presence of catalysts, for example diethylformamide, methylstearylformamide or triphenylphosphine and, if appropriate, in the presence of bases, for example pyridine or triethylamine, at a temperature between −20° C. and 200° C., preferably between 0° C. and 150° C. [0369]
  • The substituted phenylmalonic acids of the formula (XXXI) in which Z does not represent hydrogen are novel. However, they may be prepared in a simple manner by known processes (cf., for example, Organikum, VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p. 517 ff), for example by hydrolysis of substituted phenylmalonic esters of the formula (XXXII) [0370]
    Figure US20020010204A1-20020124-C00111
  • in which [0371]
  • X, Z and R[0372] 8 are each as defined above.
  • The carbonyl compounds of the formula (V) or their silyl enole ethers of the formula (Va) [0373]
    Figure US20020010204A1-20020124-C00112
  • in which [0374]
  • A, D and R[0375] 8′ are each as defined above,
  • required as starting materials for process (D) according to the invention are compounds which are commercially available, generally known or accessible by known processes. [0376]
  • The malonic acid esters of the formula (XXXII) [0377]
    Figure US20020010204A1-20020124-C00113
  • in which [0378]
  • R[0379] 8, X and Z are each as defined above, and Z is not hydrogen, are novel.
  • They can be prepared by generally known methods of organic chemistry (cf., for example, Tetrahedron Lett. 27, 2763 (1986) and Organikum VEB Deutscher Verlag der Wissenschaften, Berlin 1977, p. 587 ff). [0380]
  • The acid halides of the formula (VII), carboxylic anhydrides of the formula (VIII), chloroformic acid esters or chloroformic acid thioesters of the formula (IX), chloromonothioformic acid esters or chlorodithioformic acid esters of the formula (X), sulphonyl chlorides of the formula (XII), phosphorus compounds of the formula (XIII) and metal hydroxides, metal alkoxides or amines of the formula (XIV) and (XV) and isocyanates of the formula (XVI) and carbamoyl chlorides of the formula (XVII) additionally required as starting materials for carrying out processes (F), (G), (H), (I), (J) and (K) according to the invention are generally known compounds of organic or inorganic chemistry. [0381]
  • The compounds of the formulae (V), (VII) to (XVII), (XVIII), (XXI), (XXII), (XXIX), (XXX) and (XXXI) are moreover disclosed in the patent applications cited at the outset and/or can be prepared by the methods given there. [0382]
  • Process (A) is characterized in that compounds of the formula (II) in which A, B, X, Z and R[0383] 8 are each as defined above are subjected to an intramolecular condensation in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (A) according to the invention are all organic solvents which are inert to the reaction participants. Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and n-methyl-pyrrolidone, and also alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol. [0384]
  • Suitable bases (deprotonating agents) for carrying out process (A) according to the invention are all customary proton acceptors. Those preferably utilizable are alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, each of which can also be employed in the presence of a phase-transfer catalyst, for example triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogene 464 (=methyltrialkyl(C[0385] 8-C10)ammonium chloride) or TDA 1 (=tris-(methoxyethoxyethyl)-amine. Alkali metals such as sodium or potassium can also be used. Furthermore, alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and additionally also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide can be employed.
  • When carrying out process (A) according to the invention, the reaction temperature can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0386]
  • Process (A) according to the invention is generally carried out under atmospheric pressure. [0387]
  • When carrying out process (A) according to the invention, the reaction component of the formula (II) and the deprotonating base are generally employed in equimolar to approximately double equimolar amounts. However, it is also possible to use one component or the other in a relatively large excess (up to 3 mol). [0388]
  • Process (B) is characterized in that compounds of the formula (III) in which A, B, X, Z and R[0389] 8 are each as defined above are condensed intramolecularly in the presence of a diluent and in the presence of a base.
  • Suitable diluents for the process (B) according to the invention are all organic solvents which are inert to the reaction participants. Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore ethers, such as dibutyl ether, tetrahydrofuran, dioxane, glycol dimethyl ether and diglycol dimethyl ether, and additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone. Alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol can also be used. [0390]
  • Suitable bases (deprotonating agents) for carrying out the process (B) according to the invention are all customary proton acceptors. Those preferably utilizable are alkali metal and alkaline earth metal oxides, hydroxides and carbonates, such as sodium hydroxide, potassium hydroxide, magnesium oxide, calcium oxide, sodium carbonate, potassium carbonate and calcium carbonate, each of which can also be employed in the presence of phase-transfer catalysts, for example triethylbenzylammonium chloride, tetrabutylammonium bromide, Adogene 464 (=methyltrialkyl(C[0391] 8-C10-ammonium chloride) or TDA 1 (=tris-(methoxyethoxyethyl)-amine). Alkali metals such as sodium or potassium can also be used. Suitable are also alkali metal and alkaline earth metal amides and hydrides, such as sodium amide, sodium hydride and calcium hydride, and also alkali metal alkoxides, such as sodium methoxide, sodium ethoxide and potassium tert-butoxide.
  • When carrying out process (B) according to the invention, the reaction temperature can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0392]
  • Process (B) according to the invention is generally carried out under atmospheric pressure. [0393]
  • When carrying out the process (B) according to the invention, the reaction components of the formula (III) and the deprotonating bases are generally employed in approximately equimolar amounts. However, it is also possible to use one component or the other in a relatively large excess (up to 3 mol). [0394]
  • Process (C) is characterized in that compounds of the formula (IV) in which A, B, W, X, Z and R[0395] 8 are each as defined above are cyclized intramolecularly in the presence of an acid and, if appropriate, in the presence of a diluent.
  • Suitable diluents for the process (C) according to the invention are all organic solvents which are inert to the reaction participants. Those preferably utilizable are hydrocarbons, such as toluene and xylene, furthermore halogenated hydrocarbons, such as dichloromethane, chloroform, ethylene chloride, chlorobenzene, dichlorobenzene, and additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide and N-methyl-pyrrolidone. Alcohols such as methanol, ethanol, propanol, iso-propanol, butanol, iso-butanol and tert-butanol can also be used. [0396]
  • The acid employed can, if appropriate, also be used as a diluent. [0397]
  • Acids which can be employed in process (C) according to the invention are all customary inorganic and organic acids, for example hydrohalic acids, sulphuric acid, alkyl-, aryl- and haloalkyl sulphonic acids; halogenated alkylcarboxylic acids, for example trifluoroacetic acid, are used in particular. [0398]
  • When carrying out process (C) according to the invention, the reaction temperature can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 150° C. [0399]
  • Process (C) according to the invention is generally carried out under atmospheric pressure. [0400]
  • When carrying out process (C) according to the invention, the reaction components of the formulae (IV) and the acid are employed, for example, in equimolar amounts. However, it is, if appropriate, also possible to employ the acid in catalytic amounts. [0401]
  • Process (D) according to the invention is characterized in that carbonyl compounds of the formula (V) or their silyl enol ethers of the formula (Va) are reacted with ketene acid halides of the formula (VI), if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor. [0402]
  • Suitable diluents for the process (D) according to the invention are all organic solvents which are inert to the reaction participants. Those preferably utilizable are hydrocarbons, such as o-dichlorobenzene, tetraline, toluene and xylene, furthermore ethers, such as dibutyl ether, glycol dimethyl ether and diglycol dimethyl ether, and additionally polar solvents, such as dimethyl sulphoxide, sulpholane, dimethylformamide or N-methyl-pyrrolidone. [0403]
  • Acid acceptors which can be used when carrying out process (D) according to the invention are all customary acid acceptors. [0404]
  • Those preferably utilizable are tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecene (DBU), diazabicyclononene (DBN), Hünig base or N,N-dimethyl-aniline. [0405]
  • When carrying out process (D) according to the invention, the reaction temperature can be varied within a relatively wide range. The reaction is expediently carried out at temperatures between 0° C. and 250° C., preferably between 50° C. and 220° C. [0406]
  • Process (D) according to the invention is preferably carried out under atmospheric pressure. [0407]
  • When carrying out process (D) according to the invention, the reaction components of the formulae (V) and (VI) and, if appropriate, the acid acceptor are in general employed in approximately equimolar amounts. However, it is also possbile to use one component or the other in a relatively large excess (up to 5 mol). [0408]
  • Process (Eα) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with carboxylic acid halides of the formula (VII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0409]
  • Suitable diluents for the process (EcL) according to the invention are all solvents inert to the acid halides. Those preferably utilizable are hydrocarbons, such as benzine, benzene, toluene, xylene and tetraline, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, and also ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxan, moreover carboxylic acid esters, such as ethyl acetate, and also strongly polar solvents, such as dimethylformamide, dimethylsulphoxide and sulpholane. If the stability to hydrolysis of the acid halide permits, the reaction can also be carried out in the presence of water. [0410]
  • Suitable acid-binding agents in the reaction of process (Eα) according to the invention are all customary acid acceptors. Those preferably utilizable are tertiary amines, such as triethylamine, pyridine, diazabicyclooctane (DABCO), diazabicycloundecene (DBU), diazabicyclononene (DBN), Hünig base and N,N-dimethyl-aniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, and also alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide. [0411]
  • The reaction temperature in the process (Eα) according to the invention can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −20° C. and +150° C., preferably between 0° C. and 100° C. [0412]
  • When carrying out process (Ec) according to the invention, the starting materials of the formulae (I-1-a) to (I-4-a) and the carboxylic acid halide of the formula (VII) are in general each used in approximately equivalent amounts. However, it is also possible to employ the carboxylic acid halide in a relatively large excess (up to 5 mol). Work-up is carried out according to customary methods. [0413]
  • Process (ED) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are each reacted with carboxylic anhydrides of the formula (VIII), if appropriate in the presence of a diluent and if appopriate in the presence of an acid-binding agent. [0414]
  • Preferred diluents for the process (Eβ) according to the invention are those diluents which are also preferred when using acid halides. Otherwise, a carboxylic anhydride employed in excess may also simultaneously function as diluent. [0415]
  • Possible acid-binding agents added in process (Eβ) are preferably those acid-binding agents that are also preferred when using acid-halides. [0416]
  • The reaction temperature in the process (Eβ) according to the invention can be varied within a relatively wide range. In general, the reaction is carried out at temperatures between −20° C. and +150° C., preferably between 0° C. and 100° C. [0417]
  • When carrying out process (Eβ) according to the invention, the starting materials of the formulae (I-1-a) to (I-4-a) and the carboxylic anhydride of the formula (VIII) are in general each used in approximately equivalent amounts. Howvever, it is also possible to employ the carboxylic anhydride in a relatively large excess (up to 5 mol). Work-up is carried out according to customary methods. [0418]
  • In general, a procedure is used in which diluent and excess carboxylic anhydride and the resulting carboxylic acid are removed by distillation or by washing with an organic solvent or with water. [0419]
  • Process (F) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with chloroformic acid esters or chloroformic acid thioesters of the formula (IX), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0420]
  • Suitable acid-binding agents for process (F) according to the invention are all customary acid acceptors. Those preferably utilizable are tertiary amines, such as triethylamine, pyridine, DABCO, DBU, DBA, Huinig base and N,N-dimethylaniline, furthermore alkaline earth metal oxides, such as magnesium oxide and calcium oxide, additionally alkali metal and alkaline earth metal carbonates, such as sodium carbonate, potassium carbonate and calcium carbonate and also alkali metal hydroxides such as sodium hydroxide and potassium hydroxide. [0421]
  • Suitable diluents for the process (F) according to the invention are all solvents which are inert to the chloroformic acid esters or chloroformic acid thioesters. Those preferably utilizable are hydrocarbons, such as benzine, benzene, toluene, xylene and tetraline, furthermore halogenated hydrocarbons, such as methylene chloride, chloroform, carbon tetrachloride, chlorobenzene and o-dichlorobenzene, additionally ketones, such as acetone and methyl isopropyl ketone, furthermore ethers, such as diethyl ether, tetrahydrofuran and dioxan, moreover carboxylic acid esters, such as ethyl acetate, furthermore nitriles, such as acetonitrile, and also strongly polar solvents, such as dimethylformamide, dimethyl sulphoxide and sulpholane. [0422]
  • When carrying out process (F) according to the invention, the reaction temperature can be varied within a relatively wide range. The reaction temperature is generally between −20° C. and +100° C., preferably betwveen 0° C. and 50° C. [0423]
  • Process (F) according to the invention is in general carried out under atmospheric pressure. [0424]
  • When carrying out process (F) according to the invention, the starting materials of the formulae (I-1-a) to (I-4-a) and the appropriate chloroformic acid ester or chloroformic acid thioester of the formula (IX) are in general each used in approximately equivalent amounts. However, it is also possible to employ one component or the other in a relatively large excess (up to 2 mol). Work-up is carried out according to customary methods. In general, a procedure is used in which precipitated salts are removed and the reaction mixture which remains is concentrated by stripping off the diluent. [0425]
  • Process (G) according to the invention is characterized in that compounds of the formula (I-1-a) to (I-4-a) are in each case reacted with compounds of the formula (X) in the presence of a diluent and, if appropriate, in the presence of an acid-binding agent. [0426]
  • In preparation process (G), about 1 mol of chloromonothioformic acid ester or chlorodithioformic acid ester of the formula (X) is reacted per mol of a starting material of the formulae (I-1-a) to (I-4-a), at 0 to 120° C., preferably at 20 to 60° C. [0427]
  • Diluents which may be added, if appropriate, are all inert polar organic solvents, such as ethers, amides, sulphones, sulphoxides, and also halogenoalkanes. [0428]
  • Dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride are preferably employed. [0429]
  • If, in a preferred embodiment, the enolate salt of the compounds (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents, for example sodium hydride or potassium tert-butoxide, the further addition of acid-binding agents can be dispensed with. [0430]
  • If acid-binding agents are used, customary inorganic or organic bases are suitable; sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned by way of example. [0431]
  • The reaction can be carried out at atmospheric pressure or at elevated pressure; it is preferably carried out at atmospheric pressure. Work-up takes place according to customary methods. [0432]
  • Process (H) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with sulphonyl chlorides of the formula (XII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0433]
  • In preparation process (H), about 1 mol of sulphonyl chloride of the formula (XII) is reacted per mol of starting material of the formulae (I-1-a) to (I-4-a) at −20 to 150° C., preferably at 0 to 70° C. [0434]
  • Process (H) is preferably carried out in the presence of a diluent. [0435]
  • Suitable diluents are all inert polar organic solvents, such as ethers, amides, ketones, carboxylic acid esters, nitrites, sulphones, sulphoxides or halogenated hydrocarbons such as methylene chloride. [0436]
  • Dimethyl sulphoxide, tetrahydrofuran, dimethylformamide and methylene chloride are preferably employed. [0437]
  • If, in a preferred embodiment, the enolate salt of the compounds (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents (for example sodium hydride or potassium tert-butoxide), the further addition of acid-binding agents can be dispensed with. [0438]
  • If acid-binding agents are employed, customary inorganic or organic bases are suitable; sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned by way of example. [0439]
  • The reaction can be carried out at atmospheric pressure or at elevated pressure; it is preferably carried out at atmospheric pressure. Work-up takes place according to customary methods. [0440]
  • The process (I) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with phosphorus compounds of the formula (XIII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0441]
  • In preparation process (I), 1 to 2, preferably 1 to 1.3, mol of the phosphorus compound of the formula (XIII) is reacted per 1 mol of the compounds (I-1-a) to (I-4-a) at temperatures between −40° C. and 150° C., preferably between −10° C. and 110° C., to give compounds of the formulae (I-1-e) to (I-4-e). [0442]
  • The process (I) is preferably carried out in the presence of a dituent. [0443]
  • Suitable diluents are all inert polar organic solvents, such as ethers, carboxylic acid esters, halogenated hydrocarbons, ketones, amides, nitriles, sulphones, sulphoxides, etc. [0444]
  • Acetonitrile, dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride are preferably employed. [0445]
  • Acid-binding agents which may be added, if appropriate, are customary inorganic or organic bases, such as hydroxides, carbonates or amines. By way of example, sodium hydroxide, sodium carbonate, potassium carbonate, pyridine and triethylamine may be mentioned. [0446]
  • The reaction may be carried out at atmospheric pressure or at elevated pressure; it is preferably carried out at atmospheric pressure. Work-up takes place according to conventional methods of organic chemistry. The end products are preferably purified by crystallization, chromatographic purification or by so-called “incipient distillation”, i.e. removal of the volatile constituents in vacuo. [0447]
  • Process (J) is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with metal hydroxides or metal alkoxides of the formula (XIV) or amines of the formula (XV), if appropriate in the presence of a diluent. [0448]
  • Preferred diluents for process (J) according to the invention are ethers such as tetrahydrofuran, dioxan and diethyl ether or else alcohols such as methanol, ethanol and isopropanol, but also water. Process (J) according to the invention is generally carried out under atmospheric pressure. The reaction temperature is in general between −20° C. and 100° C., preferably between 0° C. and 50° C. [0449]
  • Process (K) according to the invention is characterized in that compounds of the formulae (I-1-a) to (I-4-a) are in each case reacted with (Kα) compounds of the formula (XVI), if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or (Kβ) with compounds of the formula (XVII), if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent. [0450]
  • In preparation process (Kox), about 1 mol of isocyanate of the formula (XVI) is reacted per mole of starting material of the formulae (I-1-a) to (I-4-a) at 0 to 100° C., preferably at 20 to 50° C. [0451]
  • Process (Kα) is preferably carried out in the presence of a diluent. [0452]
  • Suitable diluents are all inert organic solvents, such as aromatic hydrocarbons, halogenated hydrocarbons, ethers, amides, nitrites, sulphones or sulphoxides. [0453]
  • Catalysts may, if desired, be added to accelerate the reaction. The catalysts employed can very advantageously be organotin compounds, for example dibutyltin dilaurate. [0454]
  • The reaction is preferably carried out at atmospheric pressure. [0455]
  • In preparation process (Kβ), about 1 mol of carbamoyl chloride of the formula (XVII) is reacted at 0 to 150° C., preferably at 20 to 70° C., per mole of starting material of the formulae (I-1-a) to (I-4-a). [0456]
  • Possible diluents optionally added are all inert polar organic solvents, such as ethers, carboxylic acid esters, nitrites, ketones, amides, sulphones, sulphoxides or halogenated hydrocarbons. [0457]
  • Dimethyl sulphoxide, tetrahydrofuran, dimethylformamide or methylene chloride are preferably employed. [0458]
  • If, in a preferred embodiment, the enolate salt of the compound (I-1-a) to (I-4-a) is prepared by addition of strong deprotonating agents (e.g. sodium hydride or potassium tertiary butoxide), the further addition of acid-binding agents can be dispensed with. [0459]
  • If acid-binding agents are employed, customary inorganic or organic bases are suitable; those which may be mentioned by way of example are sodium hydroxide, sodium carbonate, potassium carbonate, triethylamine or pyridine. [0460]
  • The reaction can be carried out at atmospheric pressure or at elevated pressure, preferably at atmospheric pressure. Work-up takes place according to customary methods. [0461]
  • The active compounds are suitable for controlling animal pests, preferably arthropods and nematodes, in particular insects and arachnida, which are encountered in agriculture, in forestry, in the protection of stored products and of materials, and in the hygiene field. They are active against normally sensitive and resistant species and against all or some stages of development. The abovementioned pests include: [0462]
  • From the order of Isopoda, for example, [0463] Oniscus asellus, Armadillidium vulgare and Porcellio scaber.
  • From the order of the Diplopoda, for example, [0464] Blaniulus guttulatus.
  • From the order of the Chilopoda, for example, [0465] Geophilus carpophagus and Scutigera spec.
  • From the order of the Symphyla, for example, [0466] Scutigerella immaculata.
  • From the order of the Thysanura, for example, [0467] Lepisma saccharina.
  • From the order of the Collembola, for example, [0468] Onychiurus armatus.
  • From the order of the Orthoptera, for example, [0469] Blatta orientalis, Periplaneta americana, Leucophaea maderae, Blatella germanica, Acheta domesticus, Gryllotalpa spp., Locusta migratoria migratorioides, Melanoplus differentialis and Schistocerca gregaria.
  • From the order of the Dermaptera, for example, [0470] Forficula auricularia.
  • From the order of the Isoptera, for example, Reticulitermes spp. [0471]
  • From the order of the Anoplura, for example, [0472] Phylloxera vastatrix, Pemphigus spp., Pediculus humanus corporis, Haematopinus spp. and Linognathus spp.
  • From the order of the Mallophaga, for example, Trichodectes spp. and Damalinea spp. [0473]
  • From the order of the Thysanoptera, for example, [0474] Hercinothrips femoralis and Thrips tabaci.
  • From the order of the Heteroptera, for example, Eurygaster spp., [0475] Dysdercus intermedius, Piesma quadrata, Cimex lectularius, Rhodnius prolixus and Triatoma spp.
  • From the order of the Homoptera, for example, [0476] Aleurodes brassicae, Bemisia tabaci, Trialeurodes vaporariorum, Aphis gossypii, Brevicoryne brassicae, Cryptomyzus ribis, Aphis fabae, Doralis pomi, Eriosoma lanigerum, Hyalopterus arundinis, Macrosiphum avenae, Myzus spp., Phorodon humuli, Rhopalosiphum padi, Empoasca spp., Euscelis bilobatus, Nephotettix cincticeps, Lecanium corni, Saissetia oleae, Laodelphax striatellus, Nilaparvata lugens, Aonidiella aurantii, Aspidiotus hederae, Pseudococcus spp. and Psylla spp.
  • From the order of the Lepidoptera, for example, [0477] Pectinophora gossypiella, Bupalus piniarius, Cheimatobia brumata, Lithocolletis blancardella, Hyponomeuta padella, Plutella maculipennis, Malacosoma neustria, Euproctis chrysorrhoea, Lymantria spp, Bucculatrix thurberiella, Phyllocnistis citrella, Agrotis spp., Euxoa spp., Feltia spp., Earias insulana, Heliothis spp., Spodoptera exigua, Mamestra brassicae, Panolis flammea, Prodenia litura, Spodoptera spp., Trichoplusia ni, Carpocapsa pomonella, Pieris spp., Chilo spp., Pyrausta nubilalis, Ephestia kuehniella, Galleria mellonelia, Tineola bisselliella, Tinea pellionella, Hofmannophila pseudospretella, Cacoecia podana, Capua reticulana, Choristoneura fumiferana, Clysia ambiguella, Homona magnanima and Tortrix viridana.
  • From the order of the Coleoptera, for example, [0478] Anobium punctatum, Rhizopertha dominica, Acanthoscelides obtectus, Hylotrupes bajulus, Agelastica alni, Leptinotarsa decemlineata, Phaedon cochleariae, Diabrotica spp., Psylliodes chrysocephala, Epilachna varivestis, Atomaria spp., Oryzaephilus surinamensis, Anthonomus spp., Sitophilus spp., Otiorrhynchus sulcatus, Cosmopolites sordidus, Ceuthorrhynchus assimilis, Hypera postica, Dermestes spp., Trogoderma spp., Anthrenus spp., Attagenus spp., Lyctus spp., Meligethes aeneus, Ptinus spp., Niptus hololeucus, Gibbium psylloides, Tribolium spp., Tenebrio molitor, Agriotes spp., Conoderus spp., Melolontha melolontha, Amphimallon solstitialis and Costelytra zealandica.
  • From the order of the Hymenoptera, for example, Diprion spp., Hoplocampa spp., Lasius spp., [0479] Monomorium pharaonis and Vespa spp.
  • From the order of the Diptera, for example, Aedes spp., Anopheles spp., Culex spp., [0480] Drosophila melanogaster, Musca spp., Fannia spp., Calliphora erythrocephala, Lucilia spp., Chrysomyia spp., Cuterebra spp., Gastrophilus spp., Hyppobosca spp., Stomoxys spp., Oestrus spp., Hypoderma spp., Tabanus spp., Tannia spp., Bibio hortulanus, Oscinella frit, Phorbia spp., Pegomyia hyoscyami, Ceratitis capitata, Dacus oleae and Tipula paludosa.
  • From the order of the Siphonaptera, for example, [0481] Xenopsylla cheopis and Ceratophyllus spp.
  • From the order of the Arachnida, for example, [0482] Scorpio maurus and Latrodectus mactans.
  • From the order of the Acarina, for example, [0483] Acarus siro, Argas spp., Ornithodoros spp., Dermanyssus gallinae, Eriophyes ribis, Phyllocoptruta oleivora, Boophilus spp., Rhipicephalus spp., Amblyomma spp., Hyalomma spp., Ixodes spp., Psoroptes spp., Chorioptes spp., Sarcoptes spp., Tarsonemus spp., Bryobia praetiosa, Panonychus spp. and Tetranychus spp.
  • The active compounds according to the invention are distinguished by a high insecticidal and acaricidal activity. [0484]
  • They can be used to particularly good effect for controlling insects which are injurious to plants, such as, for example, against the larvae of the mustard beetle ([0485] Phaedon cochleariae), against the larvae of the green rice leaf hopper (Nephotettix cincticeps) or against the caterpillars of the cabbage moth (Plutella maculipennis) (cf. the Use Examples).
  • The active compounds can be converted into the customary formulations, such as solutions, emulsions, wettable powders, suspensions, powders, dusting agents, pastes, soluble powders, granules, suspension-emulsion concentrates, natural and synthetic materials impregnated with active compound, and very fine capsules in polymeric substances. [0486]
  • These formulations are produced in a known manner, for example by mixing the active compounds with extenders, that is liquid solvents and/or solid carriers, optionally with the use of surface-active agents, that is emulsifying agents and/or dispersing agents and/or foam-forming agents. [0487]
  • In the case of the use of water as an extender, organic solvents can, for example, also be used as auxiliary solvents. As liquid solvents, there are suitable in the main: aromatics, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics and chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes of methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, for example petroleum fractions, mineral and vegetable oils, alcohols, such as butanol or glycol as well as their ethers and esters, ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents, such as dimethylformamide and dimethyl sulphoxide, as well as water. [0488]
  • As solid carriers there are suitable: [0489]
  • for example ammonium salts and ground natural minerals, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth, and ground synthetic minerals, such as highly disperse silica, alumina and silicates, as solid carriers for granules there are suitable: for example crushed and fractionated natural rocks such as calcite, marble, pumice, sepiolite and dolomite as well as synthetic granules of inorganic and organic meals, and granules of organic material such as sawdust, coconut shells, maize cobs and tobacco stalks; as emulsifying and/or foam-forming agents there are suitable: for example non-ionic and anionic emulsifiers, such as polyoxyethylene fatty acid esters, polyoxyethylene fatty alcohol ethers, for example alkylaryl polyglycol ethers, alkylsulphonates, alkylsulphates, arylsulphonates as well as albumen hydrolysis products; as dispersing agents there are suitable: for example lignin-sulphite waste liquors and methylcellulose. [0490]
  • Adhesives such as carboxymethylcellulose and natural and synthetic polymers in the form of powders, granules or latices, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, as well as natural phospholipids such as cephalins and lecithins, and synthetic phospholipids, can be used in the formulations. Further additives can be mineral and vegetable oils. [0491]
  • It is possible to use colorants such as inorganic pigments, for example iron oxide, titanium oxide and Prussian Blue, and organic dyestuffs, such as alizarin dyestuffs, azo dyestuffs and metal phthalocyanine dyestuffs, and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. [0492]
  • The formulations in general contain between 0.1 and 95 per cent by weight of active compound, preferably between 0.5 and 90%. [0493]
  • The active compound according to the inv,ention can be present in its commercially available formulations and in the use forms prepared from these formulations, as a mixture with other active compounds, such as insecticides, attractants, sterilizing agents, acaricides, nematicides, fungicides, growth-regulating substances or herbicides. The insecticides include, for example, phosphates, carbamates, carboxylates, chlorinated hydrocarbons, phenylureas and substances produced by microorganisms. [0494]
  • Examples of particularly advantageous mixture components are the following compounds: [0495]
  • Fungicides [0496]
  • 2-aminobutane; 2-anilino-4-methyl-6-cyclopropyl-pyrimidine; 2′,6′-dibromo-2-methyl-4′-trifluoromethoxy-4′-trifluoro-methyl-1,3-thiazole-5-carboxanilide; 2,6-dichloro-N-(4-trifluoromethylbenzyl)-benzamide; (E)-2-methoxyimino-N-methyl-2-(2-phenoxyphenyl)-acetamide; 8-hydroxyquinoline sulphate; methyl (E)-2- (2-[6-(2-cyanophenoxy)-pyrimidin-4-yloxy]-phenyl)-3-methoxyacrylate; methyl (E)-methoximino-[alpha-(o-tolyloxy)-o-tolyl]-acetate; 2-phenylphenol (OPP), aldimorph, ampropylfos, anilazine, azaconazole, benalaxyl, benodanil, benomyl, binapacryl, biphenyl, bitertanol, blasticidin-S, bromuconazole, bupirimate, buthiobate, calcium polysulphide, captafol, captan, carbendazim, carboxin, quinomethionate, chloroneb, chloropicrin, chlorothalonil, chlozolinate, cufraneb, cymoxanil, cyproconazole, cyprofuram, dichlorophen, diclobutrazol, diclofluanid, diclomezin, dicloran, diethofencarb, difenoconazole, dimethirimol, dimethomorph, diniconazole, dinocap, diphenylamine, dipyrithion, ditalimfos, dithianon, dodine, drazoxolon, edifenphos, epoxyconazole, ethirimol, etridiazole, fenarimol, fenbuconazole, fenfuram, fenitropan, fenpiclonil, fenpropidin, fenpropimorph, fentin acetate, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, fluoromide, fluquinconazole, flusilazole, flusulphamide, flutolanil, flutriafol, folpet, fosetyl-aluminium, fthalide, fuberidazole, furalaxyl, furmecyclox, guazatine, hexachlorobenzene, hexaconazole, hymexazol, imazalil, imibenconazole, iminoctadine, iprobenfos (IBP), iprodione, isoprothiolane, kasugamycin, copper preparations such as: copper hydroxide, copper naphthenate, copper oxychloride, copper sulphate, copper oxide, oxine-copper and Bordeaux mixture, mancopper, mancozeb, maneb, mepanipyrim, mepronil, metalaxyl, metconazole, methasulphocarb, methfuroxam, metiram, metsulphovax, myclobutanil, nickel dimethyldithiocarbamate, nitrothal-isopropyl, nuarimol, ofurace, oxadixyl, oxamocarb, oxycarboxin, pefurazoate, penconazole, pencycuron, phosdiphen, phthalide, pimaricin, piperalin, polycarbamate, polyoxin, probenazole, prochloraz, procymidone, propamocarb, propiconazole, propineb, pyrazophos, pyrifenox, pyrimethanil, pyroquilon, quintozene (PCNB), sulphur and sulphur preparations, tebucanozole, tecloftalam, tecnazene, tetraconazole, thiabendazole, thicyofen, thiophanate-methyl, thiram, tolclophos-methyl, tolyifluanid, triadimefon, triadimenol, triazoxide, trichlamide, tricyclazole, tridemorph, triflumizole, triforine, triticonazole, validamycin A, vinclozolin, zineb, ziram. [0497]
  • Bactericides [0498]
  • bronopol, dichlorophen, nitrapyrin, nickel dimethyldithiocarbamate, kasugamycin, octhilinone, furancarboxylic acid, oxytetracyclin, probenazole, streptomycin, tecloftalam, copper sulphate and other copper preparations. [0499]
  • Insecticides/Acaricides/Nematicides [0500]
  • abamectin, AC 303 630, acephate, acrinathrin, alanycarb, aldicarb, alphamethrin, amitraz, avermectin, AZ 60541, azadirachtin, azinphos A, azinphos M, azocyclotin. Bacillus thuringiensis, bendiocarb, benfuracarb, bensultap, beta-cyfluthrin, bifenthrin, BPMC, brofenprox, bromophos A, bufencarb, buprofezin, butocarboxim, butylpyridaben, cadusafos, carbaryl, carbofuran, carbophenothion, carbosulphan, cartap, CGA 157 419, CGA 184699, chloethocarb, chlorethoxyfos, chlorfenvinphos, chlorfluazuron, chlormephos, chlorpyrifos, chlorpyrifos M, cis-resmethrin, clocythrin, clofentezine, cyanophos, cycloprothrin, cyfluthrin, cyhalothrin, cyhexatin, cypermethrin, cyromazine, deltamethrin, demeton-M, demeton-S, demeton-S-methyl, diafenthiuron, diazinon, dichlofenthion, dichlorvos, dicliphos, dicrotophos, diethion, diflubenzuron, dimethoate, dimethylvinphos, dioxathion, disulphoton, edifenphos, emamectin, esfenvalerate, ethiofencarb, ethion, ethofenprox, ethoprophos, etrimphos, fenamiphos, fenazaquin, fenbutatin oxide, fenitrothion, fenobucarb, fenothiocarb, fenoxycarb, fenpropathrin, fenpyrad, fenpyroximate, fenthion, fenvalerate, fipronil, fluazinam, flucycloxuron, flucythrinate, flufenoxuron, flufenprox, fluvalinate, fonophos, formothion, fosthiazate, fubfenprox, furathiocarb, HCH, heptenophos, hexaflumuron, hexythiazox, imidacloprid, iprobenfos, isazophos, isofenphos, isoprocarb, isoxathion, ivemectin, lambda-cyhalothrin, lufenuron, malathion, mecarbam, mevinphos, mesulphenphos, metaldehyde, methacrifos, methamidophos, methidathion, methiocarb, methomyl, metolcarb, milbemectin, monocrotophos, moxidectin, naled, NC 184, NI 25, nitenpyram, omethoate, oxamyl, oxydemethon M, oxydeprofos, parathion A, parathion M, permethrin, phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim, pirimicarb, pirimiphos M, pirimiphos A, profenofos, promecarb, propaphos, propoxur, prothiofos, prothoate, pymetrozin, pyrachlophos, pyridaphenthion, pyresmethrin, pyrethrum, pyridaben, pyrimidifen, pyriproxifen, quinalphos, RH 5992, salithion, sebufos, silafluofen, sulphotep, sulprofos, tebufenozid, tebufenpyrad, tebupirimiphos, teflubenzuron, tefluthrin, temephos, terbam, terbufos, tetrachlorvinphos, thiafenox, thiodicarb, thiofanox, thiomethon, thionazin, thuringiensin, tralomethrin, triarathen, triazophos, triazuron, trichlorfon, triflumuron, trimethacarb, vamidothion, XMC, xylylcarb, YI 5301/5302, zetamethrin. [0501]
  • Herbicides [0502]
  • for example anilides such as, for example, diflufenican and propanil; arylcarboxylic acids such as, for example, dichloropicolinic acid, dicamba and picloram; aryloxyalkanoic acids such as, for example, 2,4-D, 2,4-DB, 2,4-DP, fluroxypyr, MCPA, MCPP and triclopyr; aryloxy-phenoxy-alkanoic esters such as, for example, diclofop-methyl, fenoxaprop-ethyl, fluazifop-butyl, haloxyfop-methyl and quizalofop-ethyl; azinones such as, for example, chloridazon and norflurazon; carbamates such as, for example, chlorpropham, desmedipham, phenmedipham and propham; chloroacetanilides such as, for example, alachlor, acetochlor, butachlor, metazachlor, metolachlor, pretilachlior and propachlor; dinitroanilines such as, for example, oryzalin, pendimethalin and trifluralin; diphenyl ethers such as, for example, acifluorfen, bifenox, fluoroglycofen, fomesafen, halosafen, lactofen and oxyfluorfen; ureas such as, for example, chlortoluron, diuron, fluometuron, isoproturon, linuron and methabenz-thiazuron; hydroxylamines such as, for example, alloxydim, clethodim, cycloxydim, sethoxydim and tralkoxydim; imidazolinones such as, for example, imazethapyr, imazamethabenz, imazapyr and imazaquin; nitriles such as, for example, bromoxynil, dichlobenil and ioxynil; oxyacetamides such as, for example, mefenacet; sulphonylureas such as, for example, amidosulphuron, bensulphuron-methyl, chlorimuron-ethyl, chlorsulphuron, cinosulphuron, metsulphuron-methyl, nicosulphuron, primisulphuiron, pyrazosulphuron-ethyl, thifensulphuron-methyl, triasulphuron and tribenuron-methyl; thiocarbamates such as, for example, butylate, cycloate, di-allate, EPTC, esprocarb, molinate, prosulphocarb, thiobencarb and tri-allate; triazines such as, for example, atrazine, cyanazine, simazine, simetryne, terbutryne and terbutylazine; triazinones such as, for example, hexazinone, metamitron and metribuzin; others such as, for example, aminotriazole, benfuresate, bentazone, cinmethylin, clomazone, clopyralid, difenzoquat, dithiopyr, ethofumesate, fluorochloridone, glufosinate, glyphosate, isoxaben, pyridate, quinchlorac, quinmerac, sulphosate and tridiphane [0503]
  • The active compound according to the invention can furthermore be present in its commercially available formulations and in the use forms prepared from these formulations, as a mixture with synergistic agents. Synergistic agents are compounds which increase the action of the active compounds without it being necessary for the synergistic agent added to be active itself. [0504]
  • The active compound content of the use forms prepared from the commercially available formulations can vary within wide limits. The active compound concentration of the use forms can be from 0.0000001 to 95% by weight of active compound, preferably between 0.0001 and 1% by weight. [0505]
  • The compounds are employed in a customary manner appropriate for the use forms. [0506]
  • When used against hygiene pests and pests of stored products, the active compounds are distinguished by an excellent residual action on wood and clay as well as a good stability to alkali on limed substrates. [0507]
  • The active compounds according to the invention are not only active against plant, hygiene and stored-product pests, but also, in the veterinary medicine sector, against animal parasites (ectoparasites), such as ixodid ticks, argasid ticks, scab mites, trombiculid mites, flies (stinging and sucking), parasitic fly larvae, lice, hair lice, bird lice and fleas. These parasites include: [0508]
  • From the order of the Anoplurida, for example, Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., Solenopotes spp.. [0509]
  • From the order of the Mallophagida and the sub-orders Amblycerina and Ischnocerina, for example, Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp., Felicola spp. [0510]
  • From the order Diptera and the sub-orders Nematocerina and Brachycerina, for example, Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp., [0511]
  • From the order of the Siphonapterida, for example, Pulex spp., Ctenocephalides spp., Xenopsylla spp. and Ceratophyllus spp.. [0512]
  • From the order of the Heteropterida, for example, Cimex spp., Triatoma spp., Rhodnius spp. and Panstrongylus spp. [0513]
  • From the order of the Blattarida, for example, Blatta orientalis, Periplaneta americana, Blattela germanica and Supella spp.. [0514]
  • From the sub-class of the Acaria (Acarida) and the orders of the Meta- and Mesostigmata, for example Argas spp., Ornithodorus spp., Otabius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemaphysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp and Varroa spp. [0515]
  • From the order of the Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Octodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.. [0516]
  • For example, they show an outstanding activity against Boophilus microplus and Lucilia cuprina. [0517]
  • The active compounds of the formula (I) according to the invention are also suitable for controlling arthropods which attack agricultural livestock, such as, for example, cattle, sheep, goats, horses, pigs, donkeys, camels, buffalo, rabbits, chickens, turkeys, ducks, geese, honey bees, other domestic animals, such as, for example, dogs, cats, cage birds, aquarium fish, and so-called experimental animals such as, for example, hamsters, guinea-pigs, rats and mice. By controlling these arthropods, it is intended to reduce mortality and decreased performance (in meat, milk, wool, hides, eggs, honey and the like), so that more economical and simpler animal keeping is made possible by using the active compounds according to the invention. [0518]
  • In the veterinary sector, the active compounds according to the invention are used in a known manner by enteral administration, for example in the form of tablets, capsules, drinks, drenches, granules, pastes, boluscs, the feed-through method, suppositories, by parenteral administration, such as, for example, by means of injections (intramuscular, subcutaneous, intravenous, intraperitoneal and the like), implants, by nasal application, by dermal administration, for example in the form of dipping or bathing, spraying, pouring-on and spotting-on, washing, dusting, and with the aid of shaped articles which comprise active compound, such as collars, ear tags, tail marks, limb bands, halters, marking devices and the like. [0519]
  • When administered to livestock, poultry, domestic animals and the like, the active compounds of the formula (I) can be used as formulations (for example powders, emulsions, flowables) which comprise the active compounds in an amount of 1 to 80% by weight, either directly or after dilution by a factor of 100 to 10,000, or they may be used in the form of a chemical bath. [0520]
  • Furthermore, it has been found that the compounds of the formula (I) according to the invention have a potent insecticidal action against insects which destroy industrial materials. [0521]
  • The following insects may be mentioned by way of example and as being preferred, but without any limitation: [0522]
  • Beetles, such as [0523]
  • Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinus pecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthes rugicollis, Zyleborus spec., Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec., Dinoderus minutus. [0524]
  • Dermapterans, such as [0525]
  • Sirex juvencus, Urocerus gigas, Urocerus gigas taignus, Urocerus augur. [0526]
  • Termites, such as [0527]
  • Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis, Coptotermes formosanus. [0528]
  • Bristletails, such as [0529]
  • Lepisma saccharina. [0530]
  • Industrial materials are to be understood as meaning, in the present context, non-live materials such as, preferably, synthetic materials, glues, sizes, paper and board, leather, wood and timber products, and paint. [0531]
  • The materials to be very particularly protected against attack by insects are wood and timber products. [0532]
  • Wood and timber products which can be protected by the composition according to the invention or mixtures comprising such a composition are to be understood as meaning, for example, construction timber, wooden beams, railway sleepers, bridge components, jetties, wooden vehicles, boxes, pallets, containers, telephone poles, wood lagging, windows and doors made of wood, plywood, particle board, joiner's articles, or wood products which, quite generally, are used in the construction of houses or in joinery. [0533]
  • The active compounds can be used as such, in the form of concentrates or generally customary formulations, such as powders, granules, solutions, suspensions, emulsions or pastes. [0534]
  • The formulations mentioned can be prepared in a manner known per se, for example by mixing the active compounds with at least one solvent or diluent, emulsifier, dispersant and/or binder or fixative, water repellent, if appropriate desiccants and UV stabilizers and, if appropriate, colorants and pigments and other processing auxiliaries. [0535]
  • The insecticidal compositions or concentrates used for the protection of wood and wooden materials comprise the active compound according to the invention at a concentration of 0.0001 to 95% by weight, in particular 0.001 to 60% by weight. [0536]
  • The amount of the compositions or concentrates employed depends on the species and the occurrence of the insects and on the medium. The optimum rate of application can be determined upon use in each case by test series. However, in general, it suffices to employ 0.0001 to 20% by weight, preferably 0.001 to 10% by weight, of the active compound, based on the material to be protected. [0537]
  • The solvent and/or diluent used is an organochemical solvent or solvent mixture and/or an oily or oil-type organochemical solvent or solvent mixture of low volatility and/or a polar organochemical solvent or solvent mixture and/or water and, if appropriate, an emulsifier and/or wetting agent. [0538]
  • Organochemical solvents which are preferably employed are oily or oil-type solvents having an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C. Substances which are used as such oily and oil-type solvents which have low volatility and are insoluble in water are suitable mineral oils or their aromatic fractions, or mineral-oil-containing solvent mixtures, preferably white spirit, petroleum and/or alkylbenzene. [0539]
  • Substances which are advantageously used are mineral oils with a boiling range of 170 to 220° C., white spirit with a boiling range of 170 to 220° C., spindle oil with a boiling range of 250 to 350° C., petroleum or aromatics of boiling range 160 to 280° C., essence of turpentine and the like. [0540]
  • In a preferred embodiment, liquid aliphatic hydrocarbons with a boiling range of 180 to 210° C. or high-boiling mixtures of aromatic and aliphatic hydrocarbons with a boiling range of 180 to 220° C. and/or spindle oil and/or monochloro- naphthalene, preferably α-monochloronaphthalene, are used. [0541]
  • The organic oily or oil-type solvents of low volatility having an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C., can be partially replaced by organochemical solvents of high or medium volatility, with the proviso that the solvent mixture also has an evaporation number of above 35 and a flashpoint of above 30° C., preferably above 45° C., and that the insecticide/fungicide mixture is soluble or emulsifiable in this solvent mixture. [0542]
  • In a preferred embodiment, part of the organochemical solvent or solvent mixture is replaced by an aliphatic polar organochemical solvent or solvent mixture. Substances which are preferably used are aliphatic organochemical solvents having hydroxyl and/or ester and/or ether groups, such as, for example, glycol ether, esters and the like. [0543]
  • The organochemical binders used within the scope of the present invention are the synthetic resins and/or binding drying oils which are known per se and can be diluted with water and/or are soluble or dispersible or emulsifiable in the organochemical solvents employed, in particular binders composed of, or comprising, an acrylate resin, a vinyl resin, for example polyvinyl acetate, polyester resin, polycondensation or polyaddition resin, polyurethane resin, alkyd resin or modified alkyd resin, phenol resin, hydrocarbon resin, such as indene/coumarone resin, silicone resin, drying vegetable and/or drying oils and/or physically drying binders based on a natural and/or synthetic resin. [0544]
  • The synthetic resin used as the binder can be employed in the form of an emulsion, dispersion or solution. Up to 10% by weight of bitumen or bituminous substances can also be used as binders. In addition, colorants, pigments, water repellents, odour-masking substances and inhibitors or anticorrosives known per se and the like can also be employed. [0545]
  • The composition or the concentrate preferably comprises, in accordance with the invention, at least one alkyd resin or modified alkyd resin and/or a drying vegetable oil as the organochemical binder. Preferably used according to the invention are alkyd resins with an oil content of over 45% by weight, preferably 50 to 68% by weight. [0546]
  • All or some of the abovementioned binder can be replaced by a fixative (mixture) or a plasticizer (mixture). These additives are intended to prevent volatilization of the active compounds and crystallization or precipitation. They preferably replace 0.01 to 30% of the binder (based on 100% of binder employed). [0547]
  • The plasticizers are from the chemical classes of the phthalic esters, such as dibutyl phthalate, dioctyl phthalate or benzylbutyl phthalate, the phosphoric esters, such as tributyl phosphate, the adipic esters, such as di-(2-ethylhexyl) adipate, the stearates, such as butyl stearate or amyl stearate, the oleates, such as butyl oleate, the glycerol ethers or relatively high-molecular-weight glycol ethers, glycerol esters and p-toluene-sulphonic esters. [0548]
  • Fixatives are chemically based on polyvinyl alkyl ethers, such as, for example, polyvinyl methyl ether, or ketones, such as benzophenone or ethylene benzophenone. [0549]
  • Particularly suitable as a solvent or diluent is also water, if appropriate as a mixture with one or more of the abovementioned organochemical solvents or diluents, emulsifiers and dispersants. [0550]
  • Particularly effective protection of wood is achieved by large-scale industrial impregnation processes, for example vacuum, double-vacuum or pressure processes. [0551]
  • If appropriate, the ready-to-use compositions can additionally comprise one or more other insecticides and, if appropriate, additionally one or more fungicides. [0552]
  • Suitable additional components which may be admixed are, preferably, the insecticides and fungicides mentioned in WO 94/29 268. The compounds mentioned in that document are expressly part of the present application. [0553]
  • Very particularly preferred components which may be admixed are insecticides, such as chlorpyriphos, phoxim, silafluofin, alphamethrin, cyfluthrin, cypermethrin, deltamethrin, permethrin, imidacloprid, NI-25, flufenoxuron, hexaflumuron and triflumuron, and fungicides, such as epoxyconazole, hexaconazole, azaconazole, propiconazole, tebuconazole, cyproconazole, metconazole, imazalil, dichlorofluanide, tolylfluanide, 3-iodo-2-propinylbutyl carbamate, N-octyl-isothiazolin-3-one and 4,5-dichloro-N-octylisothiazolin-3-one. [0554]
  • The preparation and the use of the active compounds according to the invention can be seen from the examples below. [0555]
    • PREPARATION EXAMPLES Example (I-1-a-1)
  • [0556]
    Figure US20020010204A1-20020124-C00114
  • At 80° C., 17.9 g of the compound of Example II-1 in 36 ml of anhydrous dimethylformamide (DMF) are added dropwise to 14.94 g (0.128 mol) of potassium tert-butoxide in 51 ml of anhydrous DMF, and the mixture is stirred at room temperature for 1.5 hours. 440 ml of ice-water are then added, and the mixture is acidified to pH 1 at 0-20° C. using concentrated HCI and the precipitate is filtered off with suction and dried. The crude product is stirred with methyl tert-butyl ether (MTBE)/n-hexane, filtered off with suction and dried. [0557]
  • Yield: 10 g (62% of theory); mp.: >220° C. [0558]
  • Similar to Example (I-1-a-1) and/or according to the general preparation instructions, the following compounds of the formula (I-1-a) are obtained: [0559]
    Figure US20020010204A1-20020124-C00115
    Ex. Iso- mp.
    No. X Z A B mer ° C.
    I-1-a-2 CH3 H —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-3 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— β >220
    I-1-a-4 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-5 OCH3 H —(CH2)2—CHCH3—(CH2)2— β 181
    I-1-a-6 i-C3H7 H —(CH2)2—CHCH3—(CH2)2— β 193
    I-1-a-7 Cl NO2 —(CH2)2—CHCH3—(CH2)2— β >220
    I-1-a-8 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— β 128
    I-1-a-9 OCH2—C6H5 H —(CH2)2—CHCH3—(CH2)2— β 188
    I-1-a-10 CH3 CH3 i-C3H7 CH3 — 117
    I-1-a-11 CH3 CH3 CH3 CH3 — 210
    I-1-a-12 Br OCH3 —(CH2)2—CHCH3—(CH2)2— β >220
    I-1-a-13 Cl NH2 —(CH2)2—CHCH3—(CH2)2— β
    I-1-a-14 OCH3 Cl —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-15 Br OCH3 —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-16 Cl CH3 —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-17 F OCH3 —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-18 CH3 CH3 —(CH2)2—O—(CH2)2— — 215
    I-1-a-19 Cl Cl —(CH2)2—CHOCH3—(CH2)2— β 218
    I-1-a-20 F F —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-21 Br Br —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-22 Cl H —(CH2)2—CHOCH3—(CH2)2— β 218
    I-1-a-23 Cl NO2 —(CH2)2—CHOCH3—(CH2)2— β >220
    I-1-a-24 F CH3 —(CH2)2—CHOCH3—(CH2)2— β 200-
    201
    • Example (I-1-b-1)
  • [0560]
    Figure US20020010204A1-20020124-C00116
  • 2.3 g (8 mmol) of the compound of Example I-1-a-2 are precharged in 50 ml of anhydrous ethyl acetate and admixed with 1.34 ml (9.6 mmol) of triethylamine, and 1.01 ml (9.6 mmol) of isobutyryl chloride in 5 ml of anhydrous ethyl acetate are added dropwise under reflux. After 16 hours at reflux, the mixture is concentrated and the residue is taken up in methylene chloride, washed 2× with 50 ml of 0.5N NaOH each time, dried and evaporated. The residue is recrystallized from methyl tert-butyl ether (MTB ether)/n-hexane. [0561]
  • Yield: 1.8 g (a 62% of theory) mp.: 163° C. [0562]
  • Similar to Example (I-1-b-1) and/or according to the general preparation instructions, the following compounds of the formula (I-b-1) are obtained: [0563]
    Figure US20020010204A1-20020124-C00117
    mp. Iso-
    Ex. No. X Z A B R1 ° C. mer
    I-1-b-2 i-C3H7 H —(CH2)2—CHCH3—(CH2)2— i-C3H7— 183 β
    I-1-b-3 i-C3H7 H —(CH2)2—CHCH3—(CH2)2— t-C4H9— 198 β
    I-1-b-4 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— i-C3H7— 170 β
    I-1-b-5 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— t-C4H9—CH2— 198 β
    I-1-b-6 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— 4-Cl—C6H4— 213 β
    I-1-b-7 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— i-C3H7— 145 β
    I-1-b-8 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— t-C4H9—CH2— 194 β
    I-1-b-9 CH3 CH3 CH3 CH3 i-C3H7— 188 —
    I-1-b-10 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— i-C3H7— 143 β
    I-1-b-11 Br OCH3 —(CH2)2—CHCH3—(CH2)2— i-C3H7— 151 β
    I-1-b-12 Cl NO2 —(CH2)2—CHCH3—(CH2)2— i-C3H7— >220 β
    I-1-b-13 O—CH2—C6H5 H —(CH2)2—CHCH3—(CH2)2— i-C3H7— 161 β
    I-1-b-14 CH3 CH3 i-C3H7 CH3 C2H5—O—CH2— 103 —
    I-1-b-15 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— i-C4H9— 157 β
    I-1-b-16 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— cyclohexyl 171 β
    I-1-b-17 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— C2H5O—CH2— 131 β
    I-1-b-18 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— 4-Cl—C6H4— 164 β
    I-1-b-19 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2—
    Figure US20020010204A1-20020124-C00118
         		164 β
    I-1-b-20 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— t-C4H9— 129 β
    I-1-b-21 OCH3 Cl —(CH2)2—CHOCH3—(CH2)2— i-C3H7— 216- β
    218
    I-1-b-22 Br OCH3 —(CH2)2—CHOCH3—(CH2)2— i-C3H7— 123- β
    124
    I-1-b-23 Cl CH3 —(CH2)2—CHOCH3—(CH2)2— i-C3H7— β
    I-1-b-24 Br Br —(CH2)2—CHOCH3—(CH2)2— i-C3H7— 199- β
    200
    I-1-b-25 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— CH3— 187- β
    188
    I-1-b-26 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— i-C4H9— 110- β
    111
    I-1-b-27 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— C2H5O—CH2— β
    I-1-b-28 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— cyclohexyl 162- β
    164
    I-1-b-29 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— 4-Cl—C6H4— >225 β
    I-1-b-30 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2—
    Figure US20020010204A1-20020124-C00119
         		181 β
    I-1-b-31 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— s-C4H9— 103- β
    104
    • Example I-1-c-1
  • [0564]
    Figure US20020010204A1-20020124-C00120
  • 2.3 g (8 mmol) of the compound of Example I-1-a-2 are precharged in 50 ml of anhydrous methylene chloride and admixed with 1.12 ml (8 mmol) of triethylamine, and 0.8 ml (8 mmol) of ethyl chloroformate in 5 ml of anhydrous methylene chloride are added dropwise at 0-10° C. Stirring is continued at room temperature and the reaction is monitored by TLC. The mixture is then washed 2× with 50 ml of 0.5N NaOH each time, dried and evaporated, and the residue is recrystallized from MTB ether/n-hexane. [0565]
  • Yield: 1.7 g (a 59% of theory) mp.: 135° C. [0566]
  • Similar to Example (I-1-c-) and/or according to the general preparation instrucions, the following compounds of the formula (I-1-c) are obtained: [0567]
    Figure US20020010204A1-20020124-C00121
    Ex. mp. Iso-
    No. X Z A B M R2 ° C. mer
    I-1-c-2 I-C3H7 H —(CH2)2—CHCH3—(CH2)2— O C2H5 198 β
    I-1-c-3 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— O C2H5 146 β
    I-1-c-4 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— O C2H5 128 β
    I-1-c-5 CH3 CH3 CH3 CH3 O C2H5 139 —
    I-1-c-6 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— O C2H5 126 β
    I-1-c-7 Br OCH3 —(CH2)2—CHCH3—(CH2)2— O C2H5 175 β
    I-1-c-8 Cl NO2 —(CH2)2—CHCH3—(CH2)2— O C2H5 236 β
    I-1-c-9 O—CH2—C6H5 H —(CH2)2—CHCH3—(CH2)2— O C2H5 131 β
    I-1-c-10 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— O i-C4H9— 122 β
    I-1-c-11 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— O C6H5—CH2 139 β
    I-1-c-12 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— O C6H5— 193 β
    I-1-c-13 OCH3 CH3 —(CH2)2CHOCH3—(CH2)2— O C2H5— 208- β
    211
    I-1-c-14 Br OCH3 —(CH2)2—CHOCH3—(CH2)2— O C2H5— 180- β
    182
    I-1-c-15 Cl CH3 —(CH2)2—CHOCH3—(CH2)2— O C2H5— 153- β
    155
    I-1-c-16 Br Br —(CH2)2—CHOCH3—(CH2)2— O C2H5— >230 β
    I-1-c-17 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— O i-C4H9— 137- β
    139
    I-1-c-18 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— O C6H5—CH2 135- β
    137
    I-1-c-19 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— S i-C3H7— 152- β
    154
    I-1-c-20 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— S t-C4H9— 200- β
    201
    I-1-c-21 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— S C6H5—CH2— 148- β
    149
    • Example I-1-g-1
  • [0568]
    Figure US20020010204A1-20020124-C00122
  • 1.8 g (6 mmol) of the compound of Example I-1-a-4 and 1.2 ml (1.5 eq) triethylamine are precharged in 50 ml of methyl acetate and heated under reflux. 0.91 ml (1.1 g; 1.3 eq) of morpholine-N-carboxylic acid chloride in 5 ml of methyl acetate are added. The mixture is heated under reflux over night, concentrated and the residue is taken up in CH[0569] 2Cl2. The organic phase is washed twice with 40 ml of N NaOH each time, dried and concentrated. The residue (2.7 g) is stirred with petrol ether, filtered off with suction and dried.
  • Yield: 0.90 g (36% of theory), mp.: 132° C. [0570]
    • Example I-1-g-2
  • Similar to Example I-1-g-1 and/or according to the general preparation instructions the compound is obtained as an oil: [0571]
    Figure US20020010204A1-20020124-C00123
    • Example (II-1)
  • [0572]
    Figure US20020010204A1-20020124-C00124
  • At 0-10° C., 16.9 g of 2-methylphenylacetyl chloride in 20 ml of anhydrous tetrahydrofuran (THF) are added dropwise to 20.8 g of methyl 1-amino-4-methylcyclohexanecarboxylate and 29.4 ml (0.21 mol) of triethylamine in 200 ml of anhydrous THF, and the mixture is stirred at room temperature. After the reaction has ended (control by thin-layer chromatography (TLC)), the mixture is concentrated, taken up in a mixture of 0.5N HCl/methylene chloride and the organic phase is dried and concentrated. The residue is recrystallized from MTBE/n-hexane. [0573]
  • Yield: 17.9 g (59% of theory); mp.: 107° C. [0574]
  • Similar to Example (II-1) and/or according to the general preparation instructions, the following compounds of the formula (II) are obtained: [0575]
    Figure US20020010204A1-20020124-C00125
    Ex. Iso- mp.
    No. X Z A B R8 mer ° C.
    II-2 CH3 H —(CH2)2—CHOCH3—(CH2)2— CH3 β 98
    II-3 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— CH3 β 120
    II-4 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 90
    II-5 CH3 CH3 CH3 CH3 CH3 —
    II-6 OCH3 H —(CH2)2—CHCH3—(CH2)2— CH3 β 138
    II-7 O—CH2—C6H5 H —(CH2)2—CHCH3—(CH2)2— CH3 β 85
    II-8 OCH3 Cl —(CH2)2—CHOCH3—(CH2)2— CH3 β 149
    II-9 CH3 CH3 —(CH2)2—CHOC2H5—(CH2)2— CH3 β 108
    II-10 CH3 CH3 i-C3H7 CH3 CH3 — 75
    II-11 CH3 CH3 —(CH2)2—O—(CH2)2— CH3 — 153
    II-12 Cl NO2 —(CH2)2—CHCH3—(CH2)2— CH3 β 158
    II-13 Cl Cl —(CH2)2—CHOCH3—(CH2)2— CH3 β 112
    II-14 Cl CH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 171
    II-15 Cl H —(CH2)2—CHOCH3—(CH2)2— CH3 β 68
    II-16 Br OCH3 —(CH2)2—CHCH3—(CH2)2— CH3 β 131
    II-17 Br OCH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 158
    II-18 Br Br —(CH2)2—CHOCH3—(CH2)2— CH3 β 132
    II-19 F CH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 74-
    76
    II-20 F OCH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 169
    II-21 F F —(CH2)2—CHOCH3—(CH2)2— CH3 β 91
    II-22 Cl NH2 —(CH2)2—CHCH3—(CH2)2— CH3 β 94
    II-23 Cl NO2 —(CH2)2—CHOCH3—(CH2)2— CH3 β 127
    II-24 Cl Br —(CH2)2—CHOCH3—(CH2)2— CH3 β 126-
    128
    II-25 Cl CF3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 109-
    111
    II-26 Br CH3 —(CH2)2—CHOCH3—(CH2)2— CH3 β 100-
    102
    • Example (II-10)
  • At an internal temperature of 30 to 40° C., 16.7 g of the compound of Example (XXVIII-1) in 200 ml of methylene chloride are added dropwise to 32.2 g (0.326 mol) of concentrated sulphuric acid, and the mixture is stirred for a further 2 hours at this temperature. 42 ml of anhydrous methanol are then added dropwise in such a way that an internal temperature of 40° C. is obtained. The mixture is stirred at 40 to 70° C. for a further 6 hours, poured onto 0.35 kg of ice and extracted with methylene chloride, the organic phase is washed with aqueous NaHCO[0576] 3 solution, dried and concentrated and the residue is crystallized from MTBE/n-hexane.
  • Yield: 7.40 g (39% of theory), mp.: 75° C. [0577]
    • Example (II-22)
  • 37 g of the compound of Example (II-12) in 370 ml of ethanol are admixed with Raney nickel and hydrogenated. The catalyst is filtered off, the filtrate is concentrated and the residue is recrystallized from MTBE/n-hexane. 10.3 g of a solid of mp.: 94° C. are obtained. Concentration of the mother liquor affords a further 20 g of product as an oil. [0578]
  • Total yield: 89% of theory. [0579]
    • Example (I-2-a-1)
  • [0580]
    Figure US20020010204A1-20020124-C00126
  • At 0 to 10° C., a solution of 16.6 g (50 mmol) of 1-ethyloxycarbonl-cyclohexyl 2-chlorophenylacetate according to Example (III-1) in 50 ml of tetrahydrofuran (THF) are added dropwise to 8.42 g (75 mmol) of potassium tert-butoxide in 50 ml of anhydrous THF, and the mixture is stirred at room temperature for 16 h. [0581]
  • For work-up, the reaction mixture is added dropwise to 500 ml of ice-cold 1N HCl, and the precipitated product is filtered off with suction, washed with water and dried in a vacuum drying cabinet. [0582]
  • Yield: 10.19 g (80% of theory) of mp.: 231° C. [0583]
  • Similar and/or according to the general preparation instructions, the following compounds of the formula (I-2-a) are obtained: [0584]
    Figure US20020010204A1-20020124-C00127
    Ex. mp.
    No. X Z A B ° C.
    I-2-a-2 CH3 H —(CH2)5— 233
    I-2-a-3 OCH3 H —(CH2)5— 177
    I-2-a-4 F H —(CH2)5— 233
    I-2-a-5 i-C3H7 H —(CH2)5— 200
    I-2-a-6 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— 180
    I-2-a-7 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— 240
    • Example (I-2-b-1)
  • [0585]
    Figure US20020010204A1-20020124-C00128
  • 2.79 g (10 mmol) of the compound of Example (I-2-a-1) are precharged in 50 ml of a.hydrous THm, 1.21 g (12 mmol) of triethylamine are added, a solution of 1.33 g (11 mmol) of pivaloyl chloride is added dropwise with ice cooling, and the mixture is stirred at room temperature for 16 h. For work-up, the mixture is stirred into 200 ml of water and the product is filtered off with suction and dried. [0586]
  • Yield: 3.5 g (98% of theory) of mp.: 128° C. [0587]
  • Similar and/or according to the general preparation instructions, the following, compounds of the formula (I-2-b) are obtained: [0588]
    Figure US20020010204A1-20020124-C00129
    Ex. mp.
    No. X Z A B R1 ° C.
    I-2-b-2 CH3 H —(CH2)5— t-C4H9 101
    I-2-b-3 Cl H —(CH2)5— H5C2—C(CH3)2— 90-
    92
    I-2-b-4 OCH3 H —(CH2)5— t-C4H9 oil
    I-2-b-5 F H —(CH2)5— t-C4H9 88
    I-2-b-6 i-C3H7 H —(CH2)5— t-C4H9 98
    I-2-b-7 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— i-C3H7 91
    I-2-b-8 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— i-C3H7 104-
    106
    • Example (I-2-c-1)
  • [0589]
    Figure US20020010204A1-20020124-C00130
  • At 0 to 10° C., 1.43 g of the compound of Example (I-2-a-7) in 30 ml of methylene chloride are admixed with 0.55 g of triethylamine and 0.75 g of isobutyl chloroformate. [0590]
  • Work-up is carried out as described in Example (I-1-c-1). [0591]
  • Yield: 0.94 g; mp.: 70° C. [0592]
    • Example (I-2-c-2)
  • [0593]
    Figure US20020010204A1-20020124-C00131
  • This compound was obtained in a similar manner starting from the compound of Example (I-2-a-6). [0594]
  • Yield: 1.7 g, semicrystalline. [0595]
    • Example (III-1)
  • [0596]
    Figure US20020010204A1-20020124-C00132
  • 8.6 g (50 mmol) of 2-chlorophenylacetyl chloride together with 8.6 g (50 mmol) of ethyl 1-hydroxy-cyclohexanecarboxylate are stirred for 5 hours at 120° C. and degassed using an oil pump. [0597]
  • Yield: 15.26 g of 1-ethoxycarbonyl-cyclohexyl 2-chlorophenylacetate as a colourless oil. [0598]
  • [0599] 1H NMR (300 MHz, CDCl3): δ=1.18 (t, 3H, CH2 CH 3), 1.2-1.82 (m, 8H, c-Hcx), 2.12 (m, 2H, c-Hcx), 3.81 (s, 2H, CH 2—CO), 4.14 (q, 2H, O—CH 2—CH3), 7.15-7.4 (m, 4H, Ar-H)
  • In a similar manner and/or according to the general preparation instructions, the following compounds of the formula (III) are obtained: [0600]
    (III)
    Figure US20020010204A1-20020124-C00133
    Ex. mp.
    No. X Z A B R8 ° C.
    III-2 CH3 H —(CH2)5— C2H5 oil
    III-3 OCH3 H —(CH2)5— C2H5 oil
    III-4 F H —(CH2)5— C2H5 oil
    III-5 i-C3H7 H —(CH2)5— C2H5 oil
    III-6 CH3 CH3 —(CH2)2—CHOCH3—(CH2)2— C2H5 oil
    III-7 CH3 CH3 —(CH2)2—CHCH3—(CH2)2— C2H5 oil
    • Example (I-3-a-1)
  • [0601]
    Figure US20020010204A1-20020124-C00134
  • 19 g of the compound of Example (IV-1) in 86 ml of toluene and 43 ml of tri-fluoroacetic acid are heated under reflux overnight. Excess trifluoroacetic acid is removed under reduced pressure, the residue is taken up in 400 ml of water and 120 ml of MTBE and the pH is adjusted to a value of 14 by adding NaOH. The mixture is extracted twice with MTBE and the aqueous phase is acidified with HCl and extracted 3 times with MTBE. The organic phase is dried and evaporated. [0602]
  • Yield: 7.8 g (63% of theory); mp.: 185-187° C., [0603]
    • Example (I-3-b-1)
  • [0604]
    Figure US20020010204A1-20020124-C00135
  • 1.5 g of the compound of Example (I-3-a-1) in 20 ml of methylene chloride are admixed with 1.08 ml of triethylamine. Cooling with ice, a solution of 0.96 ml of pivaloyl chloride in 3 ml of methylene chloride is added dropwise, and stirring is continued at room temperature for a further 2 hours. The mixture is washed twice with 10% strength citric acid and extracted with methylene chloride. The combined organic phases are washed twice with 1N NaOH, and the aqueous alkaline phases are extracted with methylene chloride. The combined organic phases are dried and concentrated. [0605]
  • Yield: 1.90 g (98% of theory); mp.: 79-83° C. [0606]
    • Example (I-3-b-2)
  • Similar to Example (I-3-b-1), when using isobutyryl chloride instead of pivaloyl chloride the following compound of mp.: 149-152° C. is obtained in quantitative yield: [0607]
    Figure US20020010204A1-20020124-C00136
    • Example (I-3-c-1)
  • Similar to Example (I-3-b-1), when using isobutyl chloroformate instead of pivaloyl chloride the following compound of mp.: 101-103° C is obtained in a yield of 98% of theory: [0608]
    Figure US20020010204A1-20020124-C00137
    • Example (IV-I)
  • [0609]
    Figure US20020010204A1-20020124-C00138
  • A: 10 g of the compound (1) in 40 ml of toluene are admixed with 1 drop of DMF and 6.4 g of thionyl chloride and stirred for 5 minutes at room 10 temperature and then at 100° C. until the formation of gas ceases. Excess thionyl chloride is removed (high vacuum) and the acid chloride is dissolved in 20 ml of THF (tetrahydrofuran): Solution A. [0610]
  • B: At 0° C., 10.7 g of the compound (2) in 20 ml of THF are added dropwise to 32 ml of a solution of lithium diisopropylamide (LDA) (65.8 mmol) in 50 ml of THF, and the mixture is stirred at 0° C. for 30 minutes. The solution A is then added dropwise at this temperature, and the mixture is stirred for a further 1 hour without cooling. [0611]
  • The mixture is admixed with 175 ml of MTBE and a few drops of water. [0612]
  • The mixture is then washed twice with 10% strength aqueous ammonium chloride solution and the organic phase is dried and concentrated. [0613]
  • Yield: 19 g (oil). [0614]
  • [0615] 1H NMR (400 MHz, CDCl3): 1.2-2.0 (m, 10H, CH2); 2.32, 2.38 (2s, 2×3H; CH3), 3.22 (dd, 2H, CH2); 3.71, 3.76 (2s, 2×3H, OCH3); 6.7-7.4 (m, 7H, Phenyl-H).
    • Example (I-4-a-1)
  • [0616]
    Figure US20020010204A1-20020124-C00139
  • 1.9 g (10 mmol) of 2-(2-methyl-phenyl)-chlorocarbonylketene were precharged in 20 ml of anhydrous toluene. After the addition of 1.4 g (10 mmol) of ethyl 2-pyridyl ketone, the mixture is heated under reflux for 8 h. After cooling, the precipitate is filtered off with suction and washed twice with cyclohexane. [0617]
  • Yield: 2.1 g (71% of theory); mp.: 105-107° C. [0618]
  • In a similar manner and/or according to the general preparation instructions, the following compounds of the formula (I-4-a) are obtained: [0619]
    (1-4-a)
    Figure US20020010204A1-20020124-C00140
    Ex. No. X Z A D mp. ° C.
    I-4-a-2 CH3 H CH3 4-F-Phenyl 187-190
    I-4-a-3 Cl H CH3 CH3  97-100
    I-4-a-4 Cl H —[C(CH3)2]—O—[C(CH3)2]— 194-196
    I-4-a-5 CH3 CH3 —[C(CH3)2]—O—[C(CH3)2]— 174-175
    I-4-a-6 CH3 CH3 —(CH2)4— 198-200
    I-4-a-7 CH3 CH3 CH3 2-Pyridyl  99-102
    I-4-a-8 CH3 CH3 CH3 4-Pyridyl 273-275
    I-4-a-9 CH3 CH3 CH3 CH3 57-59
    • Example (I-4-b-1)
  • [0620]
    Figure US20020010204A1-20020124-C00141
  • 1.2 g (4 mmol) of the compound of Example (I-4-a-7) in 10 ml of ethyl acetate are admixed with 0.4 g (4 mmol) of triethylamine, and at 0° C. 0.7 g (4 mmol) of 6-chloropyrid-3-yl-carbonyl chloride dissolved in 4 ml of ethyl acetate are added dropwise. The mixture is kept for 20 hours at room temperature and the precipitate is filtered off with suction and washed with ethyl acetate. The organic phase is washed twice with 20 ml of half concentrated aqueous NaCl solution each time, dried and concentrated. [0621]
  • Yield: 2 g (91% of theory), mp.: 70 to 73° C. [0622]
  • Similar to Example (I-4-b-1) and/or according to the general preparation instructions, the following compounds of the formula (I-4-b) are obtained: [0623]
    (1-4-b)
    Figure US20020010204A1-20020124-C00142
    Ex. No. X Z A D R1 mp. ° C.
    I-4-b-2 CH3 CH3 CH3 2-Pyridyl 4-Cl-Phenyl 73-75
    I-4-b-3 CH3 CH3 CH3 2-Pyridyl CH3 119-120
    I-4-b-4 CH3 CH3 CH3 2-Pyridyl
    Figure US20020010204A1-20020124-C00143
         		120-121
    I-4-b-5 CH3 CH3 CH3 2-Pyridyl
    Figure US20020010204A1-20020124-C00144
         		119-121
    I-4-b-6 CH3 CH3 CH3 2-Pyridyl
    Figure US20020010204A1-20020124-C00145
         		120-122
    • Example (I-4-c-1)
  • [0624]
    Figure US20020010204A1-20020124-C00146
  • 1.5 g (5 mmol) of the compund of Example (I-4-a-7) in 20 ml of ethyl acetate are admixed with 0.5 g (5 mmol) of triethylamine, and at 0° C. 0.47 g (5 mmol) of methyl chloroformate in 5 ml of ethyl acetate are added dropwise. The mixture is stirred for 20 hours at room temperature and the precipitate is separated off and washed with ethyl acetate. The organic phase is washed twice with 25 ml of half concentrated aqueous NaCl solution each time, dried and concentrated. [0625]
  • Yield: 1.7 g (93% of theory); mp.: 136-137° C. [0626]
    • Example (XXXII-1)
  • [0627]
    Figure US20020010204A1-20020124-C00147
  • 236 g (2.8 mol) of dimethyl carbonate are precharged in 814 ml of anhydrous toluene, and 27.3 g (0.91 mol) of sodium hydride (80%) are added. At 80° C., 133 g (0.7 mol) of methyl 2-chlorophenylacetate are added dropwise, and the mixture is stirred at 80-90° C. for 16 h. The mixture is poured into 2 l of ice water and acidified with half-concentrated HCl to pH 4, the organic phase is separated off and the aqueous phase is extracted with 150 ml of toluene. The combined organic phases are dried, the solvent is distilled off and the residue is distilled using high vacuum. [0628]
  • Yield: 122.9 g (72% of theory) bp[0629] 0.6-0.7 mbar 129-131° C.
  • In a similar manner and/or according to the general preparation instructions, the following compounds of the formula (XXXII) are obtained: [0630]
    (XXXII)
    Figure US20020010204A1-20020124-C00148
    Ex. No. X Z R8 bp.
    XXXII-2 CH3 H CH3 used as crude product
    XXXII-3 CH3 CH3 CH3 1H NMR (400 MHz, CDCl3): δ = 2.25
    (s, 3H, CH3); 1.28(3H, s, CH3);
    3.78(s, 6-H, 2 × CO2CH3);
    4.88(s, 1H, CH).
    • Example (XXXI-1)
  • [0631]
    Figure US20020010204A1-20020124-C00149
  • 93.3 g (1.67 mol) of potassium hydroxide are dissolved in 125 ml of water and admixed with 250 ml of methanol. 121.3 g (0.5 mol) of the compound of Example (XXXII-1) are then added dropwise. After 5 h at reflux, the mixture is evaporated and the residue is dissolved in ethyl acetate and, at 0° C., carefully acidified with concentrated hydrochloric acid. The precipitate is filtered off with suction and is dried over calcium chloride under reduced pressure. [0632]
  • Yield: 29.2 g (27% of theory); mp.: 135-136° C. (decomposition). [0633]
  • In a similar manner and/or according to the general preparation instructions, the following compounds of the formula (XXXI) are obtained: [0634]
    (XXXI)
    Figure US20020010204A1-20020124-C00150
    Ex. No. X Z mp. ° C.
    XXXI-2 CH3 H 149-150 (Decomp.)
    XXXI-3 CH3 CH3 150
    • Example (VI-1)
  • [0635]
    Figure US20020010204A1-20020124-C00151
  • 27.9 g (0.13 mol) of 2-(2-chloro-phenyl)-malonic acid are precharged in 32 ml of anhydrous toluene, 59 g (0.391 mol) of thionyl chloride are added dropwise and the mixture is heated under reflux for 5 hours. After concentration and distillation, 20.7 g (74% of theory) of 2-(2-chlorophenyl)-2-chlorocarbonylketene of bp.[0636] 1 mbar 102° C. are obtained.
  • In a similar manner and/or according to the general preparation instructions, the following compounds of the formula (VI) are obtained: [0637]
    (VI)
    Figure US20020010204A1-20020124-C00152
    Ex. No. X Y bp. ° C.
    VI-2 CH3 H 92-94 (0.6 mbar)
    VI-3 CH3 CH3 1H NMR(400 MHz, CDCl3)
    δ = 2.20, 2.21(2s, 6H, 2CH3);
    7.05(m, 3H, Ph—H).
    • Example (XXII-1)
  • [0638]
    Figure US20020010204A1-20020124-C00153
  • A solution of 5.10 g of 98% strength lithium hydroxide in 220 ml of water is added dropwise to 55 g of the carboxylic acid ester of Example (XXIII-1) shown above in 220 ml of THF, and the mixture is stirred at room temperature overnight. The mixture is then evaporated, the residue is admixed with water and extracted with MTBE, the aqueous phase is acidified with concentrated hydrochloric acid and the precipitated acid is filtered off with suction. [0639]
  • Similar to Example (XXII-1) and/or according to the general preparation instructions, the following compounds of the formula (XXII) are obtained: [0640]
    (XXII)
    Figure US20020010204A1-20020124-C00154
    Ex. No. X Z mp. ° C.
    XXII-2 OCH3 Cl 128-130
    XXII-3 Cl CH3 116-120
    XXII-4 F CH3  89
    XXII-5 Br Br  95
    XXII-6 F F 118
    XXII-7 Cl Br 115
    XXII-8 Cl CF3 110
    XXII-9 Br CH3 117
    • Example (XXIII-1)
  • [0641]
    Figure US20020010204A1-20020124-C00155
  • With cooling, 1020 ml of a 30% strength aqueous NaOCHA[0642] 3 solution (5.67 mol) are added dropwise to 653 g (1.26 mol) (68% pure) of the compound of Example (XXIV-1) in 220 ml of methanol, and the mixture is stirred at reflux for 5 hours. With cooling, 200 ml of concentrated sulphuric acid are then added dropwise, and the mixture is stirred under reflux for a further 1 hour.
  • The mixture is concentrated, admixed with water and extracted with methylene chloride. The extract is dried and concentrated. [0643]
  • Crude yield: 355 g (81% pure). [0644]
  • Similar to Example (XXIII-1) and/or according to the general preparation instructions, the following compounds of the formula (XXIII) are obtained: [0645]
    (XXIII)
    Figure US20020010204A1-20020124-C00156
    Ex. No. X Z R8 bpmbar ° C.
    XXIII-2 OCH3 Cl CH3 120
    0.09
    XXIII-3 Cl CH3 CH3 125
    0.1
    XXIII-4 F CH3 CH3 60
    0.05
    XXIII-5 Br Br CH3 GC/MS
    308(M+, 4%)
    249(42%)
    227(77%)
    XXIII-6 F F CH3 100
    0.03
    XXIII-7 Cl Br CH3 101° C./0.25 mbar
    XXIII-8 Cl CF3 CH3 Kp: 110° C./0.35 mbar
    XXIII-9 Br CH3 CH3 GC/MS
    183(29%)
    163(100%)
    • Example (XXIV-1)
  • [0646]
    Figure US20020010204A1-20020124-C00157
  • Under argon, 202.9 g of anhydrous copper(II) chloride and then 1890 g of 1,1-dichloroethane are added to 229 g of isopentyl nitrite in 750 ml of anhydrous acetonitrile. Below 30° C., 204 g of 2,5-dichloroaniline are added a little at a time, and the mixture is stirred at room temperature overnight until the formation of gas ceases. The mixture is poured into 3600 ml of ice-cold 20% strength hydrochloric acid, stirred for 10 minutes and extracted repeatedly with MTBE. The organic phase is washed with 20% strength HCl, dried and concentrated. [0647]
  • MS in accordance with the structure. [0648]
  • Similar to example (XXIV-1) and/or according to the general preparation instructions, the following compounds of the formula (XXIV) are obtained: [0649]
    (XXIV)
    Figure US20020010204A1-20020124-C00158
    Ex. No. X Z GC/MS
    XXIV-2 OCH3 Cl 274(12%, M+)
    155(100%)
    XXIV-3 Cl CH3 256(5%, M+)
    185(7%)
    139(100%)
    XXIV-4 F CH3 242(7%, M+)
    123(100%)
    XXIV-5 Br Br 366(13%, M+)
    249(100%)
    XXIV-6 F F 246(5%, M+)
    127(100%)
    XXIV-7 Cl Br M+ 322(17%)
    205(100%)
    XXIV-8 Cl CF3 M+ 312(4%)
    193(100%)
    XXIV-9 Br CH3 M+ 302(22%)
    185(100%)
    • Example (XXVIII-1)
  • [0650]
    Figure US20020010204A1-20020124-C00159
  • At 0 to 10° C., 14.9 g of 2,5-dimethylphenylacetyl chloride in 20 ml of THF are added dropwise to 9 g (0.08 mol) of the aminonitrile shown above in 160 ml of THF and 12.3 ml of triethylamine. [0651]
  • After the reaction has ended, the mixture is concentrated, the residue is taken up in 0.5N HCl/methylene chloride and the organic phase is dried and concentrated. The residue is chromatographed over silica gel using n-hexane/ethyl acetate. [0652]
  • Yield: 16.70 g (80% of theory); mp.: 89° C. [0653]
    • Example (XXVIII-2)
  • In a similar manner, the compound of the formula [0654]
    Figure US20020010204A1-20020124-C00160
  • is obtained in quantitative yield: mp.: 198° C. [0655]
    • Use Examples
  • [0656]
    Example A
    Phaedon larvae test
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0657]
  • Cabbage leaves ([0658] Brassica oleracea) are treated by being dipped into the preparation of the active compound of the desired concentration and are infested with mustard beetle larvae (Phaedon cochleariae) while the leaves are still moist.
  • After the specified period of time, the destruction in % is determined. 100% means that all the beetle larvae have been killed; 0% means that none of the beetle larvae have been killed. [0659]
  • In this test, for example the compounds of Preparation Examples (I-1-a-1) and (I-4-a-1) at an exemplary active compound concentration of 0.1% caused a destruction of in each case 100% after 7 days. [0660]
    Example B
    Plutella test
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0661]
  • Cabbage leaves ([0662] Brassica oleracea) are treated by being dipped into the preparation of active compound of the desired concentration and are infested with caterpillars of the diamond-back moth (Plutella maculipennis) while the leaves are still moist.
  • After the specified period of time, the destruction in % is determined. 100% means that all the caterpillars have been killed; 0% means that none of the caterpillars have been killed. [0663]
  • In this test, for example the compounds of preparation examples (I-4-a-1) and (I-4-a-2) at an exemplary active compound concentration of 0.1% caused a destruction of in each case 100% after 7 days. [0664]
    Example C
    Spodoptera test
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0665]
  • Cabbage leaves ([0666] Brassica oleracea) are treated by being dipped into the preparation of the active compound of the desired concentration and are infested with caterpillars of the owlet moth (Spodoptera frugiperda) as long as the leaves are still moist.
  • After the specified period of time, the destruction in % is determined. 100% means that all the caterpillars have been killed; 0% means that none of the caterpillars have been killed. [0667]
  • In this test, for example the compounds of preparation examples (I-1-a-1) and (I-4-a-1) at an exemplary active compound concentration of 0.1% caused a destruction of in each case 85% after 7 days. [0668]
    Example D
    Myzus test
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0669]
  • Cabbage leaves ([0670] Brassica oleracea) which have been heavily infested with the peach aphid (Myzus persicae) are treated by being dipped into the preparation of the active compound of the desired concentration.
  • After the specified period of time, the destruction in % is determined. 100% means that all the aphids have been killed; 0% means that none of the aphids have been killed. [0671]
  • In this test, for example the compounds of preparation examples (I-2-a-1), (1-2-b-1), (I-2-b-2), (I-1-a-I) and (I-4-a-1) at an exemplary active compound concentration of 0.1% caused a destruction of in each case at least 90% after 6 days. [0672]
    Example E
    Nephotettix test
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0673]
  • Rice seedlings ([0674] Oryzae sativa) are treated by being dipped into the preparation of the active compound of the desired concentration and are infested with larvae of the green rice leaf hopper (Nephotettix cincticeps) while the seedling,s are still moist.
  • After the specified period of time, the destruction in % is determined. 100% means that all the larvae have been killed; 0% means that none of the larvae have been killed. [0675]
  • In this test, for example the compounds of preparation examples (I-2-a-2), (I-2-b-3), (I-1-a-1), (I-4-a-1) and (I-4-a-2) at an exemplary active compound concentration of 0.1% caused a destruction of in each case 100% after 6 days. [0676]
    Example F
    Tetranychus test (OP resistant)
    Solvent: 7 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0677]
  • Bean plants ([0678] Phaseolus vulgaris) heavily infested by all stages of the common spider mite (Tetranychus urticae) are dipped into a preparation of the active compound of the desired concentration.
  • After the specified period of time, the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed. [0679]
  • In this test, for example the compounds of preparation examples (I-2-a-l), (I-2-a-2), (I-2-b-1) and (I-2-b-2) at an exemplary active compound concentration of 0.1% had an efficacy of in each case at least 98% after 9 days. [0680]
    Example G
    Tetranychus test (OP resistant/dip treatment)
    Solvent: 3 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To produce a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0681]
  • Bean plants ([0682] Phaseolus vulgaris) heavily infested by all stages of the common spider mite (Tetranychus urticae) are dipped into a preparation of the active compound of the desired concentration.
  • After the specified period of time, the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed. [0683]
  • In this test, for example the compounds of preparation examples (I-2-a-1), (I-2-a-2), (I-2-b-1) and (I-2-b-2) at an exemplary active compound concentration of 0.01% had an efficacy of in each case at least 95% after 13 days. [0684]
    Example H
    Panonychus test
    Solvent: 3 parts by weight of dimethylformamide
    Emulsifier: 1 part by weight of alkylaryl polyglycol ether
  • To prepare a suitable preparation of active compound, 1 part by weight of active compound is mixed with the stated amount of solvent and the stated amount of emulsifier, and the concentrate is diluted with water to the desired concentration. [0685]
  • Plum trees ([0686] Prunus domestica) approximately 30 cm in height which are severely infested by all stages of the fruit tree spider mite (Panonychus ulmi) are sprayed with an active compound preparation of the desired concentration.
  • After the specified period of time, the destruction in % is determined. 100% means that all the spider mites have been killed; 0% means that none of the spider mites have been killed. [0687]
  • In this test, for example the compounds of preparation examples (I-2-b-1) and (I-2-b-2) at an exemplary active compound concentration of 0.004% had an efficacy of in each case 100% after 7 days. [0688]
    Example I
    Test with fly larvae/development-inhibitory action
    Test animals: All larval stages of Lucilia cuprina (OP resistant)
    [pupae and adults (without contact with the active
    compound)]
    Solvent: 35 parts by weight of ethylene glycol monomethyl ether
    35 parts by weight of nonylphenol polyglycol ether
  • To produce a suitable preparation, 3 parts by weight of active compound are mixed with 7 parts of the abovementioned solvent-emulsifier mixture, and the resulting emulsion concentrate is diluted with water to the desired concentration in each case. [0689]
  • For each individual concentration, 30 to 50 larvae are introduced into a test tube which contains 1 cm[0690] 3 of horse meat. 500 μl of the dilution to be tested are pipetted onto this horse meat. The test tubes are placed in plastic beakers whose bottom is covered with sea sand, and kept in a climatized room (26° C.±1.5° C., 70%±10% relative humidity). The activity is examined (larvicidal action) after 24 hours and again after 48 hours. After emergence of the larvae (about 72 h), the test tubes are removed and perforated plastic lids are fitted to the beakers. After 1.5 times the development time (hatching of the control flies), the hatched flies and the pupae/coccoons are counted.
  • The activity criterion is the incidence of death in the treated larvae after 48 h (larvicidal effect), or the inhibition of the hatching of adults from pupae or the inhibition of pupa formation. The criterion for the in vitro activity of a substance is the inhibition of the development of the flies, or a development standstill before the adult stage. 100% larvicidal action means that all the larvae have been killed after 48 hours. 100% development-inhibitory action means that no adult flies have hatched. [0691]
  • In this test, a development-inhibitory action of 100% was shown, for example, by the compound of Preparation Example (I-2-b-3) at an exemplary active compound concentration of 1000 ppm. [0692]
    Example K
    Test with Boophilus microplus resistant/SP resistant Parkhurst strain
    Test animals: adult females which have sucked themselves full
    Solvent: dimethyl sulphoxide
  • 20 mg of active substance are dissolved in 1 ml of dimethyl sulphoxide, and lesser concentrations are prepared by dilution with the same solvent. [0693]
  • The test is carried out in 5 replications. 1 μl of the solutions is injected into the abdomen, and the animals are transferred into dishes and kept in a controlled-environment cabinet. The activity is determined via the inhibition of oviposition. 100% means that no tick has deposited eggs. [0694]
  • In this test, an activity of 100% was shown, for example, by the compound of Preparation Example (I-1-a-2) at an exemplary active compound concentration of 20 μg/animal. [0695]

Claims (21)

1. Compounds of the formula (I)
Figure US20020010204A1-20020124-C00161
in which
X represents halogen, alkyl, alkenyl, alkynyl, alkoxy, benzyloxy, halogenoalkyl, halogenoalkoxy, cyano or nitro,
Z represents hydrogen, amino, halogen, alkyl, alkoxy, halogenoalkyl, halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally substituted phenoxy, phenylthio, 5- or 6-membered hetaryloxy, 5- or 6-membered hetarylthio, phenylalkyloxy or phenylalkylthio and
Het represents one of the groups
Figure US20020010204A1-20020124-C00162
in which
A represents a respectively optionally substituted radical from the group is consisting of alkyl, alkenyl, alkoxyalkyl, polyalkoxyalkyl and alkylthioalkyl, represents respectively saturated or unsaturated and optionally substituted cycloalkyl or heterocyclyl or represents respectively optionally halogen-, alkyl-, halogenoalkyl-, alkoxy-, halogenoalkoxy-, cyano- or nitro-substituted aryl, arylalkyl or hetaryl,
B represents alkyl or alkoxyalkyl or
A and B together with the carbon atom that they are attached to represent a saturated or unsaturated, optionally substituted carbocycle or heterocycle,
D represents hydrogen or represents an optionally substituted radical from the group consisting of alkyl, alkenyl, alkynyl, alkoxyalkyl, polyalkoxyalkyl, alkylthioalkyl, saturated or unsaturated cycloalkyl, saturated or unsaturated heterocyclyl, arylalkyl, aryl, hetarylalkyl or hetaryl or
A and D together with the atoms that they are attached to represent a respectively optionally substituted carbocycle or heterocycle,
G represents hydrogen (a) or represents one of the groups
Figure US20020010204A1-20020124-C00163
E (f) or
Figure US20020010204A1-20020124-C00164
in which
E represents a metal ion equivalent or an ammonium ion,
L represents oxygen or sulphur,
M represents oxygen or sulphur,
R1 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl, alkylthioalkyl or polyalkoxyalkyl or represents respectively optionally halogen-, alkyl- or alkoxy-substituted cycloalkyl or heterocyclyl or represents respectively optionally substituted phenyl, phenylalkyl, hetaryl, phenoxyalkyl or hetaryloxyalkyl,
R2 represents respectively optionally halogen-substituted alkyl, alkenyl, alkoxyalkyl or polyalkoxyalkyl or represents respectively optionally substituted cycloalkyl, phenyl or benzyl,
R3, R4 and R5 independently of one another each represent respectively optionally halogen-substituted alkyl, alkoxy, alkylamino, dialkylamino, alkylthio, alkenylthio or cycloalkylthio or represent respectively optionally substituted phenyl, benzyl, phenoxy or phenylthio,
R6 and R7 independently of one another each represent hydrogen, represent respectively optionally halogen-substituted alkyl, cyclo- alkyl, alkenyl, alkoxy, alkoxyalkyl, represent respectively optionally substituted phenyl or benzyl, or form together with the nitrogen atom that they are attached to an optionally oxygen- or sulphur-containing, optionally substituted cycle.
2. Compounds of the formula (I) according to claim 1 in which
X represents halogen, C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-alkoxy, benzyloxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, cyano or nitro,
Z represents hydrogen, amino, halogen, C1-C6-alkyl, C1-C6-alkoxy, C1-C4-halogenoalkyl, C1-C4-halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenoxy, plhenylthio, thiazolyloxy, pyridinyloxy, pyrimidinyloxy, pyrazolyloxy, phenyl-C1-C4-alkyloxy or phenyl-C1-C7-alkylthio,
Het represents one of the groups
Figure US20020010204A1-20020124-C00165
A represents respectively optionally halogen-substituted C1-C12-alkyl, C2-C8-alkenyl, C1-C10-alkoxy-C1-C8-alkyl, poly-C1-C8-alkoxy-C1-C8-alkyl or C1-C10-alkylthio-C1-C6-alkyl, represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally halogen-, C1-C6-alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyl, naphthyl, phenyl-C1-C6-alkyl, naphthyl-C1-C6-alkyl or hetaryl having 5 or 6 ring atoms and one to three hetero atoms from the group consisting of oxygen, sulphur and nitrogen,
B represents C1-C12-alkyl or C1-C8-alkoxy-C1-C6-alkyl or
A, B and the carbon atom that they are attached to represent C3-C10-cycloalkyl or C5-C10-cycloalkenyl where in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by C1-C8-alkyl, C3-C10-cycloalkyl, C1-C8-halogenoalkyl, C1-C8-alkoxy, C1-C8-alkylthio, halogen or phenyl or
A, B and the carbon atom that they are attached to represent C5-C6-cycloalkyl which is substituted by an alkylenediyl group optionally containing one or two not directly adjacent oxygen and/or sulphur atoms, or by an alkylenedioxy group or an alkylenedithioyl group forming a further five- to eight-membered ring with the carbon atom that it is attached to, or
A, B and the carbon atom that they are attached to preferably represent C3-C8-cycloalkyl or C5-C8-cycloalkenyl in which two carbon atoms are linked to each other by respectively optionally C1-C6-alkyl-, C1-C6-alkoxy- or halogen-substituted C3-C6-alkanediyl, C3-C6-alkenediyl or C4-C6-alkanedienediyl, one methylene group in each case being optionally replaced by oxygen or sulphur,
D represents hydrogen, represents respectively optionally halogen-substituted C1-C12-alkyl, C3-C8-alkenyl, C3-C8-alkynyl, C1-C10-alkoxy-C2-C8-alkyl, poly-C1-C8-alkoxy-C2-C8-alkyl or C1-C10-alkylthio-C2-C8-alkyl, represents optionally halogen-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C4-halogenoalkyl-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally halogen-, C1-C6 alkyl-, C1-C6-halogenoalkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkoxy-, cyano- or nitro-substituted phenyt, hetaryl having 5 or 6 ring atoms and one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen, phenyl-C1-C6-alkyl or hetaryl-C1-C6-alkyl having 5 or 6 ring atoms and one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen,
A and D together represent a C3-C6-alkanediyl, C3-C6-alkenediyl or C4-C6-alkadienediyl group in which respectively optionally one methylene group is replaced by oxygen or sulphur and which are respectively optionally substituted by halogen or respectively optionally halogen-substituted C1-C10-alkyl, C1-C6-alkoxy, C1-C6-alkylthio, C3-C7-cycloalkyl, phenyl or benzyloxy or by a further C3-C6-alkanediyl, C3-C6-alkenediyl or C4-C6-alkadienediyl group forming a fused ring, in which optionally respectively one methylene group is replaced by oxygen or sulphur and which are optionally substituted by C1-C6-alkyl, or
A and D together represent a C3-C6-alkanediyl or C3-C6-alkenediyl group containing in each case optionally one of the following groups
Figure US20020010204A1-20020124-C00166
G represents hydrogen (a) or represents one of the groups
Figure US20020010204A1-20020124-C00167
in which
E represents a metal ion equivalent or a ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur,
R1 represents respectively optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio-C1-C8-alkyl or poly-C1-C8-alkoxy-C1-C8-alkyl or represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
represents optionally halogen-, cyano-, nitro-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl-, C1-C6-halogenoalkoxy-, C1-C6-alkylthio- or C1-C6-alkylsulphonyl-substituted phenyl,
represents optionally halogen-, nitro-, cyano-, C1-C6-alkyl, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl-C1-C6-alkyl,
represents optionally halogen- or C1-C6-alkyl-substituted 5- or 6-membered hetaryl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen,
represents optionally halogen- or C1-C6-alkyl-substituted phenoxy-C1-C6-alkyl or
represents optionally halogen-, amino- or C1-C6-alkyl-substituted 5- or 6-membered hetaryloxy-C1-C6-alkyl having one or two hetero atoms from the group consisting of oxygen, sulphur and nitrogen,
R2 represents respectively optionally halogen-substituted C1-C20-alkyl, C2-C20-alkenyl, C1-C8-alkoxy-C2-C8-alkyl or poly-C1-C8-alkoxy-C2-C8-alkyl,
represents optionally halogen-, C1-C6-alkyl- or C1-C6-alkoxy-substituted C3-C8-cycloalkyl or
represents respectively optionally halogen-, cyano-, nitro-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C6-halogenoalkyl- or C1-C6-halogenoalkoxy-substituted phenyl or benzyl,
R3 represents optionally halogen-substituted C1-C8-alkyl or respectively optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl or benzyl,
R4 and R5 independently of one another each represent respectively optionally halogen-substituted C1-C8-alkyl, C1-C8-alkoxy, C1-C8-alkylamino, di-(C1-C8-alkyl)-amino, C1-C8-alkylthio or C3-C8-alkenylthio or represent respectively optionally halogen-, nitro-, cyano-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, C1-C4-alkylthio-, C1-C4-halogenoalkylthio-, C1-C4-alkyl- or C1-C4-halogenoalkyl-substituted phenyl, phenoxy or phenylthio,
R6 and R7 independently of one another each represent hydrogen, represent respectively optionally halogen-substituted C1-C8-alkyl, C3-C8-cycloalkyl, C1-C8-alkoxy, C3-C8-alkenyl or C1-C8-alkoxy-C2-C8-alkyl, represent respectively optionally halogen-, C1-C8-alkyl-, C1-C8-halogenoalkyl- or C1-C8-alkoxy-substituted phenyl or benzyl or together represent an optionally C1-C6-alkyl-substituted C3-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur,
R13 represents hydrogen or respectively optionally halogen-substituted C1-C8-alkyl or C1-C8-alkoxy, represents optionally halogen-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C8-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or represents respectively optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C4-alkyl or phenyl-C1-C4-alkoxy,
R14 represents hydrogen or C1-C8-alkyl or
R13 and R14 together represent C4-C6-alkanediyl,
R15 and R16 are identical or different and each represent C1-C6-alkyl or
R15 and R16 together represent a C2-C4-alkanediyl radical which is optionally substituted by C1-C6-alkyl or by optionally halogen-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl,
R17 and R18 independently of one another each represent hydrogen, represent optionally halogen-substituted C1-C8-alkyl or represent optionally halogen-, C1-C6-alkyl-, C1-C6-alkoxy-, C1-C4-halogenoalkyl-, C1-C4-halogenoalkoxy-, nitro- or cyano-substituted phenyl or
R17 and R18 together with the carbon atom that they are attached to represent optionally C1-C4-alkyl-substituted C5-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur and
R19 and R20 independently of one another each represent C1-C10-alkyl, C2-C10-alkenyl, C1-C10-alkoxy, C1-C10-alkylamino, C3-C10-alkenylamino, di-(C1-C10-alkyl)-amino or di-(C3-C10-alkenyl)-amino.
3. Compounds of the formula (I) according to claim 1 in which
X represents fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, benzyloxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, cyano or nitro,
Z represents hydrogen, amino, fluorine, chlorine, bromine, C1-C4-alkyl, C1-C4-alkoxy, C1-C2-halogenoalkyl, C1-C2-halogenoalkoxy, hydroxyl, cyano, nitro or respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkyl-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenoxy or benzyloxy,
Het represents one of the groups
Figure US20020010204A1-20020124-C00168
A represents respectively optionally fluorine- or chlorine-substituted C1-C10-alkyl, C2-C6-alkenyl, C1-C8-alkoxy-C1-C6-alkyl, poly-C1-C6-alkoxy-C1-C6-alkyl or C1-C8-alkylthio-C1-C6-alkyl or represents optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl-, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, cyano, or nitro-substituted phenyl, furanyl, pyridyl, imidazolyl, triazolyl, pyrazolyl, indolyl, thiazolyl, thienyl or phenyl-C1-C4-alkyl,
B represents C1-C10-alkyl or C1-C6-alkoxy-C1-C4-alkyl or
A, B and the carbon atom that they are attached to represent C3-C8-cycloalkyl or C5-C8-cycloalkenyl where one methylene group in each case is optionally replaced by oxygen or sulphur and which are optionally substituted by C1-C6-alkyl, C3-C8-cycloalkyl, C1-C3-halogenoalkyl, C1-C6-alkoxy, C1-C6-alkylthio, fluorine, chlorine or phenyl or
A, B and the carbon atom that they are attached to represent C5-C6-cycloalkyl which is substituted by an alkylenediyl group optionally containing one or two not directly adjacent oxygen or sulphur atoms or by an alkylenedioxy group or by an alkylenedithiol group which forms together with the carbon atom that it is attached to a further five- to seven-membered ring or
A, B and the carbon atom that they are attached to represent C3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two carbon atoms are linked to each other by respectively optionally C1-C4-alkyl-, C1-C4-alkoxy-, fluorine-, chlorine- or bromine-substituted C3-C5-alkanediyl or C3-C5-alkenediyl, one methylene group in each case being optionally replaced by oxygen or sulphur, or are linked to each other by butadienediyl,
D represents hydrogen, represents respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl or C1-C6-alkoxy, represents optionally fluorine-, chlorine-, C1-C4-alkyl-, C1-C4-alkoxy- or C1-C2-halogenoalkyl-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-halogenoalkyl, C1-C4-alkoxy-, C1-C4-halogenoalkoxy-, cyano- or nitro-substituted phenyl, furanyl, imidazolyl, pyridyl, thiazolyl, pyrazolyl, pyrimidyl, pyrrolyl, thienyl, triazolyl or phenyl-C1-C4-alkyl or
A and D together represent a C3-C5-alkanediyl or C3-C5-alkenediyl group in which in each case one methylene group is optionally replaced by oxygen or sulphur and which are optionally substituted by fluorine, chlorine or by respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C3-C6-cycloalkyl, phenyl or benzyloxy or
in which in each case optionally one of the following groups is contained:
Figure US20020010204A1-20020124-C00169
G represents hydrogen (a) or represents one of the groups
Figure US20020010204A1-20020124-C00170
E (f) or
Figure US20020010204A1-20020124-C00171
in which
E represents a metal ion equivalent or an ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur,
R1 represents respectively optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C1-C6-alkyl, C1-C6-alkylthio-C1-C6-alkyl or poly-C1-C6-alkoxy-C1-C6-alkyl or represents optionally fluorine-, chlorine-, C1-C5-alkyl- or C1-C5-alkoxy-substituted C3-C7-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl-, C1-C3-halogenoalkoxy-, C1-C4-alkylthio- or C1-C4-alkyl sulphonyl-substituted phenyl,
represents optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl-C1-C4-alkyl,
represents respectively optionally fluorine-, chlorine-, bromine- or C1-C4-alkyl-substituted pyrazolyl, thiazolyl, pyridyl, pyrimidyl, furanyl or thienyl,
represents optionally fluorine-, chlorine-, bromine- or C1-C4-alkyl-substituted phenoxy-C1-C5-alkyl or
represents respectively optionally fluorine-, chlorine-, bromine-, amino- or C1-C4-alkyl-substituted pyridyloxy-C1-C5-alkyl, pyrimidyloxy-C1-C5-alkyl or thiazolyloxy-C1-C5-alkyl,
R2 represents respectively optionally fluorine- or chlorine-substituted C1-C16-alkyl, C2-C16-alkenyl, C1-C6-alkoxy-C2-C6-alkyl or poly-C1-C6-alkoxy-C2-C6-alkyl,
represents optionally fluorine-, chlorine-, C1-C4-alkyl- or C1-C4-alkoxy-substituted C3-C7-cycloalkyl or
represents respectively optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, C1-C4-alkyl-, C1-C3-alkoxy-, C1-C3-halogenoalkyl- or C1-C3-halogenoalkoxy-substituted phenyl or benzyl,
R3 represents optionally fluorine- or chlorine-substituted C1-C6-alkyl or respectively optionally fluorine-, chlorine-, bromine-, C1-C4-alkyl-, C1-C4-alkoxy-, C1-C2-halogenoalkoxy-, C1-C2-halogenoalkyl-, cyano-, or nitro-substituted phenyl or benzyl,
R4 and R5 independently of one another each represent respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C1-C6-alkoxy, C1-C6-alkylamino, di-(C1-C6-alkyl)-amino, C1-C6-alkylthio or C3-C4-alkenylthio or represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, C1-C3-alkoxy-, C1-C3-halogenoalkoxy-, C1-C3-alkylthio-, C1-C3-halogenoalkylthio-, C1-C3-alkyl- or C1-C3-halogenoalkyl-substituted phenyl, phenoxy or phenylthio,
R6 and R7 independently of one another each represent hydrogen, represent respectively optionally fluorine- or chlorine-substituted C1C6-alkyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-alkenyl or C1-C6-alkoxy-C2-C6-alkyl, represent respectively optionally fluorine-, chlorine-, bromine-, C1-C5-halogenoalkyl-, C1-C5-alkyl- or C1-C5-alkoxy-substituted phenyl or benzyl, or together represent an optionally C1-C4-alkyl-substituted C3-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur,
R13 represents hydrogen or respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl or C1-C6-alkoxy, represents optionally fluorine-, C1-C2-alkyl- or C1-C2-alkoxy-substituted C3-C7-cycloalkyl in which optionally one methylene group is replaced by oxygen or sulphur, or represents respectively optionally fluorine-, chlorine-, bromine-, C1-C5-alkyl-, C1-C5-alkoxy-, C1-C2-halogenoalkyli-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenyl, phenyl-C1-C3-alkyl or phenyl-C1-C2-alkyloxy,
R14 represents hydrogen or C1-C6-alkyl or
R13 and R14 together represent C4-C6-alkanediyl,
R15 and R16 are identical or different and each represent C1-C4-alkyl or
R15 and R16 together represent a C2-C3-alkanediyl radical which is optionally substituted by C1-C4-alkyl or by optionally fluorine-, chlorine-, bromine-, C1-C2-alkyl-, C1-C2-halogenoalkyl-, C1-C2-alkoxy-, C1-C2-halogenoalkoxy-, nitro- or cyano-substituted phenyl.
4. Compounds of the formula (I) according to claim 1 in which
X represents fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro,
Z represents hydrogen, amino, fluorine, chlorine, bromine, methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, tert-butyl, methoxy, ethoxy, n-propoxy, iso-propoxy, trifluoromethyl, trifluoromethoxy, difluoromethoxy, cyano or nitro,
Het represents one of the groups
Figure US20020010204A1-20020124-C00172
A represents respectively optionally fluorine- or chlorine-substituted C1-C8-alkyl, C2-C4-alkenyl, C1-C6-alkoxy-C1-C4-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or C1-C6-alkylthio-C1-C4-alkyl, or represents optionally fluorine-, chlorine-, methyl- or methoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl, pyridyl or benzyl,
B represents C1-C8-alkyl or C1-C4-alkoxy-C1-C2-alkyl or
A, B and the carbon atom that they are attached to represent C3-C8-cycloalkyl or C5-C8-cycloalkenyl in which in each case optionally one methylene group is replaced by oxygen or sulphur and which are optionally substituted by metlhyl, ethyl, n-propyl, iso-propyl, butyl, iso-butyl, sec-butyl, tert-butyl, cyclohexyl, trifluoromethyl, methoxy, ethoxy, n-propoxy, iso-propoxy, butoxy, iso-butoxy, sec-butoxy, tert-butoxy, methylthio, ethylthio, fluorine, chlorine or phenyl or
A, B and the carbon atom that they are attached to represent C3-C6-cycloalkyl or C5-C6-cycloalkenyl in which two carbon atoms are linked together by C3-C4-alkanediyl or C3-C4-alkenediyl in which in each case optionally one methylene group is replaced by oxygen or sulphur, or are linked together by butadienediyl,
D represents hydrogen, represents respectively optionally fluorine-substituted C1-C4-alkyl or C1-C4-alkoxy or C3-C6-cyctoalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur, or represents respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, iso-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro- substituted phenyl, furanyl, pyridyl, thienyl or benzyl,
or
A and D together represent a C3-C5-alkanediyl or C3-C5-alkenediyl group in which in each case optionally one methylene group is replaced by oxygen or sulphur and which are optionally substituted by fluorine, chlorine or by respectively optionally fluorine- or chlorine-substituted C1-C6-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, C3-C6-cycloalkyl, phenyl or benzyloxy,
G represents hydrogen (a) or represents one of the groups
Figure US20020010204A1-20020124-C00173
E (f) or
Figure US20020010204A1-20020124-C00174
in which
E represents a metal ion equivalent or an ammonium ion,
L represents oxygen or sulphur and
M represents oxygen or sulphur,
R1 represents respectively optionally fluorine- or chlorine-substituted C1-C14-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C1-C6-alkyl, C1-C4-alkylthio-C1-C6-alkyl, poly-C1-C4-alkoxy-C1-C4-alkyl or represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, i-propyl-, n-butyl-, i-butyl-, tert-butyl-, methoxy-, ethoxy-, n-propoxy- or iso-propoxy-substituted C3-C6-cycloalkyl in which optionally one or two not directly adjacent methylene groups are replaced by oxygen and/or sulphur,
represents optionally fluorine-, chlorine-, bromine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl-, trifluoromethoxy-, methylthio-, ethylthio-, methylsulphonyl- or ethylsulphonyl-substituted phenyl,
represents optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoro- methoxy-substituted benzyl,
represents respectively optionally fluorine-, chlorine-, bromine-, methyl- or ethyl-substituted furanyl, thienyl or pyridyl,
represents optionally fluorine-, chlorine-, methyl- or ethyl-substituted phenoxy-C1-C4-alkyl or
represents respectively optionally fluorine-. chlorine-, amino-, methyl- or ethyl-substituted pyridyloxy-C1-C4-alkyl, pyrimidyloxy-C1-C4-alkyl or thiazolyloxy-C1-C4-alkyl,
R2 represents respectively optionally fluorine- or chlorine-substituted C1-C4-alkyl, C2-C14-alkenyl, C1-C4-alkoxy-C2-C6-alkyl or poly-C1-C4-alkoxy-C2-C6-alkyl,
represents optionally fluorine-, chlorine-, methyl-, ethyl-, n-propyl-, iso-propyl- or methoxy-substituted C3-C6-cycloalkyl,
or represents respectively optionally fluorine-, chlorine-, cyano-, nitro-, methyl-, ethyl-, n-propyl-, i-propyl-, methoxy-, ethoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl or benzyl,
R3 represents optionally fluorine- or chlorine-substituted methyl, ethyl, propyl, iso-propyl, n-butyl, tert-butyl or respectively optionally fluorine-, chlorine-, bromine-, methyl-, ethyl-, iso-propyl-, tert-butyl-, methoxy-, ethoxy-, iso-propoxy-, trifluoromethyl-, trifluoromethoxy-, cyano- or nitro-substituted phenyl or benzyl,
R4 and R5 independently of one another each represent respectively optionally fluorine- or chlorine-substituted C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylamino, di-(C1-C4-alkyl)-amino or C1-C4-alkylthio or represent respectively optionally fluorine-, chlorine-, bromine-, nitro-, cyano-, methyl-, methoxy-, trifluoromethyl- or trifluoromethoxy-substituted phenyl, phenoxy or phenylthio and
R6 and R7 independently of one another each represent hydrogen, represent respectively optionally fluorine- or chlorine-substituted C1-C4-alkyl, C3-C6-cycloalkyl, C1-C4-alkoxy, C3-C4-alkenyl or C1-C4-alkoxy-C2-C4-alkyl, represent respectively optionally fluorine-, chlorine-, bromine-, methyl-, methoxy- or trifluoromethyl-substituted phenyl or benzyl, or together represent an optionally methyl- or ethyl-substituted C5-C6-alkylene radical in which optionally one methylene group is replaced by oxygen or sulphur.
5. Process for preparing compounds of the formula (I) according to claim 1, characterized in that
(A) compounds of the formula (I-1-a)
Figure US20020010204A1-20020124-C00175
in which
A, B, X and Z are each as defined in claim 1, are obtained by the intramolecular condensation of compounds of the formula (II)
Figure US20020010204A1-20020124-C00176
in which
A, B, X and Z are each as defined in claim 1, and
R8 represents alkyl, in the presence of a diluent and in the presence of a base,
(B) compounds of the formula (I-2-a)
Figure US20020010204A1-20020124-C00177
in which
A, B, X and Z are each as defined above, are obtained by the intramolecular condensation of compounds of the formula (III)
Figure US20020010204A1-20020124-C00178
in which
A, B, X, Z and R8 are each as defined above, in the presence of a diluent and in the presence of a base,
(C) compounds of the formula (I-3-a)
Figure US20020010204A1-20020124-C00179
in which
A, B, X and Z are each as defined above, are obtained by the intramolecular cyclization of compounds of the formula (IV)
Figure US20020010204A1-20020124-C00180
in which
A, B, X, Z and R8 are each as defined above and
W represents hydrogen, halogen, alkyl or alkoxy, if appropriate in the presence of a diluent and in the presence of an acid,
(D) compounds of the formula (I-4-a)
Figure US20020010204A1-20020124-C00181
in which
A, D, X and Z are each as defined in claim 1, are obtained by reacting compounds of the formula (V)
Figure US20020010204A1-20020124-C00182
in which
A and D are each as defined above, or their silyl enol ethers of the formula (Va)
Figure US20020010204A1-20020124-C00183
in which
A and D are each as defined above and
R8′ represents alkyl, with compounds of the formula (VI)
Figure US20020010204A1-20020124-C00184
in which
X and Z are each as defined above and
Hal represents halogen, if appropriate in the presence of a diluent and if appropriate in the presence of an acid acceptor,
(E)α) with acid halides of the formula (VII)
Figure US20020010204A1-20020124-C00185
in which
R1 is as defined in claim 1 and
Hal represents halogen,
or
β) with carboxylic anhydrides of the formula (VIII)
R1—CO—O—CO—R1  (VIII)
in which
R1 is as defined above, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, or
(F) with chloroformic esters or chloroformic thioesters of the formula (IX)
R2—M—CO—Cl  (IX)
in which
R2 and M are each as defined in claim 1, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, or
(G) with chloromonothioformic esters or-chlorodithioformic esters of the formula (X)
Figure US20020010204A1-20020124-C00186
in which
M and R2 are each as defined above, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, or
(H) with sulphonyl chlorides of the formula (XII)
R3—SO2—Cl  (XII)
in which
R3 is as defined in claim 1, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, or
(I) with phosphorus compounds of the formula (XIII)
Figure US20020010204A1-20020124-C00187
in which
L, R4 and R5 are each as defined above and
Hal represents halogen, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent, or
(J) with metal compounds or amines of the formulae (XIV) or (XV)
Figure US20020010204A1-20020124-C00188
in which
Me represents a mono- or divalent metal,
t represents the number 1 or 2 and
R10, R11, R12 independently of one another each represent hydrogen or alkyl, if appropriate in the presence of a diluent, or
(K)α) with isocyanates or isothiocyanates of the formula (XVI)
R6—N═C═L  (XVI)
in which
R6 and L are each as defined in claim 1, if appropriate in the presence of a diluent and if appropriate in the presence of a catalyst, or
β) with carbamoyl chlorides or thiocarbamoyl chlorides of the formula (XVII)
Figure US20020010204A1-20020124-C00189
in which
L, R6 and R7 are each as defined above, if appropriate in the presence of a diluent and if appropriate in the presence of an acid-binding agent.
6. Compounds of the formula (II)
Figure US20020010204A1-20020124-C00190
in which
A, B, X and Z are each as defined in claim 1 and
R8 represents alkyl.
7. Compounds of the formula (III)
Figure US20020010204A1-20020124-C00191
in which
A, B, X and Z are each as defined in claim 1 and
R8 represents alkyl.
8. Compounds of the formula (XX)
Figure US20020010204A1-20020124-C00192
in which
A, B, X and Z ari each as defined in claim 1.
9. Compounds of the formula (XXVIII)
Figure US20020010204A1-20020124-C00193
in which
A, B, X and Z are each as defined in claim 1.
10. Compounds of the formula (IV)
Figure US20020010204A1-20020124-C00194
in which
A, B, X and Z are each as defined in claim 1,
R8 represents alkyl and
W represents hydrogen, halogen, alkyl or alkoxy.
11. Compounds of the formula (VI)
Figure US20020010204A1-20020124-C00195
in which
X and Z are each as defined in claim 1, Z not representing hydrogen, and
Hal represents chlorine or bromine.
12. Compounds of the formula (XXXI)
Figure US20020010204A1-20020124-C00196
in which
X and Z are each as defined in claim 1, Z not representing hydrogen.
13. Compounds of the formula (XXXII)
Figure US20020010204A1-20020124-C00197
in which
X and Z are each as defined in claim 1, Z not representing hydrogen, and
R8 represents alkyl.
14. Compounds of the formula (XXII)
Figure US20020010204A1-20020124-C00198
in which
X and Z are each as defined in claim 1,
with the exception of 2,5-dichlorophenylacetic acid, 5-chloro-2-methoxyphenylacetic acid, 2-chloro-5-methylphenylacetic acid, 2,5-difluorophenylacetic acid, 2-bromo-5-methylphenylacetic acid and 2-chloro-5-trifluoromethylphenylacetic acid.
15. Compounds of the formula (XXIII)
Figure US20020010204A1-20020124-C00199
in which
X and Z are each as defined in claim 1 and,
R8 represents alkyl, with the exception of methyl 2,5-dichlorophenylacetate and methyl 5-chloro-2-methoxy-phenylacetate.
16. Compounds of the formula (XXIV)
Figure US20020010204A1-20020124-C00200
in which
X and Z are each as defined in claim 1.
17. Pesticides, characterized in that they comprise at least one compound of the formula (I) according to claim 1.
18. Use of compounds of the formula (I) according to claim 1 for controlling pests.
19. Method for controlling pests, characterized in that compounds of the formula (I) according to claim 1 are allowed to act on pests and/or their habitat.
20. Process for preparing pesticides, characterized in that compounds of the formula (I) according to claim 1 are mixed with extenders and/or surface-active agents.
21. Use of compounds of the formula (I) according to claim 1 for preparing pesticides.
US09/809,619 1996-08-05 2001-03-15 2- and 2,5-substituted phenylketoenols Expired - Fee Related US6359151B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09/809,619 US6359151B2 (en) 1996-08-05 2001-03-15 2- and 2,5-substituted phenylketoenols
US10/006,115 US6504036B1 (en) 1996-08-05 2001-12-10 2- and 2.5-substituted phenylketoenols
US10/264,424 US6596873B1 (en) 1996-08-05 2002-10-04 2-and 2,5-substituted phenylketoenols

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
DE19631586 1996-08-05
DE19631586 1996-08-05
DE19631586.7 1996-08-05
DE19716591A DE19716591A1 (en) 1996-08-05 1997-04-21 2- and 2,5-substituted phenylketoenols
DE19716591 1997-04-21
DE19716591.5 1997-04-21
US09/230,653 US6114374A (en) 1996-08-05 1997-07-23 2-and 2,5-substituted phenylketoenols
US09/548,129 US6255342B1 (en) 1996-08-05 2000-04-12 2-and 2,5-substituted phenylketoenols
US09/809,619 US6359151B2 (en) 1996-08-05 2001-03-15 2- and 2,5-substituted phenylketoenols

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/548,129 Division US6255342B1 (en) 1996-08-05 2000-04-12 2-and 2,5-substituted phenylketoenols

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/006,115 Division US6504036B1 (en) 1996-08-05 2001-12-10 2- and 2.5-substituted phenylketoenols

Publications (2)

Publication Number Publication Date
US20020010204A1 true US20020010204A1 (en) 2002-01-24
US6359151B2 US6359151B2 (en) 2002-03-19

Family

ID=26028129

Family Applications (5)

Application Number Title Priority Date Filing Date
US09/230,653 Expired - Lifetime US6114374A (en) 1996-08-05 1997-07-23 2-and 2,5-substituted phenylketoenols
US09/548,129 Expired - Lifetime US6255342B1 (en) 1996-08-05 2000-04-12 2-and 2,5-substituted phenylketoenols
US09/809,619 Expired - Fee Related US6359151B2 (en) 1996-08-05 2001-03-15 2- and 2,5-substituted phenylketoenols
US10/006,115 Expired - Fee Related US6504036B1 (en) 1996-08-05 2001-12-10 2- and 2.5-substituted phenylketoenols
US10/264,424 Expired - Fee Related US6596873B1 (en) 1996-08-05 2002-10-04 2-and 2,5-substituted phenylketoenols

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/230,653 Expired - Lifetime US6114374A (en) 1996-08-05 1997-07-23 2-and 2,5-substituted phenylketoenols
US09/548,129 Expired - Lifetime US6255342B1 (en) 1996-08-05 2000-04-12 2-and 2,5-substituted phenylketoenols

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/006,115 Expired - Fee Related US6504036B1 (en) 1996-08-05 2001-12-10 2- and 2.5-substituted phenylketoenols
US10/264,424 Expired - Fee Related US6596873B1 (en) 1996-08-05 2002-10-04 2-and 2,5-substituted phenylketoenols

Country Status (18)

Country Link
US (5) US6114374A (en)
EP (1) EP0915846B1 (en)
JP (1) JP4202423B2 (en)
KR (1) KR100518374B1 (en)
CN (3) CN1240679C (en)
AU (1) AU726090B2 (en)
BR (1) BRPI9711024B1 (en)
DE (3) DE59712761D1 (en)
DK (4) DK1277751T3 (en)
ES (4) ES2193389T3 (en)
HU (1) HU228370B1 (en)
ID (1) ID19770A (en)
IL (1) IL128235A (en)
NZ (1) NZ334028A (en)
PL (1) PL201168B1 (en)
PT (1) PT915846E (en)
TR (1) TR199900239T2 (en)
WO (1) WO1998005638A2 (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096806A1 (en) * 1998-04-27 2003-05-22 Folker Lieb Arylphenyl-substituted cyclic ketoenols
US20030100604A1 (en) * 2000-03-28 2003-05-29 Reiner Fischer Active substance combinations having insecticidal and acaricidal properties
US20030148999A1 (en) * 2000-06-29 2003-08-07 Reiner Fischer Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US20030185813A1 (en) * 2000-04-14 2003-10-02 Reiner Fischer Active substance combinations with insecticidal and acaricidal properties
US6642180B1 (en) 1999-07-30 2003-11-04 Bayer Aktiengesellschaft Biphenyl-substituted cyclic ketoenols as pesticides
US20030211944A1 (en) * 2000-04-11 2003-11-13 Reiner Fischer Active substance combinations having insecticidal and acaricidal properties
US6653343B2 (en) 2000-02-18 2003-11-25 Bayer Aktiengesellschaft Active substance combinations comprising insecticidal and acaricidal properties
US20040102326A1 (en) * 2000-10-09 2004-05-27 Reiner Fischer Active ingredient combinations with insecticidal, fungicidal and acaricidal properties
US20040161757A1 (en) * 2000-12-14 2004-08-19 Reiner Fischer Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
US20040235934A1 (en) * 2000-05-19 2004-11-25 Reiner Fischer Active substance combinations having insecticidal and acaricdal properties
US20050054535A1 (en) * 2001-08-10 2005-03-10 Reiner Fischer Selective herbicides based on substituted cyclic keto-enols and safeners
US7060692B2 (en) 2000-08-31 2006-06-13 Bayer Cropscience Ag Active ingredient combinations comprising insecticidal and acaricidal properties
US20060160847A1 (en) * 2003-01-20 2006-07-20 Reiner Fischer 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
US7084138B2 (en) 2000-09-05 2006-08-01 Bayer Cropscience Ag Active ingredient combinations with insecticidal and acaricidal properties
US7183238B2 (en) 2001-12-06 2007-02-27 Bayer Cropscience Ag [1,2]-oxazine-3,5-diones
US20070142463A1 (en) * 2003-07-08 2007-06-21 Reiner Fischer Active agents combination exhibiting insecticidal and acaricide properties
US20070275858A1 (en) * 2002-08-28 2007-11-29 Reiner Fischer Substituted spirocyclic ketoenols
US20090012152A1 (en) * 2005-01-22 2009-01-08 Bayer Cropscience Aktiengesellschaft Use of Tetramic Acid Derivatives for Controlling Insects from the Genus of the Plane Lice (Sternorrhyncha)
US20090010501A1 (en) * 2007-07-05 2009-01-08 Sony Corporation Image processing apparatus and image processing method
US20090099247A1 (en) * 2006-03-08 2009-04-16 Macom Thomas E Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection
US7585887B2 (en) 2000-11-10 2009-09-08 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US20100173987A1 (en) * 2006-06-16 2010-07-08 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US20110003875A1 (en) * 2008-02-25 2011-01-06 Bayer Cropscience Ag Oil-Based Suspension Concentrates
US7888285B2 (en) 2003-03-14 2011-02-15 Bayer Cropscience Ag 2,4,6-phenyl substituted cyclic ketoenols
US7915282B2 (en) 2000-04-03 2011-03-29 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
US20110200571A1 (en) * 2010-02-12 2011-08-18 Bell John W Methods for Reducing Nematode Damage to Plants
AU2006326300B2 (en) * 2005-12-13 2011-10-27 Bayer Cropscience Aktiengesellschaft Insecticidal compositions having improved effect
US8202875B2 (en) 2004-07-20 2012-06-19 Bayer Cropscience Ag Selective insecticides based on substituted cyclic ketoenols and safeners
WO2012061012A3 (en) * 2010-11-02 2012-07-26 The University Of North Carolina At Chapel Hill 4-amino-2h-pyran-2-one analogs as anticancer agents
US8710238B2 (en) 2011-03-11 2014-04-29 Bayer Intellectual Property Gmbh Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
US8859782B2 (en) 2011-01-25 2014-10-14 Bayer Cropscience Ag Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US8946124B2 (en) 2011-02-17 2015-02-03 Bayer Intellectual Property Gmbh Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols
US9089135B2 (en) 2009-03-25 2015-07-28 Bayer Intellectual Property Gmbh Nematicidal, insecticidal and acaricidal active ingredient combinations comprising pyridyl-ethylbenzamides and insecticides
US9198432B2 (en) 2011-08-11 2015-12-01 Bayer Intellectual Property Gmbh 1,2,4-triazolyl-substituted ketoenols
US9204640B2 (en) 2011-03-01 2015-12-08 Bayer Intellectual Property Gmbh 2-acyloxy-pyrrolin-4-ones
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
CN106748861A (en) * 2012-03-28 2017-05-31 拜耳知识产权有限责任公司 Preparation of cis-alkoxy-substituted spirophenylacetamido acid esters and spirocyclic 1H-pyrrolidine-2, 4-dione derivatives
US10577320B2 (en) 2016-05-04 2020-03-03 Bayer Cropscience Aktiengesellschaft Method for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives

Families Citing this family (151)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2193389T3 (en) * 1996-08-05 2003-11-01 Bayer Cropscience Ag PHENYLCETOENOLS 2-AND 2,5-SUBSTITUTED.
DE19742492A1 (en) 1997-09-26 1999-04-01 Bayer Ag Spirocyclic phenylketoenols
DE19808261A1 (en) * 1998-02-27 1999-10-28 Bayer Ag Arylphenyl substituted cyclic ketoenols
DE19813354A1 (en) 1998-03-26 1999-09-30 Bayer Ag Arylphenyl substituted cyclic ketoenols
DE19946625A1 (en) * 1999-09-29 2001-04-05 Bayer Ag Trifluoromethyl substituted spirocyclic ketoenols
DE19953775A1 (en) * 1999-11-09 2001-05-10 Bayer Ag Active ingredient combinations with insecticidal and acaricidal properties
DE10013914A1 (en) 2000-03-21 2001-09-27 Bayer Ag Synergistic pesticidal composition comprising 4-hydroxy-3-phenyl-furan-2(5H)-one derivative and bifenazate, abamectin or bifenthrin, are useful as insecticide, acaricide, ectoparasiticide or antifouling agents
DE10032587A1 (en) * 2000-07-05 2002-01-17 Bayer Ag 4-alkoxy-cyclohexane-1-amino-carboxylic acid esters and process for their preparation
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
MXPA04000371A (en) * 2001-07-18 2004-05-04 Basf Ag Substituted 6-(2-tolyl)-triazolopyrimidines as fungicides.
DE10146910A1 (en) * 2001-09-24 2003-04-10 Bayer Cropscience Ag Spirocyclic 3-phenyl-3-substituted-4-ketolactams and lactones
DE10213051B4 (en) * 2002-03-23 2013-03-07 Grünenthal GmbH Substituted 4-aminocyclohexanols
DE10216737A1 (en) * 2002-04-16 2003-10-30 Bayer Ag Control of parasites in animals
WO2003099272A1 (en) * 2002-05-22 2003-12-04 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
EP1511729A4 (en) * 2002-05-22 2006-09-06 Errant Gene Therapeutics Llc Histone deacetylase inhibitors based on alphachalcogenmethylcarbonyl compounds
DE10231333A1 (en) * 2002-07-11 2004-01-22 Bayer Cropscience Ag Cis-alkoxy-substituted 1-H-pyrrolidine-2,4-dione spirocyclic derivatives
DE10249055A1 (en) * 2002-10-22 2004-05-06 Bayer Cropscience Ag 2-Phenyl-2-substituted-1,3-diketones
DE10320782A1 (en) * 2003-05-09 2004-11-25 Bayer Cropscience Ag Substituted oxyarenes
DE10326386A1 (en) 2003-06-12 2004-12-30 Bayer Cropscience Ag N-heterocyclyl-phenyl-substituted cyclic ketoenols
DE10330724A1 (en) * 2003-07-08 2005-01-27 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE10331675A1 (en) 2003-07-14 2005-02-10 Bayer Cropscience Ag Hetaryl-substituted pyrazolidinedione derivatives
DE10337497A1 (en) 2003-08-14 2005-03-10 Bayer Cropscience Ag 4-biphenyl-pyrazolidine-3,5-dione derivatives
DE10353281A1 (en) * 2003-11-14 2005-06-16 Bayer Cropscience Ag Combination of active ingredients with insecticidal and acaricidal properties
DE10354628A1 (en) 2003-11-22 2005-06-16 Bayer Cropscience Ag 2-ethyl-4,6-dimethylphenyl-substituted tetramic acid derivatives
DE10354629A1 (en) 2003-11-22 2005-06-30 Bayer Cropscience Ag 2-ethyl-4,6-dimethyl-phenyl substituted spirocyclic tetramic acid derivatives
WO2005053405A1 (en) 2003-12-04 2005-06-16 Bayer Cropscience Aktiengesellschaft Active substance combination having insecticidal and acaricidal properties
DE102004011006A1 (en) * 2004-03-06 2005-09-22 Bayer Cropscience Ag Suspension concentrates based on oil
DE102004011007A1 (en) * 2004-03-06 2005-09-22 Bayer Cropscience Ag Suspension concentrates based on oil
DE102004014620A1 (en) * 2004-03-25 2005-10-06 Bayer Cropscience Ag 2,4,6-phenyl-substituted cyclic ketoenols
DE102004030753A1 (en) 2004-06-25 2006-01-19 Bayer Cropscience Ag 3'-alkoxy spirocyclic tetramic and tri-acids
DE102004044827A1 (en) * 2004-09-16 2006-03-23 Bayer Cropscience Ag Iodine-phenyl-substituted cyclic ketoenols
DE102004053192A1 (en) * 2004-11-04 2006-05-11 Bayer Cropscience Ag 2-alkoxy-6-alkyl-phenyl substituted spirocyclic tetramic acid derivatives
DE102004053191A1 (en) 2004-11-04 2006-05-11 Bayer Cropscience Ag 2,6-diethyl-4-methyl-phenyl substituted tetramic acid derivatives
DE102005008021A1 (en) 2005-02-22 2006-08-24 Bayer Cropscience Ag New spiroketal-substituted cyclic ketoenol compounds used for combating animal parasites, undesired plant growth and/or undesired microorganisms
DE102005008033A1 (en) * 2005-02-22 2006-08-24 Bayer Cropscience Ag Agent used to combat animal parasites and to prepare insecticide and acaricide agents, comprises a pyrrole or pyrrolidine ketoenol compound and ethiprole
DE102005051325A1 (en) 2005-10-27 2007-05-03 Bayer Cropscience Ag Alkoxyalkyl spirocyclic tetramic and tetronic acids
DE102005059891A1 (en) 2005-12-15 2007-06-28 Bayer Cropscience Ag New spiro-cyclopentyl-pyrrole or -furan derivatives, useful as pesticides, herbicides and fungicides, also new intermediates
DE102006007882A1 (en) 2006-02-21 2007-08-30 Bayer Cropscience Ag New cyclic keto enol derivatives useful for controlling animal pests and/or unwanted plant growth
AU2013200344B2 (en) * 2006-03-28 2014-10-23 Bayer Intellectual Property Gmbh Use of tetramic acid derivatives for controlling pests by drenching, drip application, dip application or soil injection
DE102006014480A1 (en) * 2006-03-29 2007-10-04 Bayer Cropscience Ag Active agent combination, useful to e.g. combat animal parasites, comprises 2-chloro-pyridine-furan-2-one compound and spirotetramat compound, spirodiclofen compound and/or spiromesifen compound
DE102006018828A1 (en) 2006-04-22 2007-10-25 Bayer Cropscience Ag Alkoxyalkyl-substituted cyclic ketoenols
DE102006022821A1 (en) 2006-05-12 2007-11-15 Bayer Cropscience Ag Use of tetramic acid derivatives for controlling insects of the order of beetles (Coleoptera), thrips (Tysanoptera), bugs (Hemiptera), flies (Diptera) and cicadas (Auchenorrhynchae)
DE102006025874A1 (en) 2006-06-02 2007-12-06 Bayer Cropscience Ag Alkoxyalkyl-substituted cyclic ketoenols
DE102006027730A1 (en) * 2006-06-16 2007-12-20 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006027731A1 (en) 2006-06-16 2007-12-20 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006031976A1 (en) * 2006-07-11 2008-01-17 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
DE102006031978A1 (en) * 2006-07-11 2008-01-17 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
US20090281157A1 (en) * 2006-07-11 2009-11-12 Bayer Cropscience Ag Active Ingredient Combinations With Insecticidal and Acaricidal Properties
DE102006033154A1 (en) * 2006-07-18 2008-01-24 Bayer Cropscience Ag Drug combinations with insecticidal and acaricidal properties
EP1905300A1 (en) * 2006-09-30 2008-04-02 Bayer CropScience AG Water dispersible agrochemical formulations comprising polyalkoxytriglycerides as penetration promoters
DE102006050148A1 (en) * 2006-10-25 2008-04-30 Bayer Cropscience Ag New trifluoromethoxy-phenyl substituted tetramic acid-derivatives useful to combat parasites including insects, arachnid, helminth, nematode and mollusk and/or undesirable plant growth and in hygienic sectors
DE102006057037A1 (en) * 2006-12-04 2008-06-05 Bayer Cropscience Ag New cis-alkoxyspirocyclic biphenyl-substituted acid derivatives used in pesticides and/or herbicides, for combating animal parasites and undesirable plant growth and as insecticides and/or acaricides in crop protection
DE102006057036A1 (en) 2006-12-04 2008-06-05 Bayer Cropscience Ag New biphenyl substituted spirocyclic ketoenol derivatives useful for the manufacture of herbicides and for combating parasites
CL2007003746A1 (en) * 2006-12-22 2008-07-18 Bayer Cropscience Ag PESTICIDE COMPOSITION INCLUDING PROPAMOCARB-HCL AND AN INSECTICIDE COMPOUND; AND METHOD FOR CONTROLLING FITOPATOGEN FUNDS OR DANIN INSECTICIDES OF THE PLANTS, CROPS OR SEEDS THAT INCLUDE APPLYING SUCH COMPOSITION.
CL2007003748A1 (en) * 2006-12-22 2008-07-18 Bayer Cropscience Ag PESTICIDE COMPOSITION INCLUDING FOSETIL-AL, PROPAMOCARB-HCL AND AN ACTIVE INSECTED SUBSTANCE; AND METHOD FOR CONTROLLING FITOPATOGEN FUNDS OR DANIN INSECTICIDES OF THE PLANTS, CROPS OR SEEDS THAT INCLUDE APPLYING SUCH COMPOSITION.
CL2007003745A1 (en) * 2006-12-22 2008-07-11 Bayer Cropscience Ag PESTICIDE COMPOSITION INCLUDING FOSETIL-AL, PROPAMOCARB-HCL AND AN ACTIVE INSECTED SUBSTANCE; AND METHOD FOR CONTROLLING FITOPATOGEN FUNDS OR DANIN INSECTICIDES OF THE PLANTS, CROPS OR SEEDS THAT INCLUDE APPLYING SUCH COMPOSITION.
DE102007009957A1 (en) 2006-12-27 2008-07-03 Bayer Cropscience Ag Process for improving the use of the productive potential of a transgenic plant e.g. maize, soya bean, cotton, tobacco, rice, comprises treating the plant with 3-aryl-pyrrolidin-2,4-dione compound
DE102007001866A1 (en) 2007-01-12 2008-07-17 Bayer Cropscience Ag Spirocyclic tetronic acid derivatives
EP2008519A1 (en) * 2007-06-28 2008-12-31 Bayer CropScience AG Use of agent combinations with insecticidal properties for controlling animal pests from the stinkbug family
EP2011394A1 (en) * 2007-07-03 2009-01-07 Bayer CropScience AG Use of tetramic acid derivatives for controlling virus-transmitting vectors
EP2014169A1 (en) 2007-07-09 2009-01-14 Bayer CropScience AG Water-soluble concentrates of 3-(2-alkoxy 4-chlorine-6-alkyl-phenyl)-substituted tetramates with their corresponding enols
EP2020413A1 (en) 2007-08-02 2009-02-04 Bayer CropScience AG Oxaspirocyclical spiro-substituted tetram and tetron acid derivatives
EP2039248A1 (en) * 2007-09-21 2009-03-25 Bayer CropScience AG Active agent combinations with insecticide and acaricide properties
EP2045240A1 (en) 2007-09-25 2009-04-08 Bayer CropScience AG Halogen alkoxy spirocyclic tetram and tetron acid derivatives
DE102007045919B4 (en) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Drug combinations with insecticidal and acaricidal properties
KR101457993B1 (en) 2007-12-20 2014-11-04 바이엘 크롭사이언스 아게 Use of tetramic acid derivatives for controlling nematodes
EP2071952A1 (en) 2007-12-21 2009-06-24 Bayer CropScience AG Use of tetramic acid derivatives for combating plant diseases through drench or drip application
EP2090167A1 (en) 2008-02-13 2009-08-19 Bayer CropScience AG Use of tetramic acid derivatives for combating animal pests by treating roots, branches, florescence and buds
EP2103615A1 (en) 2008-03-19 2009-09-23 Bayer CropScience AG 4'4'-Dioxaspiro-spirocyclic substituted tetramates
KR20100134066A (en) * 2008-03-27 2010-12-22 바이엘 크롭사이언스 아게 Use of Tetronic Acid Derivatives to Control Insects and / or Leaf Mites by Ground Spraying, Droplet Application, or Immersion Application
US8404260B2 (en) 2008-04-02 2013-03-26 Bayer Cropscience Lp Synergistic pesticide compositions
EP2113172A1 (en) 2008-04-28 2009-11-04 Bayer CropScience AG Method for improved utilisation of the production potential of transgene plants
EP2127522A1 (en) 2008-05-29 2009-12-02 Bayer CropScience AG Active-agent combinations with insecticidal and acaricidal properties
TW201031327A (en) 2008-11-14 2010-09-01 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US8683346B2 (en) * 2008-11-17 2014-03-25 Sap Portals Israel Ltd. Client integration of information from a supplemental server into a portal
US8389443B2 (en) * 2008-12-02 2013-03-05 Bayer Cropscience Ag Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives
US8846946B2 (en) 2008-12-02 2014-09-30 Bayer Cropscience Ag Germinal alkoxy/alkylspirocyclic substituted tetramate derivatives
EP2227951A1 (en) 2009-01-23 2010-09-15 Bayer CropScience AG Application of enaminocarbonyl compounds for combating viruses transmitted by insects
AR075126A1 (en) 2009-01-29 2011-03-09 Bayer Cropscience Ag METHOD FOR THE BEST USE OF THE TRANSGENIC PLANTS PRODUCTION POTENTIAL
MX338802B (en) 2009-03-11 2016-05-02 Bayer Cropscience Ag Halogenalkylmethylenoxy-phenyl-substituted ketoenols.
WO2010102761A1 (en) 2009-03-12 2010-09-16 Bayer Cropscience Aktiengesellschaft Method for producing aromatic chlorine and bromine compounds
MA33140B1 (en) 2009-03-25 2012-03-01 Bayer Cropscience Ag COMBINATIONS OF ACTIVE AGENTS HAVING INSECTICIDAL AND ACARICIDE PROPERTIES
EP2432785B1 (en) 2009-05-19 2014-10-15 Bayer CropScience AG Herbicidal spiroheterocyclic tetronic acid derivatives
CN102474332B (en) 2009-07-17 2015-04-01 飞思卡尔半导体公司 Diversity receiver and transceiver
CN102474322B (en) 2009-07-17 2015-04-01 飞思卡尔半导体公司 Diversity antenna system and transmission method
DE102009028001A1 (en) 2009-07-24 2011-01-27 Bayer Cropscience Ag Use of an active agent combination (comprising a 3-phenyl-1-aza-spiro(4.5)dec-3-en-2-one compound, and an agent e.g. alanycarb, aldicarb, acephate, camphechlor or chlordane) for combating animal pests e.g. insects, acarids and helminths
JP2011037760A (en) 2009-08-11 2011-02-24 Sumitomo Chemical Co Ltd Pest-controlling composition
JP2013503910A (en) 2009-09-09 2013-02-04 バイエル・クロップサイエンス・アーゲー Use of cyclic ketoenols to control phytopathogenic bacteria
BR112012006841B8 (en) 2009-10-15 2021-06-08 Bayer Cropscience Ag combination of active compound, its uses and method to curatively or preventively control phytopathogenic fungi and/or microorganisms and/or plant or crop pests
ES2700996T3 (en) 2010-02-10 2019-02-20 Bayer Cropscience Ag Cyclic ketoenols substituted with biphenyl
EP2534147B1 (en) 2010-02-10 2015-06-17 Bayer Intellectual Property GmbH Spiroheterocyclic-substituted tetramic acid derivatives
DE102010008642A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumors
DE102010008644A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 Cyclic ketoenols for therapy
DE102010008643A1 (en) 2010-02-15 2011-08-18 Bayer Schering Pharma Aktiengesellschaft, 13353 New 5'-biphenyl substituted cyclic ketoenol compounds are acetyl-coenzyme A carboxylase 1 inhibitors, useful for treating cancer e.g. breast cancer, pancreatic cancer, renal cell carcinoma, hepatocellular carcinoma and skin tumor
CN102939007B (en) 2010-04-20 2015-09-02 拜耳知识产权有限责任公司 Insecticidal and/or herbicidal compositions with improved activity based on spiroheterocyclic substituted tetramic acid derivatives
EP2563144A1 (en) 2010-04-27 2013-03-06 Syngenta Participations AG Methods of controlling neonicotinoid resistant aphids
JP2011236130A (en) * 2010-05-06 2011-11-24 Sumitomo Chemical Co Ltd Method for controlling planthopper in paddy field where rice plant grows
CN101928272B (en) * 2010-06-12 2013-05-22 湖南化工研究院 3-o-methylphenyl-2-oxo-1-oxaspiro[4,5]-decyl-3-alkene-4-ol derivative
JP5720137B2 (en) * 2010-08-04 2015-05-20 住友化学株式会社 Harmful arthropod control composition and harmful arthropod control method
EP2446742A1 (en) 2010-10-28 2012-05-02 Bayer CropScience AG Insecticide or acaricide compositions containing mono- or disaccharides as activity enhancers
CN103270020B (en) 2010-12-22 2016-01-20 拜耳知识产权有限责任公司 Method for preparing cis-1-ammonium-4-alkoxycyclohexanecarbonitrile salt
DE102011011040A1 (en) 2011-02-08 2012-08-09 Bayer Pharma Aktiengesellschaft (5s, 8s) -3- (4'-chloro-3'-fluoro-4-methylbiphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro [4.5] dec-3-en-2- on (compound A) for therapy
DE102011080405A1 (en) 2011-08-04 2013-02-07 Bayer Pharma AG New substituted 3-biphenyl-3-yl-8,8-difluoro-4-hydroxy-1-azaspiro(4.5)dec-3-en-2-one derivatives useful for prophylaxis or therapy of tumor diseases comprising breast cancer, prostate cancer, colorectal cancer or non-small cell lung cancer
CN102228039A (en) * 2011-05-11 2011-11-02 青岛海利尔药业有限公司 Pesticide composition containing spirotetramat and chlorfenapyr
DE102011080406A1 (en) 2011-08-04 2013-02-07 Bayer Pharma AG Substituted 3- (biphenyl-3-yl) -4-hydroxy-8-methoxy-1-azaspiro8 [4.5] dec-3-ene-2-ones
EP2739142A1 (en) 2011-08-05 2014-06-11 Bayer Intellectual Property GmbH Use of tetramic acid derivatives for controlling pathogens by foliar application
CA2862335C (en) 2012-01-26 2021-04-13 Bayer Intellectual Property Gmbh Phenyl-substituted ketoenols for controlling fish parasites
CN103283738B (en) * 2012-03-02 2015-12-09 陕西韦尔奇作物保护有限公司 A kind of Pesticidal combination containing spiral shell worm ethyl ester
CN103300006B (en) * 2012-03-12 2016-09-07 陕西韦尔奇作物保护有限公司 A kind of insecticidal composition containing fenozide
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
CN103109824A (en) * 2013-03-05 2013-05-22 海利尔药业集团股份有限公司 Insecticidal composition containing pyridalyl and spirotetramat
DK3022204T3 (en) 2013-07-19 2018-10-08 Syngenta Participations Ag UNKNOWN PROCEDURE FOR THE PREPARATION OF SPIROHETEROCYCLIC PYRROLIDE INDIONS
CN104286018A (en) * 2014-09-18 2015-01-21 青岛润鑫伟业科贸有限公司 Efficient insecticide containing chlorpyrifos, triazophos and spirotetramat
CN104273168A (en) * 2014-09-29 2015-01-14 青岛康和食品有限公司 Efficient insecticide containing spirotetramat, acephate and chlorfenvinphos
EA035255B1 (en) 2015-10-06 2020-05-21 Байер Кропсайенс Акциенгезельшафт Alkynyl-substituted 3-phenylpyrrolidine-2,4-diones and use thereof as herbicides
CN118978425A (en) 2016-01-15 2024-11-19 拜耳作物科学股份公司 Process for preparing substituted 2-arylethanol
CN105766954A (en) * 2016-03-31 2016-07-20 广东中迅农科股份有限公司 Seed treatment composition containing carboxin and spirotetramat
EP3532630B1 (en) 2016-10-31 2020-06-24 Eastman Chemical Company Enzymatic preparation of propamocarb
JP6933413B2 (en) 2017-11-03 2021-09-08 華南農業大学 Use as nitrogen-containing condensed tricyclic compounds and agricultural and forestry pesticides
JP7407123B2 (en) 2018-04-13 2023-12-28 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Use of tetramic acid derivatives to control pests by irrigation or droplet application
WO2019197617A1 (en) 2018-04-13 2019-10-17 Bayer Cropscience Aktiengesellschaft Use of tetramic acid derivatives for controlling animal pests by watering, drip application plant hole treatment or furrow application
BR112020020766A2 (en) 2018-04-13 2021-01-19 Bayer Cropscience Aktiengesellschaft USE OF TETRAMIC ACID DERIVATIVES TO CONTROL SPECIFIC INSECTS
WO2019197652A1 (en) 2018-04-13 2019-10-17 Bayer Aktiengesellschaft Solid formulation of insecticidal mixtures
WO2019197620A1 (en) 2018-04-13 2019-10-17 Bayer Cropscience Aktiengesellschaft Use of tetramic acid derivatives for controlling specific insects
AR115089A1 (en) 2018-05-15 2020-11-25 Bayer Ag 2-ALKYL-6-ALCOXIFENIL-3-PIRROLIN-2-ONAS SPECIALLY SUBSTITUTED AND THEIR USE AS HERBICIDES
EA202092643A1 (en) 2018-05-15 2021-03-22 Байер Акциенгезельшафт 2-BROMINE-6-ALCOXYPHENYL-SUBSTITUTED PYRROLIN-2-ONES AND THEIR USE AS HERBICIDES
WO2019219585A1 (en) 2018-05-15 2019-11-21 Bayer Aktiengesellschaft New 3-(4-alkynyl-6-alkoxy-2-chlorophenyl)-3-pyrrolin-2-ones and their use as herbicides
WO2019219584A1 (en) 2018-05-15 2019-11-21 Bayer Aktiengesellschaft New spiro cyclohexyl pyrrolin-2-ones and their use as herbicides
WO2019228788A1 (en) 2018-05-29 2019-12-05 Bayer Aktiengesellschaft 2-bromo-6-alkoxyphenyl-substituted pyrrolin-2-ones and their use as herbicides
WO2019228787A1 (en) 2018-05-29 2019-12-05 Bayer Aktiengesellschaft Specifically substituted 2-alkyl-6-alkoxyphenyl-3-pyrrolin-2-ones and their use as herbicides
JP2022525174A (en) 2019-03-15 2022-05-11 バイエル・アクチエンゲゼルシヤフト Specifically substituted 3- (2-alkoxy-6-alkyl-4-propynylphenyl) -3-pyrroline-2-ones and their use as herbicides
US20220183293A1 (en) 2019-03-15 2022-06-16 Bayer Aktiengesellschaft Active compound combinations having insecticidal/acaricidal properties
CN113544119A (en) 2019-03-15 2021-10-22 拜耳公司 3-(2-Bromo-4-ynyl-6-alkoxyphenyl)-substituted 5-spirocyclohexyl-3-pyrrolin-2-ones and their use as herbicides
US20220056040A1 (en) 2019-03-15 2022-02-24 Bayer Aktiengesellschaft Novel 3-(2-bromo-4-alkynyl-6-alkoxyphenyl)-3-pyrrolin-2-ones and their use as herbicides
WO2020187623A1 (en) 2019-03-15 2020-09-24 Bayer Aktiengesellschaft Specifically substituted 3-(2-halogen-6-alkyl-4-propinylphenyl)-3-pyrrolin-2-ones and to the use thereof as herbicides
WO2020187626A1 (en) 2019-03-15 2020-09-24 Bayer Aktiengesellschaft Specifically substituted 3-phenyl-5-spirocyclopentyl-3-pyrrolin-2-ones and their use as herbicides
WO2021204884A1 (en) 2020-04-09 2021-10-14 Bayer Aktiengesellschaft 3-(4-alkenyl-phenyl)-3-pyrrolin-2-ones and their use as herbicides
WO2021209486A1 (en) 2020-04-15 2021-10-21 Bayer Aktiengesellschaft Specifically substituted pyrroline-2-ones and their use as herbicides
WO2021239673A1 (en) 2020-05-27 2021-12-02 Bayer Aktiengesellschaft Substituted pyrroline-2-ones and their use as herbicides
CN114149433A (en) * 2020-09-07 2022-03-08 海利尔药业集团股份有限公司 Nitrogen-containing spiro derivative or salt thereof acceptable as pesticide, composition and application thereof
CA3194486A1 (en) 2020-09-30 2022-04-07 Control Solutions, Inc. Powder pest control compositions and methods of using
US20220272980A1 (en) 2021-03-01 2022-09-01 Control Solutions, Inc. Solid particulate pest control compositions and methods
EP4337015A1 (en) 2021-05-14 2024-03-20 Syngenta Crop Protection AG Insect, acarina and nematode pest control
BR112023023835A2 (en) 2021-05-14 2024-01-30 Syngenta Crop Protection Ag COMPOSITIONS FOR SEED TREATMENT
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023274869A1 (en) 2021-06-29 2023-01-05 Bayer Aktiengesellschaft 3-(4-alkenyl-phenyl)-3-pyrrolino-2-ones and their use as herbicides
WO2023021136A1 (en) 2021-08-20 2023-02-23 Syngenta Crop Protection Ag Method of controlling pests on tea plants
CN114014795A (en) * 2021-11-30 2022-02-08 新乡医学院三全学院 Preparation method of high-purity spirotetramat
WO2023105064A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2024209478A1 (en) 2023-04-07 2024-10-10 Adama Makhteshim Ltd. Synthesis of cyclic ketone from cyclic amino acid

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542809A (en) 1968-10-23 1970-11-24 Pfizer Synthesis of arylchlorocarbonyl ketenes
EP0100935B1 (en) * 1982-08-12 1986-02-26 Firmenich Sa Spirolactones, their use as perfumes, perfume compositions containing them and process for their preparation
DE3314249A1 (en) * 1983-04-20 1984-10-25 Bayer Ag, 5090 Leverkusen METHOD FOR PRODUCING FLUORINATED PHENYL ACETIC ESTERS AND NEW FLUORINATED TRICHLORETHYLBENZOLES
US4925868A (en) 1986-08-29 1990-05-15 Takeda Chemical Industries, Ltd. 4-Hydroxy-3-pyrrolin-2-ones and treatment of circulatory disorders therewith
US4871719A (en) * 1987-03-24 1989-10-03 Ciba-Geigy Corporation Composition for controlling parasites in productive livestock
US5142065A (en) 1988-08-20 1992-08-25 Bayer Aktiengesellschaft 3-aryl-pyrrolidine-2,4-diones
DE3913682A1 (en) 1989-04-26 1990-10-31 Bayer Ag 3-ARYL-PYRROLIDIN-2,4-DIONE
ES2063108T3 (en) 1989-01-07 1995-01-01 Bayer Ag DERIVATIVES OF 3-ARYL-PIRROLIDIN-2,4-DIONA.
US5186737A (en) 1989-01-07 1993-02-16 Bayer Aktiengesellschaft Pesticidal 3-aryl-pyrrolidine-2,4-diones
DE3929087A1 (en) 1989-09-01 1991-03-07 Bayer Ag 3-ARYL-PYRROLIDIN-2,4-DION DERIVATIVES
US5207817A (en) 1989-09-23 1993-05-04 Bayer Aktiengesellschaft Herbicidal 5H-furan-2-one derivatives
DE4014420A1 (en) 1989-09-23 1991-04-04 Bayer Ag 5H-FURAN-2-ON DERIVATIVES
DE4032090A1 (en) 1990-02-13 1991-08-14 Bayer Ag POLYCYCLIC 3-ARYL-PYRROLIDIN-2,4-DION DERIVATIVES
DE4004496A1 (en) 1990-02-14 1991-08-22 Bayer Ag New 3-aryl-pyrrolidine -2,4-di:one deriv(s) - useful as insecticides, acaricides and herbicides, esp. effective against tetranychus urticae
DE4107394A1 (en) 1990-05-10 1991-11-14 Bayer Ag 1-H-3-ARYL-PYRROLIDIN-2,4-DION DERIVATIVES
US5358924A (en) * 1991-03-21 1994-10-25 Bayer Aktiengesellschaft 3-hydroxy-4-aryl-5-oxo-pyrozoline derivatives, compositions and use
DE4121365A1 (en) * 1991-06-28 1993-01-14 Bayer Ag SUBSTITUTED 1-H-3-ARYL-PYRROLIDIN-2,4-DION DERIVATIVES
DE4216814A1 (en) * 1991-07-16 1993-01-21 Bayer Ag 3-ARYL-4-HYDROXY- (DELTA) (UP ARROW) 3 (UP ARROW) -DIHYDROFURANONE- AND 3-ARYL-4-HYDROXY- (DELTA) (UP ARROW) 3 (UP ARROW) -DIHYDROTHIOPHENONE DERIVATIVES
GB9210393D0 (en) 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
DE4308451A1 (en) * 1992-09-10 1994-04-14 Bayer Ag 3-aryl-pyrone derivatives
AU666040B2 (en) * 1992-10-28 1996-01-25 Bayer Aktiengesellschaft Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
DE4326909A1 (en) * 1992-10-28 1994-05-05 Bayer Ag Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
DE4236400A1 (en) * 1992-10-28 1994-05-05 Bayer Ag N-phenylacetaminonitrile
US5616563A (en) 1992-12-07 1997-04-01 University Of Maryland Baltimore Campus Glutathione N-hydroxycarbamoyl thioesters and method of inhibiting neoplastic growth
DE4243818A1 (en) 1992-12-23 1994-06-30 Bayer Ag 5-aryl-1,3-thiazine derivatives
DE4306259A1 (en) 1993-03-01 1994-09-08 Bayer Ag Dialkyl-1-H-3- (2,4-dimethylphenyl) pyrrolidine-2,4-diones, their preparation and their use
DE4306257A1 (en) 1993-03-01 1994-09-08 Bayer Ag Substituted 1-H-3-phenyl-5-cycloalkylpyrrolidin-2,4-diones, their preparation and their use
AU6845094A (en) 1993-06-07 1995-01-03 Bayer Aktiengesellschaft Iodopropargyl carbamates and their use as biocides in the protection of plants and materials
BR9407046A (en) 1993-07-02 1996-08-13 Bayer Ag Derivatives of 1h-3-aryl-pyrrolidine-2,4-dione spiroheterocyclic substituted processes for their preparation and use as pesticides
DE4415334A1 (en) * 1993-07-02 1995-01-12 Bayer Ag Substituted spirocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives
JP3404747B2 (en) 1993-07-05 2003-05-12 バイエル・アクチエンゲゼルシヤフト Substituted arylketo-enol type heterocyclic compounds
AU7159994A (en) 1993-09-17 1995-03-30 Bayer Aktiengesellschaft 3-aryl-4-hydroxy-delta3-dihydrofuranone derivatives
DE4337853A1 (en) * 1993-09-17 1995-03-23 Bayer Ag 3-aryl-4-hydroxy-DELTA.3 · dihydrofuranone derivatives
DE4425617A1 (en) * 1994-01-28 1995-08-03 Bayer Ag 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
DE4431730A1 (en) 1994-02-09 1995-08-10 Bayer Ag Substituted 1H-3-aryl-pyrrolidine-2,4-dione derivatives
DE4410420A1 (en) * 1994-03-25 1995-09-28 Bayer Ag 3-aryl-4-hydroxy-DELTA · 3 · -dihydrothiophenone derivatives
JP3651897B2 (en) 1994-04-05 2005-05-25 バイエル アクチェンゲゼルシャフト Alkoxy-alkyl-substituted 1-H-3-aryl-pyrrolidine-2,4-diones for use as herbicides and pest control agents
DE4411667A1 (en) 1994-04-05 1995-10-12 Bayer Ag Process for the preparation of substituted phenylacetic acid derivatives and new intermediates
EP0694605B1 (en) 1994-07-01 1999-10-13 Firmenich Sa Cyclic diester and its use as perfuming ingredient
US6096930A (en) * 1994-08-18 2000-08-01 Korea Research Institute Of Chemical Technology Herbicidal cyclohexane-1,3-dione derivatives and their preparation process
DE19540736A1 (en) * 1994-12-23 1996-06-27 Bayer Ag 3-aryl-tetronic acid derivatives
US5830825A (en) * 1994-12-23 1998-11-03 Bayer Aktiengesellschaft 3-aryl-tetronic acid derivatives, the production thereof and the use thereof as antiparasitic agents
CA2186483A1 (en) * 1995-02-03 1996-08-08 Akira Nishiyama Processes for producing .alpha.-halo ketones, .alpha.-halohydrins and epoxides
HUP9800031A3 (en) * 1995-02-13 1998-06-29 Bayer Ag 2-phenyl-substituted heterocyclic ketoenols, intermediates, preparation and use thereof, pesticide and herbicide compositions containing these compounds as active ingredients
DE19543864A1 (en) * 1995-02-13 1996-08-14 Bayer Ag Phenyl-substituted cyclic ketoenols
US5562328A (en) 1995-03-22 1996-10-08 Schottenfeld; Barbara Toy novelty dispenser vehicle
US6316486B1 (en) 1995-05-09 2001-11-13 Bayer Aktiengesellschaft Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
US5616917A (en) 1995-05-16 1997-04-01 Brown & Sharpe Manufacturing Company Device for measuring an angle between pivotally-connected members
GB9512819D0 (en) * 1995-06-23 1995-08-23 Rhone Poulenc Agriculture Herbicides
EP0847977B1 (en) 1995-06-20 2001-08-29 Nippon Soda Co., Ltd. 2,3-dihalogeno-6-trifluoromethylbenzene derivatives and process for producing the same
US6110872A (en) * 1995-06-28 2000-08-29 Bayer Aktiengesellschaft 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
DE19602524A1 (en) * 1995-06-28 1997-01-02 Bayer Ag 2,4,5-trisubstituted phenylketoenols
CA2532743C (en) * 1995-06-30 2008-08-26 Bayer Aktiengesellschaft Intermediates for preparing dialkyl-halogenophenyl-substituted ketoenols
DE19603332A1 (en) * 1995-06-30 1997-01-02 Bayer Ag Dialkyl halophenyl substituted ketoenols
US5795985A (en) * 1996-03-05 1998-08-18 Ciba Specialty Chemicals Corporation Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
ES2128984B1 (en) * 1996-05-24 2000-02-01 Bayer Ag HERBICIDES BASED ON HETEROARILOXI-ACETAMIDAS FOR USE IN RICE CULTIVATION.
US5698708A (en) * 1996-06-20 1997-12-16 Monsanto Company Preparation of substituted 3-aryl-5-haloalkyl-pyrazoles having herbicidal activity
ES2193389T3 (en) * 1996-08-05 2003-11-01 Bayer Cropscience Ag PHENYLCETOENOLS 2-AND 2,5-SUBSTITUTED.
US5998595A (en) 1996-11-05 1999-12-07 Wako Pure Chemical Industries, Ltd. Azidohalogenobenzyl derivatives, sugar compounds and protection of hydroxy groups
WO1999001420A1 (en) 1997-07-03 1999-01-14 Taito Co., Ltd. Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process
US6096929A (en) * 1998-06-02 2000-08-01 Eastman Kodak Company Process for the preparation of thioether-substituted aromatic ketones
DE19846517A1 (en) * 1998-10-09 2000-04-20 Bayer Ag New 3-phenyl-4-hydroxy-2-pyrone derivatives useful as pesticides, herbicides and fungicides
JP2000169419A (en) 1998-12-02 2000-06-20 Central Glass Co Ltd Manufacture of benzoic acids and their esters
US6448204B1 (en) * 1999-11-17 2002-09-10 Basf Aktiengesellschaft Herbicidal 2-aryloxy-4-methyl-6-pyrazol-1-yl-pyridines
US6303812B1 (en) 2000-02-15 2001-10-16 Occidental Chemical Corporation Isolation of products from selective dehalogenation of haloaromatics
US6465509B2 (en) * 2000-06-30 2002-10-15 Merck Frosst Canada & Co. Pyrones as inhibitors of cyclooxygenase-2

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096806A1 (en) * 1998-04-27 2003-05-22 Folker Lieb Arylphenyl-substituted cyclic ketoenols
US6642180B1 (en) 1999-07-30 2003-11-04 Bayer Aktiengesellschaft Biphenyl-substituted cyclic ketoenols as pesticides
US7232845B2 (en) 2000-02-18 2007-06-19 Bayer Cropscience Ag Active substance combinations comprising insecticidal and acaricidal properties
US20060128796A1 (en) * 2000-02-18 2006-06-15 Reiner Fischer Active substance combinations comprising insecticidal and acaricidal properties
US7091233B2 (en) 2000-02-18 2006-08-15 Bayer Aktiengesellschaft Active substance combinations comprising insecticidal and acaricidal properties
US6653343B2 (en) 2000-02-18 2003-11-25 Bayer Aktiengesellschaft Active substance combinations comprising insecticidal and acaricidal properties
US20040044071A1 (en) * 2000-02-18 2004-03-04 Reiner Fischer Active substance combinations comprising insecticidal and acaricidal properties
US20030100604A1 (en) * 2000-03-28 2003-05-29 Reiner Fischer Active substance combinations having insecticidal and acaricidal properties
US6900190B2 (en) 2000-03-28 2005-05-31 Bayer Aktiengesellschaft Active substance combinations having insecticidal and acaricidal properties
US20110183849A1 (en) * 2000-04-03 2011-07-28 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic ketonols
US8334300B2 (en) 2000-04-03 2012-12-18 Bayer Aktiengesellshaft C2-phenyl-substituted cyclic ketonols
US8673818B2 (en) 2000-04-03 2014-03-18 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic ketonols
US7915282B2 (en) 2000-04-03 2011-03-29 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic keto-enols used as pesticides and herbicides
US8193120B2 (en) 2000-04-03 2012-06-05 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic ketonols
US20110143943A1 (en) * 2000-04-03 2011-06-16 Bayer Aktiengesellschaft C2-phenyl-substituted cyclic ketonols
US6762183B2 (en) 2000-04-11 2004-07-13 Bayer Aktiengesellschaft Active substance combinations having insecticidal and acaricidal properties
US7098225B2 (en) 2000-04-11 2006-08-29 Bayer Aktiengesellschaft Active compound combinations having insecticidal and acaricidal properties
US20030211944A1 (en) * 2000-04-11 2003-11-13 Reiner Fischer Active substance combinations having insecticidal and acaricidal properties
US20040209947A1 (en) * 2000-04-11 2004-10-21 Reiner Fischer Active compound combinations having insecticidal and acaricidal properties
US7244750B2 (en) 2000-04-11 2007-07-17 Bayer Cropscience Aktiengesellschaft Active substance combinations having insecticidal and acaricidal properties
US20060167085A1 (en) * 2000-04-11 2006-07-27 Reiner Fischer Active substance combinations having insecticidal and acaricidal properties
US20030185813A1 (en) * 2000-04-14 2003-10-02 Reiner Fischer Active substance combinations with insecticidal and acaricidal properties
US6919090B2 (en) 2000-04-14 2005-07-19 Bayer Aktiengesellschaft Active substance combinations with insecticidal and acaricidal properties
US7214701B2 (en) 2000-05-19 2007-05-08 Bayer Cropscience Ag Active substance combinations having insecticidal and acaricdal properties
US6864276B2 (en) 2000-05-19 2005-03-08 Bayer Cropscience Ag Active substance combinations having insecticidal and acaricidal properties
US20040235934A1 (en) * 2000-05-19 2004-11-25 Reiner Fischer Active substance combinations having insecticidal and acaricdal properties
US20030148999A1 (en) * 2000-06-29 2003-08-07 Reiner Fischer Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US8722070B2 (en) 2000-06-29 2014-05-13 Bayer Cropscience Ag Active compound combinations having insecticidal and acaricidal properties
US6994866B2 (en) 2000-06-29 2006-02-07 Bayer Cropscience Ag Combinations of active ingredients, which exhibit insecticidal and acaricidal properties
US7060692B2 (en) 2000-08-31 2006-06-13 Bayer Cropscience Ag Active ingredient combinations comprising insecticidal and acaricidal properties
US7084138B2 (en) 2000-09-05 2006-08-01 Bayer Cropscience Ag Active ingredient combinations with insecticidal and acaricidal properties
US20040102326A1 (en) * 2000-10-09 2004-05-27 Reiner Fischer Active ingredient combinations with insecticidal, fungicidal and acaricidal properties
US7585887B2 (en) 2000-11-10 2009-09-08 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US8044085B2 (en) 2000-11-10 2011-10-25 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US8962672B2 (en) 2000-11-10 2015-02-24 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US20040161757A1 (en) * 2000-12-14 2004-08-19 Reiner Fischer Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect
US7432225B2 (en) 2001-08-10 2008-10-07 Bayer Cropscience Ag Selective herbicides based on substituted cyclic keto-enols and safeners
US20050054535A1 (en) * 2001-08-10 2005-03-10 Reiner Fischer Selective herbicides based on substituted cyclic keto-enols and safeners
US7183238B2 (en) 2001-12-06 2007-02-27 Bayer Cropscience Ag [1,2]-oxazine-3,5-diones
US8314254B2 (en) 2002-08-28 2012-11-20 Bayer Cropscience Ag Substituted spirocyclic ketoenols
US7754654B2 (en) 2002-08-28 2010-07-13 Bayer Cropscience Ag Substituted spirocyclic ketoenols
US20070275858A1 (en) * 2002-08-28 2007-11-29 Reiner Fischer Substituted spirocyclic ketoenols
US20060160847A1 (en) * 2003-01-20 2006-07-20 Reiner Fischer 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives
US20110092368A1 (en) * 2003-03-14 2011-04-21 Reiner Fischer 2,4,6-Phenyl-substituted cyclic ketoenols
US7888285B2 (en) 2003-03-14 2011-02-15 Bayer Cropscience Ag 2,4,6-phenyl substituted cyclic ketoenols
US7795303B2 (en) 2003-07-08 2010-09-14 Bayer Cropscience Ag Active agents combination exhibiting insecticidal and acaricide properties
US20070142463A1 (en) * 2003-07-08 2007-06-21 Reiner Fischer Active agents combination exhibiting insecticidal and acaricide properties
US8202875B2 (en) 2004-07-20 2012-06-19 Bayer Cropscience Ag Selective insecticides based on substituted cyclic ketoenols and safeners
US20090012152A1 (en) * 2005-01-22 2009-01-08 Bayer Cropscience Aktiengesellschaft Use of Tetramic Acid Derivatives for Controlling Insects from the Genus of the Plane Lice (Sternorrhyncha)
AU2006326300B2 (en) * 2005-12-13 2011-10-27 Bayer Cropscience Aktiengesellschaft Insecticidal compositions having improved effect
US20090099247A1 (en) * 2006-03-08 2009-04-16 Macom Thomas E Use of tetramic acid derivatives for controlling pets by drenching, drip application, dip application or soil injection
AU2007243670B2 (en) * 2006-03-28 2013-09-26 Bayer Intellectual Property Gmbh Use of tetramic acid derivatives for controlling pests by drenching, drip application, dip application or soil injection
AU2007243670C1 (en) * 2006-03-28 2014-04-03 Bayer Intellectual Property Gmbh Use of tetramic acid derivatives for controlling pests by drenching, drip application, dip application or soil injection
US20100173987A1 (en) * 2006-06-16 2010-07-08 Bayer Cropscience Ag Active agent combinations with insecticidal and acaricidal properties
US20090010501A1 (en) * 2007-07-05 2009-01-08 Sony Corporation Image processing apparatus and image processing method
US20110003875A1 (en) * 2008-02-25 2011-01-06 Bayer Cropscience Ag Oil-Based Suspension Concentrates
US9089135B2 (en) 2009-03-25 2015-07-28 Bayer Intellectual Property Gmbh Nematicidal, insecticidal and acaricidal active ingredient combinations comprising pyridyl-ethylbenzamides and insecticides
US20110200571A1 (en) * 2010-02-12 2011-08-18 Bell John W Methods for Reducing Nematode Damage to Plants
WO2012061012A3 (en) * 2010-11-02 2012-07-26 The University Of North Carolina At Chapel Hill 4-amino-2h-pyran-2-one analogs as anticancer agents
US8859782B2 (en) 2011-01-25 2014-10-14 Bayer Cropscience Ag Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US9272997B2 (en) 2011-01-25 2016-03-01 Bayer Intellectual Property Gmbh Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
US8946124B2 (en) 2011-02-17 2015-02-03 Bayer Intellectual Property Gmbh Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy and halogen-substituted spirocyclic ketoenols
US9204640B2 (en) 2011-03-01 2015-12-08 Bayer Intellectual Property Gmbh 2-acyloxy-pyrrolin-4-ones
US8710238B2 (en) 2011-03-11 2014-04-29 Bayer Intellectual Property Gmbh Cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives
US9265252B2 (en) 2011-08-10 2016-02-23 Bayer Intellectual Property Gmbh Active compound combinations comprising specific tetramic acid derivatives
US9198432B2 (en) 2011-08-11 2015-12-01 Bayer Intellectual Property Gmbh 1,2,4-triazolyl-substituted ketoenols
CN106748861A (en) * 2012-03-28 2017-05-31 拜耳知识产权有限责任公司 Preparation of cis-alkoxy-substituted spirophenylacetamido acid esters and spirocyclic 1H-pyrrolidine-2, 4-dione derivatives
US10577320B2 (en) 2016-05-04 2020-03-03 Bayer Cropscience Aktiengesellschaft Method for preparing cis-alkoxy-substituted spirocyclic 1-H-pyrrolidine-2,4-dione derivatives

Also Published As

Publication number Publication date
CN1232450A (en) 1999-10-20
PL331585A1 (en) 1999-07-19
JP4202423B2 (en) 2008-12-24
ES2271170T3 (en) 2007-04-16
CN1651392A (en) 2005-08-10
US6596873B1 (en) 2003-07-22
JP2000516918A (en) 2000-12-19
HU228370B1 (en) 2013-03-28
US6114374A (en) 2000-09-05
US6504036B1 (en) 2003-01-07
US6359151B2 (en) 2002-03-19
CN1931827A (en) 2007-03-21
CN100339352C (en) 2007-09-26
PL201168B1 (en) 2009-03-31
EP0915846A2 (en) 1999-05-19
KR100518374B1 (en) 2005-10-04
DE59712811D1 (en) 2007-03-22
WO1998005638A3 (en) 1998-03-19
TR199900239T2 (en) 1999-03-22
IL128235A0 (en) 1999-11-30
DE59712761D1 (en) 2006-12-14
AU726090B2 (en) 2000-11-02
DK1277749T3 (en) 2007-01-29
CN1240679C (en) 2006-02-08
DK0915846T3 (en) 2003-08-11
DK1277751T3 (en) 2007-02-26
ID19770A (en) 1998-07-30
IL128235A (en) 2004-03-28
NZ334028A (en) 2000-11-24
AU3770697A (en) 1998-02-25
ES2278856T3 (en) 2007-08-16
WO1998005638A2 (en) 1998-02-12
HUP0001833A3 (en) 2001-12-28
DE59712738D1 (en) 2006-11-09
DK1277734T3 (en) 2007-06-04
ES2275796T3 (en) 2007-06-16
HUP0001833A2 (en) 2000-08-28
PT915846E (en) 2003-09-30
KR20000029671A (en) 2000-05-25
US6255342B1 (en) 2001-07-03
BR9711024A (en) 1999-08-17
ES2193389T3 (en) 2003-11-01
EP0915846B1 (en) 2003-04-23
CN1931827B (en) 2012-05-16
BRPI9711024B1 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
US6359151B2 (en) 2- and 2,5-substituted phenylketoenols
US6388123B1 (en) Substituted phenyl keto enols as pesticides and herbicides
US6458965B1 (en) Aryl phenyl substituted cyclic ketoenols
US6288102B1 (en) Substituted phenylketoenols and their use as pesticides and herbicides
US6511942B1 (en) 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
US6316486B1 (en) Alkyl dihalogenated phenyl-substituted ketoenols useful as pesticides and herbicides
US6358887B1 (en) 2-Phenyl-substituted heterocyclic 1,3-ketonols as herbicides and pesticides
US6451843B1 (en) Arylphenyl-substituted cyclic keto enols
US6469196B2 (en) Dialkyl phenyl halide-substituted keto-enols for use as herbicides and pesticides
US6391912B1 (en) Substituted phenylketoenols
KR100517636B1 (en) 2- and 2,5-substituted phenylketoenols

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20140319

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载